Fifteen-year-old	female	patient	previously	healthy	referred	to	our	center	for	presenting	abdominal	pain	vomiting	diarrhea	malar	erythema	palpebral	and	lower	limb	edema	arthralgia	morning	stiffness	and	bilateral	blurred	vision	Laboratory	and	imaging	studies	together	with	the	clinic	allowed	the	diagnosis	of	nephrotic	syndrome	secondary	to	systemic	lupus	erythematosus	Ophthalmology	examination	revealed	a	visual	acuity	of	8	10	in	both	eyes	and	bilateral	disc	edema	with	partial	macular	star	findings	compatible	with	bilateral	neuroretinitis	Renal	biopsy	established	the	diagnosis	of	membranous	lupus	nephritis	Immunosuppressive	treatment	was	started	obtaining	gradual	clinical	improvement	Although	systemic	lupus	erythematosus	with	membranous	lupus	nephritis	and	neuroretinitis	is	a	very	infrequent	association	when	faced	with	a	patient	with	bilateral	neuroretinitis	we	must	consider	systemic	lupus	erythematosus	within	the	differential	diagnoses
The	severity	of	the	2019	coronavirus	disease	COVID-19	and	its	effects	remain	unpredictable	Certain	factors	such	as	obesity	hypertension	and	type	2	diabetes	mellitus	may	increase	the	severity	of	the	disease	Rheumatology	experts	suggest	that	patients	with	active	autoimmune	conditions	and	controlled	autoimmune	diseases	on	immunosuppressive	therapy	may	be	at	higher	risk	of	developing	severe	COVID-19	In	this	retrospective	observational	study	we	aimed	to	examine	the	patterns	of	COVID-19	in	patients	with	underlying	rheumatological	diseases	and	their	association	with	disease	severity	and	hospital	outcomes	A	total	of	34	patients	with	underlying	rheumatological	diseases	who	tested	positive	for	severe	acute	respiratory	syndrome	coronavirus-2	SARS-CoV-2	by	polymerase	chain	reaction	PCR	were	included	between	March	2020	and	April	2021	at	King	Fahd	Hospital	of	the	University	The	study	population	consisted	of	76	47	female	and	23	53	male	patients	with	a	mean	age	ranging	from	20	to	40	years	Female	gender	p	0	0001	and	younger	age	p	0	004	were	associated	with	milder	disease	The	most	frequent	rheumatological	disease	was	systemic	lupus	erythematosus	SLE	38	24	which	was	associated	with	a	milder	infection	p	0	045	Patients	treated	with	mycophenolate	mofetil	MMF	had	a	milder	disease	course	p	0	0037	Hypertension	was	significantly	associated	with	severe	COVID-19	disease	p	0	037	There	was	no	significant	relationship	between	SLE	and	the	need	for	ICU	admission	Patients	on	hydroxychloroquine	and	MMF	tended	to	develop	milder	disease	and	there	was	no	association	between	the	severity	of	the	infection	and	the	treatment	with	steroids
Systemic	lupus	erythematosus	SLE	is	a	systemic	autoimmune	disorder	and	numerous	aberrations	of	T	cell	responses	have	been	reported	and	were	implicated	in	its	pathophysiology	Recently	CD4-positive	T	cells	with	cytotoxic	potential	were	shown	to	be	involved	in	autoimmune	disease	progression	and	tissue	damage	However	the	effector	functions	of	this	cell	type	and	their	potential	molecular	mechanisms	in	SLE	patients	remain	to	be	elucidated	In	this	study	we	find	that	cytotoxic	CD4	CD28-	T	cells	are	expanded	in	SLE	patients	with	flow	cytometry	analysis	and	the	percentage	of	CD4	CD28-	T	cells	positively	correlates	with	the	Systemic	Lupus	International	Collaborating	Clinics	ACR	Damage	Index	SDI	Furthermore	our	study	suggests	that	interleukin-15	IL-15	promotes	the	expansion	proliferation	and	cytotoxic	function	of	CD4	CD28-	T	cells	in	SLE	patients	through	activation	of	the	Janus	kinase3-STAT5	pathway	Further	study	indicates	that	IL-15	not	only	mediates	the	upregulation	of	NKG2D	but	also	cooperates	with	the	NKG2D	pathway	to	regulate	the	activation	of	the	phosphatidylinositol	3-kinase	PI3K	protein	kinase	B	AKT	pathway	Together	our	study	demonstrated	that	proinflammatory	and	cytolytic	CD4	CD28-	T	cells	expand	in	SLE	patients	The	pathogenic	potential	of	these	CD4	CD28-	T	cells	is	driven	by	the	coupling	of	the	IL-15	IL-15R	signaling	pathway	and	the	NKG2D	DAP10	signaling	pathway	which	may	open	new	avenues	for	therapeutic	intervention	to	prevent	SLE	progression
The	goal	of	this	study	was	to	compare	health	care	costs	health	care	resource	utilization	and	adverse	events	associated	with	sustained	oral	corticosteroid	OCS	use	versus	no	OCS	use	in	systemic	lupus	erythematosus


This	OBSErve	Spain	study	a	part	of	the	international	OBSErve	programme	evaluated	belimumab	real-world	use	and	effectiveness	following	6	months	of	treatment	in	patients	with	active	systemic	lupus	erythematosus	SLE	in	clinical	practice	in	Spain
Systemic	lupus	erythematosus	SLE	is	a	chronic	autoimmune	disease	characterized	by	various	autoantibodies	and	multi-organ	Microbiota	dysbiosis	in	the	gut	skin	oral	and	other	surfaces	has	a	significant	impact	on	SLE	development	This	article	summarizes	relevant	research	and	provides	new	microbiome-related	strategies	for	exploring	the	mechanisms	and	treating	patients	with	SLE
To	generate	comparative	efficacy	evidence	of	belimumab	versus	anifrolumab	in	SLE	that	can	inform	treatment	practices
Systemic	lupus	erythematosus	SLE	is	a	prototypical	autoimmune	disease	affecting	multiple	organs	and	tissues	with	high	cellular	heterogeneity	CD8	T	cell	activity	is	involved	in	the	SLE	pathogenesis	However	the	cellular	heterogeneity	and	the	underlying	mechanisms	of	CD8	T	cells	in	SLE	remain	to	be	identified
Systemic	lupus	erythematosus	SLE	is	a	complex	autoimmune	disease	characterized	by	a	heterogeneous	clinical	picture	that	makes	the	diagnosis	and	follow-up	of	these	patients	difficult	This	study	aimed	to	identify	correlations	between	clinical	immunological	and	genetic	biomarkers	and	clinical	manifestations	in	SLE	A	retrospective	study	of	data	from	medical	records	and	immunological	and	genetic	studies	of	SLE	patients	in	Paraguay	was	carried	out	A	descriptive	analysis	was	performed	based	on	the	type	of	variable	Human	leukocyte	antigen	HLA	allele	frequencies	DPA1	DPB1	DQA1	DQB1	and	DRB1	were	calculated	and	univariate	logistic	regression	analyses	were	performed	between	each	of	the	explanatory	variables	and	the	presence	or	absence	of	each	phenotype	Odds	ratios	95	confidence	intervals	and	p	values	were	recorded	Associations	with	p	0	05	were	considered	statistically	significant	104	SLE	patients	were	included	86	were	female	with	a	mean	age	of	32	80	10	36	years	An	association	was	identified	between	anti-double	stranded	DNA	anti-dsDNA	and	the	presence	of	the	renal	phenotype	and	between	anti-dsDNA	and	the	absence	of	the	joint	and	hematological	phenotypes	Immunoglobulin	M	isotype	rheumatoid	factor	was	associated	with	the	absence	of	a	renal	phenotype	HLA-DQB1	02	02	and	HLA-DRB1	07	01	were	associated	with	the	cutaneous	phenotype	An	association	was	identified	between	age	at	disease	onset	over	30	years	and	the	presence	of	the	joint	phenotype	No	other	associations	were	identified	Potential	clinical	immunological	and	genetic	biomarkers	of	phenotypes	have	been	identified	in	SLE	Paraguayan	patients
Endolysosomal	Toll-like	receptors	TLRs	play	crucial	roles	in	immune	responses	to	pathogens	while	aberrant	activation	of	these	pathways	is	associated	with	autoimmune	diseases	including	systemic	lupus	erythematosus	SLE	The	endolysosomal	solute	carrier	family	15	member	4	SLC15A4	is	required	for	TLR7	8	9-induced	responses	and	disease	development	in	SLE	models	SLC15A4	has	been	proposed	to	affect	TLR7-9	activation	through	its	transport	activity	as	well	as	by	assembling	an	IRF5-activating	complex	with	TASL	but	the	relative	contribution	of	these	functions	remains	unclear	Here	we	show	that	the	essential	role	of	SLC15A4	is	to	recruit	TASL	to	endolysosomes	while	its	transport	activity	is	dispensable	when	TASL	is	tethered	to	this	compartment	Endolysosomal-localized	TASL	rescues	TLR7-9-induced	IRF5	activation	as	well	as	interferon	and	cytokine	production	in	SLC15A4-deficient	cells	SLC15A4	acts	as	signaling	scaffold	and	this	function	is	essential	to	control	TLR7-9-mediated	inflammatory	responses	These	findings	support	targeting	the	SLC15A4-TASL	complex	as	a	potential	therapeutic	strategy	for	SLE	and	related	diseases
Lupus	anti-coagulant	hypoprothrombinemia	syndrome	LAHPS	is	a	rare	condition	that	can	be	difficult	to	treat	It	increases	the	risk	of	thrombosis	and	bleeding	due	to	the	presence	of	lupus	anti-coagulant	and	factor	II	deficiency	respectively	There	are	a	limited	number	of	cases	described	in	the	literature	Herein	we	describe	a	case	of	LAHPS	with	bleeding	symptoms	as	a	first	clinical	manifestation	of	systemic	lupus	erythematosus	SLE	in	an	8-year-old	female	She	has	had	multiple	recurrences	of	her	bleeding	symptoms	requiring	treatment	with	steroids	cyclophosphamide	mycophenolate	mofetil	and	rituximab	Her	course	was	later	complicated	by	development	of	arthritis	and	lupus	nephritis	Her	complicated	course	provides	a	new	perspective	on	the	clinical	course	and	treatment	of	LAHPS	We	also	present	a	comprehensive	literature	review	which	demonstrates	the	difficulty	in	treating	patients	with	LAHPS	with	underlying	SLE	and	the	variability	of	the	clinical	course	and	management	of	LAHPS	depending	on	the	age	at	presentation

Proteinuria	is	broadly	classified	into	glomerular	and	tubular	proteinuria	Urinary	beta-2-microglobulin	2-MG	is	known	as	a	marker	for	detecting	tubulointerstitial	diseases	However	tubulointerstitial	damage	can	also	lead	to	an	increase	in	urinary	2-MG	level	in	some	patients	with	glomerular	diseases	This	study	aimed	to	determine	the	ratio	of	urinary	2-MG	to	total	protein	TP	concentration	in	patients	with	both	isolated	tubulointerstitial	and	glomerular	disease
We	aim	to	quantify	the	risk	of	maternal	and	fetal	complications	in	patients	with	SLE	in	order	to	identify	the	impact	of	SLE	on	pregnancy	and	of	pregnancy	on	SLE
Pancytopenia	due	to	systemic	lupus	erythematosus	SLE	is	rarely	reported	and	among	those	reported	it	is	mostly	due	to	immunologically	mediated	cell	destruction	Pancytopenia	due	to	bone	marrow	fibrosis	secondary	to	SLE	is	an	extremely	rare	entity	Myelofibrosis	secondary	to	SLE	per	se	is	reported	only	in	21	cases	in	the	literature	Ours	probably	is	the	22nd	case	report	on	SLE	with	myelofibrosis	Primary	presentation	of	SLE	with	bleeding	manifestation	is	also	a	rare	phenomenon	Partial	to	complete	regression	of	myelofibrosis	is	noted	following	treatment	in	secondary	myelofibrosis	caused	by	SLE	We	report	a	case	of	a	woman	in	her	late	40s	who	presented	to	us	with	bleeding	manifestations	of	petechial	rash	and	menorrhagia	which	on	further	evaluation	showed	pancytopenia	due	to	myelofibrosis	secondary	to	SLE	Our	case	underlines	multiple	features	like	primary	bleeding	manifestation	and	regression	of	myelofibrosis	following	treatment	which	is	rarely	reported	in	association	with	SLE
This	study	is	designed	to	evaluate	the	potential	influences	of	Mediterranean	fever	gene	MEFV	gene	polymorphism	on	systemic	lupus	erythematosus	SLE	in	a	cohort	of	juvenile	patients	A	case-control	study	was	performed	on	Iranian	patients	with	a	mixed	ethnicity	population
Macrophage	activation	syndrome	MAS	is	a	disorder	related	to	hemophagocytic	lymphohistiocytosis	and	is	a	life-threatening	complication	of	rheumatic	diseases	The	diagnosis	is	challenging	because	MAS	symptoms	are	quite	similar	to	those	of	many	active	autoimmune	diseases	or	severe	sepsis	We	describe	the	case	of	a	female	patient	with	systemic	lupus	erythematosus	that	presented	with	symptoms	suggesting	acute	decompensation	of	autoimmune	disease	and	sepsis	She	was	later	diagnosed	with	MAS	Despite	an	aggressive	immunosuppressive	treatment	she	developed	a	fatal	outcome
Several	laboratory	techniques	for	anti	double-stranded	ds	DNA	detection	in	systemic	lupus	erythematosus	SLE	are	available	with	variable	diagnostic	performance	We	aimed	to	evaluate	anti-dsDNA	s	diagnostic	performance	by	indirect	immunofluorescence	IIF	and	enzyme-linked	immunosorbent	assay	EIA
We	aimed	to	explore	the	underlying	pathomechanisms	of	the	comorbidity	between	three	common	systemic	autoimmune	disorders	SADs	i	e	insulin-dependent	diabetes	mellitus	IDDM	systemic	lupus	erythematosus	SLE	and	rheumatoid	arthritis	RA	and	temporal	lobe	epilepsy	TLE	using	bioinformatics	tools	We	hypothesized	that	there	are	shared	genetic	variations	among	these	four	conditions
Cytosolic	5	-nucleotidase	1A	cN-1A	autoantibodies	have	been	recognized	as	myositis-related	autoantibodies	However	their	correlations	with	clinical	characteristics	and	other	myositis-specific	and	myositis-associated	autoantibodies	MSAs	MAAs	are	still	unclear	We	aimed	to	establish	the	prevalence	and	clinical	and	laboratory	associations	of	cN-1A	autoantibodies	in	a	cohort	of	patients	with	connective	tissue	diseases
There	are	relatively	few	studies	investigating	cardiac	structural	and	functional	abnormalities	associated	with	systemic	lupus	erythematous	SLE	The	long-term	prognosis	of	SLE	patients	is	closely	related	to	the	cardiovascular	events	caused	by	SLE	Accordingly	it	is	necessary	to	assess	early	myocardial	systolic	function	and	synchrony
Neuroinflammation	has	been	identified	as	one	of	the	primary	pathogenic	factors	of	neuropsychiatric	systemic	lupus	erythematosus	NPSLE	However	there	are	no	dedicated	treatments	available	in	clinics	to	alleviate	neuroinflammation	in	NPSLE	It	has	been	proposed	that	stimulating	basal	forebrain	BF	cholinergic	neurons	may	provide	potent	anti-inflammatory	effects	in	several	inflammatory	diseases	but	its	potential	role	in	NPSLE	remains	unexplored	This	study	aims	to	investigate	whether	and	how	stimulating	BF	cholinergic	neurons	has	a	protective	effect	on	NPSLE
Serum	from	systemic	lupus	erythematosus	SLE	patients	has	been	shown	to	induce	T-lymphocyte	TL	apoptosis	Given	that	different	cells	of	the	immune	system	display	different	sensitivity	to	apoptosis	we	set	to	evaluate	the	in	vitro	effect	of	SLE	serum	on	regulatory	T-cells	Treg	Th17	Th1	and	Th2	from	SLE	patients	and	healthy	controls
To	evaluate	the	utility	of	neutrophil	to	lymphocyte	ratio	NLR	systemic	immune-inflammation	index	SII	and	systemic	immune-response	index	SIRI	in	the	prediction	of	adverse	pregnancy	outcomes	in	pregnant	women	with	systemic	lupus	erythematosus	SLE	This	retrospective	case-control	study	was	conducted	in	Ankara	City	Hospital	perinatology	clinic	between	2019	and	2023	First-trimester	NLR	SII	NLR	X	platelet	count	and	SIRI	NLR	X	monocyte	count	values	were	compared	between	pregnant	women	with	SLE	n	29	and	low-risk	controls	n	110	Afterward	pregnant	women	with	SLE	were	divided	into	two	groups	1	SLE	with	perinatal	complications	n	15	and	2	SLE	without	perinatal	complications	n	14	NLR	SII	and	SIRI	values	were	compared	between	the	two	subgroups	Finally	a	ROC	analysis	was	performed	to	determine	optimal	cut-off	values	for	NLR	SII	and	SIRI	in	the	prediction	of	composite	adverse	pregnancy	outcomes	The	study	group	had	significantly	higher	first-trimester	NLR	SII	and	SIRI	values	compared	to	the	controls	The	SLE	with	perinatal	complications	group	had	significantly	higher	NLR	SII	and	SIRI	values	than	the	SLE	group	without	perinatal	complications	p	0	05	Optimal	cut-off	values	were	6	5	66	7	sensitivity	71	4	specificity	1612	6	73	3	sensitivity	71	4	specificity	and	4	7	73	3	sensitivity	77	6	specificity	for	NLR	SII	and	SIRI	respectively	SII	SIRI	and	NLR	may	be	used	to	predict	adverse	pregnancy	outcomes	in	pregnant	women	with	SLE
Treat-to-target	T2T	is	a	therapeutic	strategy	currently	being	studied	for	its	application	in	systemic	lupus	erythematosus	SLE	Patients	and	rheumatologists	have	little	support	in	making	the	best	treatment	decision	in	the	context	of	a	T2T	strategy	thus	the	use	of	information	technology	for	systematically	processing	data	and	supporting	information	and	knowledge	may	improve	routine	decision-making	practices	helping	to	deliver	value-based	care
Global	myocardial	work	MW	is	a	novel	indicator	that	accounts	for	deformation	and	afterload	which	may	provide	additional	value	for	assessment	of	myocardial	function	Non-invasive	echocardiographic	estimated	left	ventricular	LV	MW	incorporates	longitudinal	strain	curves	and	blood	pressure	data	This	study	sought	to	assess	MW	in	systemic	lupus	erythematosus	SLE	patients	with	normal	LV	ejection	fraction	LVEF	by	two-dimensional	speckle-tracking	imaging	2D-STI	to	reflect	subclinical	myocardial	damage
Frailty	is	a	risk	factor	for	adverse	health	in	adults	with	SLE	including	those	65	years	Emergency	department	ED	utilisation	is	high	in	adults	with	SLE	but	to	our	knowledge	whether	frailty	is	associated	with	ED	use	is	unknown	In	a	large	administrative	claims	dataset	we	assessed	risk	of	ED	utilisation	among	frail	adults	with	SLE	65	years	of	age	relative	to	non-frail	adults	65	years	of	age	with	SLE
There	is	a	paucity	of	studies	assessing	multidisciplinary	interventions	focused	on	tackling	physical	inactivity	sedentary	behavior	and	poor	dietary	habits	in	SLE	The	Living	well	with	Lupus	LWWL	is	a	randomized	controlled	trial	to	investigate	whether	a	six-month	lifestyle	change	intervention	will	improve	cardiometabolic	risk	factors	primary	outcome	among	systemic	lupus	erythematosus	SLE	patients	with	low	disease	activity	SLEDAI	score	4	and	with	high	cardiovascular	risk	As	secondary	goals	we	will	evaluate	1	the	intervention	s	safety	efficacy	and	feasibility	in	promoting	lifestyle	changes	and	2	the	effects	of	the	intervention	on	secondary	outcomes	i	e	clinical	parameters	functional	capacity	fatigue	psychological	aspects	sleep	quality	and	health-related	quality	of	life	Patients	will	be	randomly	allocated	to	either	a	control	i	e	standard	care	or	a	lifestyle	intervention	group	using	a	simple	randomization	1	1	ratio	blocks	of	20	Mixed	Model	analyses	will	be	conducted	for	comparing	groups	following	an	intention-to-treat	approach	A	per	protocol	analysis	will	also	be	conducted	This	study	has	the	potential	to	generate	new	clinically	relevant	data	able	to	refine	the	multidisciplinary	management	of	SLE	patients	Protocol	version	number	NCT04431167	first	version
A	preliminary	definition	of	disease	modification	DM	in	lupus	nephritis	LN	was	recently	developed	focusing	on	long-term	remission	and	damage	prevention	with	minimal	treatment-associated	toxicity	We	aimed	to	further	specify	aspects	of	DM	criteria	in	LN	assess	DM	achievement	in	a	real-world	setting	and	examine	potential	DM	predictors	and	long-term	outcomes
Granulomatosis	with	Polyangiitis	GPA	is	a	small	vessel	vasculitis	typically	associated	with	release	of	neutrophil	extracellular	traps	NETs	by	activated	neutrophils	In	this	study	we	further	aimed	to	investigate	the	contributions	of	neutrophils	and	NETs	to	the	complex	disease	pathogenesis	We	characterized	the	phenotype	of	neutrophils	and	their	capacity	to	induce	NETs	In	addition	the	level	of	circulating	NETs	determined	by	neutrophil	elastase	DNA	complexes	and	the	capacity	of	patient	sera	to	degrade	NETs	were	investigated	from	blood	samples	of	12	GPA	patients	21	patients	with	systemic	lupus	erythematosus	SLE	and	21	healthy	donors	HD	We	found	that	GPA	patients	had	significantly	increased	levels	of	low-density	granulocytes	LDGs	compared	to	HD	which	displayed	an	activated	and	more	immature	phenotype	While	the	propensity	of	normal-density	granulocytes	to	release	NETs	and	the	levels	of	circulating	NETs	were	not	significantly	different	from	HD	patient	sera	from	GPA	patients	degraded	NETs	less	effectively	which	weakly	correlated	with	markers	of	disease	activity	In	conclusion	increased	levels	of	immature	and	activated	LDGs	and	altered	degradation	of	circulating	NETs	may	contribute	to	pathogenesis	of	GPA	potentially	by	providing	a	source	of	autoantigens	that	trigger	or	further	enhance	autoimmune	responses
Neonatal	lupus	erythematosus	NLE	is	a	very	rare	autoimmune	disease	occurring	in	neonates	born	to	mothers	who	present	auto-antibodies	to	cytoplasmic	antigens	of	Sj	gren	s	syndrome	In	most	cases	the	clinical	course	is	benign	toward	spontaneous	resolution	but	there	is	a	group	of	patients	who	develop	severe	involvement	of	the	cardiac	conduction	system	therefore	early	detection	is	critical
The	kidney	is	a	comparatively	hostile	microenvironment	characterized	by	highsodium	concentrations	however	lymphocytes	infiltrate	and	survive	therein	in	autoimmune	diseases	such	as	lupus	The	effects	of	sodium-lymphocyte	interactions	on	tissue	injury	in	autoimmune	diseases	and	the	mechanisms	used	by	infiltrating	lymphocytes	to	survive	the	highsodium	environment	of	the	kidney	are	not	known	Here	we	show	that	kidney-infiltrating	B	cells	in	lupus	adapt	to	elevated	sodium	concentrations	and	that	expression	of	sodium	potassium	adenosine	triphosphatase	Na	-K	-ATPase	correlates	with	the	ability	of	infiltrating	cells	to	survive	Pharmacological	inhibition	of	Na	-K	-ATPase	and	genetic	knockout	of	Na	-K	-ATPase	subunit	resulted	in	reduced	B	cell	infiltration	into	kidneys	and	amelioration	of	proteinuria	B	cells	in	human	lupus	nephritis	biopsies	also	had	high	expression	of	Na	-K	-ATPase	Our	study	reveals	that	kidney-infiltrating	B	cells	in	lupus	initiate	a	tissue	adaption	program	in	response	to	sodium	stress	and	identifies	Na	-K	-ATPase	as	an	organ-specific	therapeutic	target
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	disease	characterized	by	T-cell	immune-dysregulation	and	loss	of	tolerance	to	self-antigens	CTLA-4	and	PTPN-22	are	involved	in	the	inhibition	of	T-lymphocytes	activation	IL-37	is	an	anti-inflammatory	cytokine	that	suppresses	innate	immunity	The	relative	expression	of	CTLA-4	IL-37	and	PTPN-22	were	evaluated	as	negative	regulators	of	immune	response	in	SLE	patients	lupus	nephritis	LN	and	disease	activity
Interleukin	10	IL-10	plays	a	role	in	inflammation	and	cell-type	responses	The	anti-SS-A	Ro	antibody	contributes	to	leucopenia	and	cutaneous	and	neonatal	lupus
BACKGROUND	Lupus	erythematosus	LE	is	mainly	clinically	divided	into	cutaneous	lupus	erythematosus	CLE	and	systemic	lupus	erythematosus	SLE	depending	on	the	presence	of	multi-system	manifestations	The	most	common	subtype	of	CLE	is	discoid	lupus	erythematosus	DLE	Graves	disease	GD	is	immunologically	characterized	by	lymphocytic	infiltration	of	the	thyroid	gland	and	the	presence	of	thyroid-stimulating	hormone	TSH	receptor	antibodies	TSH-R-Ab	and	is	the	most	common	autoimmune	pathogenic	cause	of	hyperthyroidism	Autoimmune	thyroid	dysfunction	has	been	widely	described	in	association	with	rheumatic	diseases	A	certain	rate	of	coexistence	of	GD	with	LE	mainly	SLE	has	been	reported	in	the	literature	Herein	we	present	a	rare	case	of	Graves	hyperthyroidism	complicated	with	DLE	CASE	REPORT	A	30-year-old	female	patient	with	a	history	of	hyperthyroidism	and	discontinued	methimazole	treatment	initially	presented	with	symptoms	of	infection	and	oral	ulcers	Thyroid	hormone	thyroid-stimulating	hormone	receptor	antibody	and	immunological	tests	were	consistent	with	a	diagnosis	of	Graves	hyperthyroidism-associated	DLE	Corticosteroids	and	radioactive	iodine	RAI	were	used	to	treat	DLE	and	GD	respectively	Post-treatment	evaluation	suggested	the	remission	of	her	hyperthyroidism	and	active	DLE	CONCLUSIONS	Autoimmune	thyroid	diseases	have	been	previously	described	in	association	with	rheumatic	diseases	This	association	shows	the	importance	of	prompt	awareness	of	the	increased	risk	of	DLE	when	evaluating	autoimmune	thyroid	dysfunction	especially	under	certain	conditions	such	as	after	treatment	with	anti-thyroid	drugs	ATDs	or	in	the	absence	of	multiple	organ	damage	manifestations	of	SLE
Glucocorticoid	receptor	GR	is	expressed	in	normal	renal	podocytes	however	its	expression	differs	among	renal	diseases	The	expression	of	GR	as	well	as	its	epigenetic	regulators	microRNA	miR	30a	miR24	and	miR370	was	studied	in	the	renal	tissues	of	patients	with	systemic	lupus	nephritis	LN	minimal	changes	disease	MCD	and	pauci-immune	glumeronephritis	PIN	A	total	of	51	patients	undergoing	renal	biopsy	and	22	nephrectomised	controls	with	no	history	of	parenchymal	renal	disease	were	recruited	from	the	Clinic	of	Nephrology	and	Renal	Transplantation	of	General	Laikon	hospital	between	November	2016	and	March	2019	All	patients	were	newly-diagnosed	and	they	were	na	ve	of	any	treatment	The	mRNA	and	protein	expression	were	analyzed	through	reverse	transcription-quantitative	PCR	and	immunohistochemistry	respectively	Written	consent	was	obtained	from	all	participants	GR	mRNA	expression	was	significantly	reduced	in	all	pathological	samples	compared	with	the	normal	renal	tissues	used	as	controls	P	0	023	for	LN	P	0	05	for	MCD	and	P	0	004	for	PIN	Similarly	GR	protein	expression	was	lower	in	all	pathological	samples	6	GR	positive	podocytes	glomerulus	in	50	of	patients	with	LN	and	MCD	and	18	with	PIN	compared	with	controls	6	positive	podocytes	glomerulus	in	all	the	controls	PIN	samples	presented	significantly	lower	GR	mRNA	and	protein	expression	compared	with	LN	and	MCD	samples	No	significant	differences	were	observed	in	the	miR30a	expression	when	comparing	pathological	with	normal	renal	samples	miR24	and	miR370	expression	demonstrated	statistically	significant	difference	in	all	pathological	compared	with	normal	tissues	Moreover	GR	expression	was	not	significantly	associated	with	either	LN	disease	activity	score	or	the	response	to	the	treatment	GR	and	miR24	expression	was	significantly	reduced	whereas	miR370	significantly	increased	in	all	pathological	compared	with	normal	renal	tissues	implying	their	protentional	role	in	nephritis	pathogenesis	and	treatment	Analysis	of	larger	samples	are	required	for	more	robust	statistical	analysis
The	presence	of	antiphospholipid	antibodies	aPLs	plays	a	pivotal	role	in	the	pathogenesis	of	antiphospholipid	antibody	syndrome	APS	This	study	aimed	to	examine	the	diagnostic	value	of	a	set	of	non-criteria	aPLs	and	their	relevance	with	APS-related	criteria	and	extra-criteria	manifestations
Systemic	lupus	erythematosus	SLE	is	a	systemic	autoimmune	disorder	caused	by	the	loss	of	tolerance	to	endogenous	nuclear	antigens	such	as	double	stranded	DNA	leading	to	the	proliferation	of	T	cells	and	subsequent	activation	of	B	cells	which	results	in	serious	organ	damage	and	life	threatening	complications	such	as	lupus	nephritis	Lupus	nephritis	LN	develops	as	a	frequent	complication	of	SLE	accounting	for	60	of	SLE	cases	and	is	characterized	by	proteinuria	and	heterogeneous	histopathological	findings	Glomerular	injury	serves	a	role	in	proteinuria	as	podocyte	damage	is	the	leading	contributor	Numerous	studies	have	reported	that	podocytes	are	involved	in	the	immune	response	that	promotes	LN	progression	In	LN	immune	complex	deposition	stimulates	dendritic	cells	to	secrete	inflammatory	cytokines	that	activate	T	cells	and	B	cells	B	cells	secrete	autoantibodies	that	attack	and	damage	the	renal	podocytes	leading	to	renal	podocyte	injury	The	injured	podocytes	trigger	inflammatory	cells	through	the	expression	of	toll	like	receptors	and	trigger	T	cells	through	major	histocompatibility	complexes	and	CD86	thereby	participating	in	the	local	immune	response	and	the	exacerbation	of	podocyte	injury	Based	on	the	existing	literature	the	present	review	summarizes	the	research	progress	of	podocytes	in	LN	under	the	local	immune	microenvironment	of	the	kidney	explores	the	mechanism	of	podocyte	injury	under	the	immune	microenvironment	and	evaluates	podocytes	as	a	potential	therapeutic	target	for	LN
Quality	of	life	QoL	is	an	important	measure	in	health	assessment	It	is	impacted	by	unclear	factors	in	Systemic	Lupus	Erythematosus	SLE	patients	The	study	aimed	to	investigate	the	factors	related	to	QoL	in	SLE	patients
Fatigue	is	one	of	the	most	common	complaints	and	is	a	potentially	modifiable	issue	in	systemic	lupus	erythematosus	SLE	Studies	suggest	that	alcohol	consumption	has	a	protective	effect	against	the	development	of	SLE	however	an	association	between	alcohol	consumption	and	fatigue	in	patients	with	SLE	has	not	been	studied	Here	we	assessed	whether	alcohol	consumption	was	associated	with	fatigue	using	lupus	patient-reported	outcomes	LupusPRO
Systemic	Lupus	Erythematosus	SLE	occurs	in	the	reproductive	age	group	Renal	involvement	occurs	less	frequently	in	late-onset	SLE	than	in	reproductive-age	SLE	patients	Here	we	aimed	to	study	the	clinical	serological	and	histopathological	characteristics	of	late-onset	lupus	nephritis	LN	Late-onset	LN	was	defined	as	disease	onset	after	47	years	of	age	corresponding	to	the	average	menopausal	age	Records	of	biopsy	proven	late-onset	lupus	nephritis	patients	diagnosed	between	June	2000	and	June	2020	were	reviewed	Late-onset	LN	constituted	53	of	4420	patients	1	2	biopsied	during	the	study	period	Females	represented	90	65	of	the	cohort	Mean	age	of	the	cohort	was	49	5	7	05	years	at	the	time	of	SLE	diagnosis	while	its	renal	presentation	was	delayed	by	median	duration	of	10	months	IQR	3-48	months	Renal	failure	was	present	in	28	patients	52	8	with	acute	kidney	injury	AKI	28	3	n	15	as	the	most	common	presentation	On	histopathological	analysis	class	IV	was	observed	in	23	patients	43	5	crescents	were	observed	in	one-third	cases	and	lupus	vasculopathy	in	4	patients	7	5	All	patients	received	steroids	Majority	of	patients	43	3	n	23	received	Euro	lupus	protocol	for	induction	On	median	follow	up	duration	of	82	months	renal	flares	were	noted	in	9	patients	17	and	8	patients	15	1	became	dialysis	dependent	Among	11	patients	21	with	infectious	complications	7	patients	13	2	suffered	from	tuberculosis	Infections	caused	three-fourth	of	the	deaths	Late-onset	lupus	nephritis	is	rare	and	presents	as	renal	failure	in	majority	Renal	biopsy	affects	the	clinical	decision	of	judicious	use	of	immunosuppression	which	is	imperative	due	to	high	rate	of	infections	in	this	cohort
Dynamic	susceptibility	contrast	DSC	magnetic	resonance	imaging	MRI	has	previously	shown	alterations	in	cerebral	perfusion	in	patients	with	systemic	lupus	erythematosus	SLE	However	the	results	have	been	inconsistent	in	particular	regarding	neuropsychiatric	NP	SLE	Thus	we	investigated	perfusion-based	measures	in	different	brain	regions	in	SLE	patients	with	and	without	NP	involvement	and	additionally	in	white	matter	hyperintensities	WMHs	the	most	common	MRI	pathology	in	SLE	patients
Systemic	lupus	erythematosus	SLE	is	a	rare	chronic	autoimmune	inflammatory	disease	with	a	prevalence	varying	from	4	3	to	150	people	in	100	000	or	approximately	five	million	people	worldwide	Systemic	manifestations	frequently	include	internal	organ	involvement	a	characteristic	malar	rash	on	the	face	pain	in	joints	and	muscles	and	profound	fatigue	Exercise	is	purported	to	be	beneficial	for	people	with	SLE	For	this	review	we	focused	on	studies	that	examined	all	types	of	structured	exercise	as	an	adjunctive	therapy	in	the	management	of	SLE
Concerns	about	the	affordability	of	medications	are	common	in	systemic	lupus	erythematosus	SLE	but	the	relationship	between	medication	cost	concerns	and	health	outcomes	is	poorly	understood	We	assessed	the	association	of	self-reported	medication	cost	concerns	and	patient-reported	outcomes	PROs	in	a	multiethnic	SLE	cohort
Despite	advances	in	general	and	targeted	immunosuppressive	therapies	limiting	all	mainstay	treatment	options	in	refractory	systemic	lupus	erythematosus	SLE	cases	has	necessitated	the	development	of	new	therapeutic	strategies	Mesenchymal	stem	cells	MSCs	have	recently	emerged	with	unique	properties	including	a	solid	propensity	to	reduce	inflammation	exert	immunomodulatory	effects	and	repair	injured	tissues
Systemic	lupus	erythematosus	SLE	is	a	heterogeneous	disease	with	multiple	clinical	manifestations	which	causes	a	significant	deterioration	in	the	quality	of	life	QoL	The	Systemic	Lupus	Erythematosus	Quality	of	Life	Questionnaire	L-QoL	is	a	lupus-specific	measure	used	to	determine	the	burden	of	the	disease	and	it	applies	the	need-based	model	of	QoL	Our	aim	was	to	produce	the	first	successfully	validated	foreign	language	version	of	the	questionnaire
Systemic	lupus	erythematosus	SLE	is	a	systemic	autoimmune	complex	disease	that	affects	any	organ	characterized	by	immune	complex	formation	and	autoantibody	production	Lupus	vasculitis	begins	at	a	young	age	These	patients	generally	have	a	longer	disease	duration	Ninety	percent	of	cases	in	lupus-associated	vasculitis	present	with	cutaneous	vasculitis	Disease	activity	severity	organ	involvement	response	to	treatment	and	drug	toxicity	determine	the	frequency	of	outpatient	control	in	lupus	Depression	and	anxiety	are	observed	more	frequently	in	SLE	than	in	the	normal	population	Our	case	it	is	an	example	of	the	patient	s	disruption	of	controls	due	to	psychological	trauma	and	that	lupus	can	cause	serious	cutaneous	vasculitis	In	addition	psychiatric	evaluation	of	lupus	cases	from	the	time	of	diagnosis	may	have	a	positive	effect	on	the	prognosis
Urine	neutrophil	gelatinase-associated	lipocalin	NGAL	is	a	marker	of	acute	kidney	injury	and	indicates	tubular	damage	Lupus	nephritis-associated	renal	injury	is	characterized	by	damage	to	the	glomeruli	and	tubular	portions	of	the	kidneys	Therefore	NGAL	concentrations	are	expected	to	vary	according	to	the	severity	of	systemic	lupus	erythematosus	SLE	In	this	study	samples	from	NZB	NZW	F1	mice	at	an	advanced	stage	of	SLE	were	used	to	determine	whether	serum	and	urine	NGAL	concentrations	or	the	urine	NGAL	creatinine	uNGAL	C	ratio	can	be	used	to	reflect	diet	disease	state	and	treatment	efficacy	Additionally	the	relationship	between	the	levels	of	NGAL	and	various	cytokines	in	the	serum	in	SLE	was	evaluated	Mice	were	divided	into	the	following	four	groups	n	15	CN	chow	diet	and	no	treatment	saline	intraperitonially	injected	i	p	200	L	day	CP	chow	diet	and	methylprednisolone	i	p	5	mg	kg	day	HN	high-fat	diet	and	no	treatment	saline	i	p	200	L	day	and	HP	high-fat	diet	and	methylprednisolone	treatment	i	p	5	mg	kg	day	every	day	from	6	to	42	weeks	of	age	The	serum	and	urine	NGAL	levels	and	uNGAL	C	values	were	significantly	lower	in	the	CP	group	than	those	in	the	CN	group	Further	serum	NGAL	concentration	demonstrated	a	strong	positive	correlation	with	urine	NGAL	levels	uNGAL	C	urine	protein	concentrations	urine	protein	creatinine	ratio	and	the	expression	of	several	cytokines	associated	with	SLE	pathogenesis	interleukin	IL	-6	tumor	necrosis	factor	TNF	-	and	interferon-induced	protein	IP	-10	These	results	suggest	that	NGAL	has	a	strong	positive	correlation	with	the	clinicopathological	parameters	and	several	key	cytokines	in	SLE
Diffuse	alveolar	haemorrhage	DAH	is	a	rare	but	life-threatening	complication	of	systemic	lupus	erythematosus	SLE	We	describe	the	clinical	characteristics	treatment	and	survival	outcomes	of	SLE	patients	with	DAH	in	Singapore
Metabolic	rewiring	underlies	the	effector	functions	of	macrophages1-3	but	the	mechanisms	involved	remain	incompletely	defined	Here	using	unbiased	metabolomics	and	stable	isotope-assisted	tracing	we	show	that	an	inflammatory	aspartate-argininosuccinate	shunt	is	induced	following	lipopolysaccharide	stimulation	The	shunt	supported	by	increased	argininosuccinate	synthase	ASS1	expression	also	leads	to	increased	cytosolic	fumarate	levels	and	fumarate-mediated	protein	succination	Pharmacological	inhibition	and	genetic	ablation	of	the	tricarboxylic	acid	cycle	enzyme	fumarate	hydratase	FH	further	increases	intracellular	fumarate	levels	Mitochondrial	respiration	is	also	suppressed	and	mitochondrial	membrane	potential	increased	RNA	sequencing	and	proteomics	analyses	demonstrate	that	there	are	strong	inflammatory	effects	resulting	from	FH	inhibition	Notably	acute	FH	inhibition	suppresses	interleukin-10	expression	which	leads	to	increased	tumour	necrosis	factor	secretion	an	effect	recapitulated	by	fumarate	esters	Moreover	FH	inhibition	but	not	fumarate	esters	increases	interferon-	production	through	mechanisms	that	are	driven	by	mitochondrial	RNA	mtRNA	release	and	activation	of	the	RNA	sensors	TLR7	RIG-I	and	MDA5	This	effect	is	recapitulated	endogenously	when	FH	is	suppressed	following	prolonged	lipopolysaccharide	stimulation	Furthermore	cells	from	patients	with	systemic	lupus	erythematosus	also	exhibit	FH	suppression	which	indicates	a	potential	pathogenic	role	for	this	process	in	human	disease	We	therefore	identify	a	protective	role	for	FH	in	maintaining	appropriate	macrophage	cytokine	and	interferon	responses

NLRC4	gain-of-function	variants	are	known	to	cause	various	autoinflammatory	phenotypes	including	familial	cold	autoinflammatory	syndrome	FCAS4	and	NLRC4	macrophage	activation	syndrome	NLRC4-MAS	However	to	date	no	study	has	linked	NLRC4	gain-of-function	variants	to	systemic	lupus	erythematosus	SLE	In	this	study	we	identified	a	novel	NLRC4	W655S	variant	in	an	SLE	patient	and	her	son	who	had	neonatal	lupus	complicated	with	macrophage	activation	syndrome	Our	in	vitro	experiments	demonstrated	that	the	W655S	NLRC4	increased	ASC	speck	formation	and	mature	IL-1	secretion	compared	to	the	wild-type	NLRC4	In	addition	the	patient	had	elevated	levels	of	IL-1	and	IL-18	in	both	serum	and	PBMCs	RNA	sequencing	showed	that	NF-	B	and	interferon	signaling	pathways	were	significantly	activated	in	the	patient	compared	to	healthy	controls	Furthermore	gene	set	enrichment	analysis	revealed	upregulation	of	NLRC4-related	pathways	in	patient	PBMCs	In	conclusion	our	study	identified	the	NLRC4	W655S	variant	in	a	patient	with	SLE	This	is	the	first	report	linking	inflammasomopathy	to	monogenic	SLE	Our	findings	suggest	that	inflammasome	activation	may	be	a	critical	driver	in	the	pathogenicity	of	lupus	and	autoinflammatory	pathways	may	play	important	roles	in	the	development	of	the	disease
Lupus	nephritis	LN	is	a	major	course	of	morbidity	and	mortality	in	patients	with	systemic	lupus	erythematosus	SLE	best	managed	by	a	multidisciplinary	group	To	this	end	we	gathered	a	group	of	rheumatologists	nephrologists	and	a	nephropathologist	to	review	current	evidence	regarding	diagnosis	and	management	of	LN	In	this	consensus	paper	we	summarize	the	key	points	from	this	meeting	and	provide	practice	guidelines	for	the	management	of	kidney	involvement	in	SLE	in	view	of	emerging	new	data	concerning	novel	agents	approved	recently	Renal	biopsy	is	indispensable	for	the	management	of	LN	Yet	important	pearls	and	pitfalls	need	to	be	considered	regarding	indications	and	interpretation	which	are	summarized	in	informative	tables	In	new-onset	LN	experts	agreed	that	although	belimumab	may	be	added	from	disease	onset	patients	with	moderate	to	severe	proliferative	nephritis	defined	as	NIH	activity	index	5	plus	1	of	the	following	i	NIH	chronicity	index	2	ii	proteinuria	3	g	24	h	and	iii	increase	in	serum	creatinine	20	may	be	more	likely	to	benefit	the	most	In	all	other	patients	who	have	already	started	standard-of-care	treatment	with	either	mycophenolate	mofetil	MMF	or	cyclophosphamide	CY	belimumab	could	be	considered	in	cases	with	an	inadequate	clinical	response	by	3	months	or	in	cases	that	experience	a	nephritic	flare	following	initial	response	or	have	an	inability	to	reduce	the	dose	of	glucocorticoids	In	all	circumstances	the	drug	should	be	given	as	add-on	therapy	that	is	in	combination	with	a	standard-of-care	therapy	MMF	or	CY	Voclosporin	could	be	considered	for	up	to	3	years	in	combination	with	MMF	in	patients	with	heavy	proteinuria	well	above	the	nephrotic	range	wherein	a	quick	reduction	of	protein	loss	in	urine	is	desirable	to	avoid	the	complications	of	the	nephrotic	syndrome	either	as	part	of	the	initial	regimen	or	in	cases	of	inadequate	reduction	of	proteinuria	with	MMF	In	view	of	the	potential	scarring	effects	long-term	administration	beyond	the	first	year	requires	further	documentation
Objective	To	explore	the	role	of	autophagy	apoptosis	of	neutrophils	and	neutrophils	extracellular	traps	NET	formation	in	systemic	lupus	erythematosus	SLE	Methods	Thirty-six	patients	with	SLE	were	recruited	as	research	subjects	and	32	healthy	controls	matched	accordingly	were	enrolled	as	control	subjects	The	expression	levels	of	microtubule	associated	protein	1	light	chain	3B	LC3B	autophagy-related	gene5	ATG5	P62	B-cell	lymphoma	2	Bcl2	Bcl2-related	X	protein	BAX	in	neutrophils	were	detected	by	Western	blot	analysis	Flow	cytometry	was	employed	to	analyze	the	expression	of	LC3B	on	neutrophils	The	expression	level	of	myeloperoxidase	MPO	in	plasma	was	estimated	by	ELISA	Furthermore	neutrophils	were	cultured	in	vitro	and	stimulated	by	100	nmol	L	rapamycin	and	10	g	mL	lipopolysaccharide	LPS	for	6	hours	respectively	And	then	the	expression	levels	of	LC3B	ATG5	P62	Bcl2	and	BAX	in	neutrophils	were	detected	by	Western	blot	analysis	The	level	of	MPO	in	culture	supernatant	was	detected	by	ELISA	The	change	of	fluorescence	intensity	of	NET	in	culture	supernatant	was	assayed	by	SytoxTM	Green	staining	combined	with	fluorescence	spectrophotometry	Results	Compared	with	healthy	controls	the	levels	of	autophagy	and	apoptosis	of	neutrophils	and	NET	formation	in	SLE	patients	were	increased	The	level	of	apoptosis	and	NET	formation	was	positively	associated	with	neutrophil	autophagy	The	level	of	autophagy	showed	an	increase	but	had	no	effect	on	apoptosis	and	NET	formation	for	neutrophil	stimulated	by	rapamycin	The	levels	of	autophagy	and	NET	formation	also	increased	with	no	significant	effect	on	apoptosis	for	neutrophil	induced	by	LPS	Conclusion	The	autophagy	apoptosis	and	NET	formation	of	neutrophils	increase	in	SLE	patients	The	activation	of	autophagy	and	NET	in	neutrophils	possibly	result	from	the	inflammatory	internal	environment	in	SLE	patients
Antiphospholipid	antibodies	APLAs	are	primarily	directed	toward	phospholipid-binding	proteins	and	are	responsible	for	thrombotic	events	APLAs	include	anti-	2Glycoprotein	I	anti-	2GPI	anticardiolipin	anti-CL	antibodies	and	lupus	anticoagulant	These	antibodies	are	typical	markers	of	antiphospholipid	syndrome	APS	and	are	a	part	of	its	diagnostic	criteria	Many	data	underline	the	presence	of	APLAs	in	other	rheumatic	diseases	e	g	systemic	lupus	erythematosus	systemic	sclerosis	Sj	gren	s	syndrome	rheumatoid	arthritis	and	Beh	et	s	disease	However	they	are	also	detected	in	patients	with	cancer	infection	and	neurological	disorders	Furthermore	healthy	individuals	may	be	carriers	of	APLAs	Chronic	asymptomatic	APLAs	presence	is	most	common	in	the	elderly	and	subjects	with	chronic	diseases	including	malignancies	Specific	kinds	of	APLAs	are	considered	markers	of	oncological	progression	These	antibodies	occur	in	6	of	pregnant	women	without	diagnosed	APS	and	are	related	to	many	pregnancy	complications	Of	worth	various	types	of	APLAs	are	reported	to	have	different	prothrombotic	properties	The	risk	of	thrombotic	events	in	APLA-positive	but	clinically	na	ve	patients	raises	many	questions	in	clinical	practice	This	manuscript	analyses	various	clinical	situations	and	consequences	of	the	APLAs	presence	particularly	in	patients	without	diagnosed	APS	The	prevalence	etiology	molecular	background	and	prothrombotic	properties	of	numerous	APLAs	are	broadly	discussed	The	new	management	approach	in	different	clinical	conditions	and	organ	complications	is	present	in	the	context	of	recent	recommendations	Discussed	data	underlines	that	adequate	and	timely	introduced	thromboprophylaxis	can	decrease	the	risk	of	thrombus	formation	and	prevent	increased	morbidity
To	describe	skin	involvement	SI	in	patients	with	systemic	lupus	erythematosus	SLE	at	onset	and	during	follow-up	of	the	disease	and	to	determine	factors	associated	with	SI	at	lupus	diagnosis
The	aim	of	this	work	is	to	describe	the	clinical	manifestations	at	onset	and	during	follow-up	in	a	monocentric	cohort	of	patients	with	juvenile	systemic	lupus	erythematosus	jSLE	from	the	Paediatric	Rheumatology	group	of	the	Milan	area	PRAGMA
To	achieve	a	consensus-based	definition	of	Low	Disease	Activity	LDA	for	use	in	cSLE	trials
Systemic	Lupus	Erythematosus	SLE	is	an	auto-immune	disease	in	which	the	immune	system	assaults	its	tissues	We	aimed	to	analyse	the	maternal	and	foetal	outcomes	during	pregnancy	in	SLE	mothers	A	literature	search	was	conducted	by	two	investigators	to	assess	SLE	s	outcomes	on	maternal	and	foetal	during	pregnancies	We	searched	PubMed	Medline	Embase	and	Google	scholar	to	collect	evidence	from	different	research	studies	draw	the	conclusion	and	report	it	In	our	investigation	we	found	out	that	SLE	could	cause	a	spectrum	of	complications	during	pregnancy	not	only	for	the	mother	but	also	for	the	foetus	It	could	affect	fertility	and	cause	difficult	pregnancies	for	the	couple	as	well	which	includes	certain	complications	such	as	preterm	labour	and	delivery	high	blood	pressure	preeclampsia	placental	insufficiency	miscarriage	or	stillbirth	whereas	in	the	foetus	SLE	can	cause	mortality	preterm	birth	and	neonatal	lupus	a	temporary	condition	in	the	baby	caused	by	SLE-related	antibodies	and	structural	abnormalities	The	literature	suggests	that	SLE	could	prove	fatal	for	the	foetus	and	induce	many	complications	in	the	mother	However	this	could	be	avoided	if	pregnancy	is	planned	right	from	the	start	and	proper	management	is	provided	to	the	mother	during	pregnancy	and	delivery	p
EZH2	regulates	B	cell	development	and	differentiation	We	previously	demonstrated	increased	EZH2	expression	in	peripheral	blood	mononuclear	cells	from	lupus	patients	The	goal	of	this	study	was	to	evaluate	the	role	of	EZH2	expression	in	B	cells	in	the	pathogenesis	of	lupus


This	study	is	to	investigate	whether	dietary	fiber	intake	prevents	vascular	and	renal	damage	in	a	genetic	mouse	model	of	systemic	lupus	erythematosus	SLE	and	the	contribution	of	gut	microbiota	in	the	protective	effects	Female	NZBWF1	SLE	mice	were	treated	with	resistant-starch	RS	or	inulin-type	fructans	ITF	In	addition	inoculation	of	fecal	microbiota	from	these	experimental	groups	to	recipient	normotensive	female	C57Bl	6J	germ-free	GF	mice	was	performed	Both	fiber	treatments	especially	RS	prevented	the	development	of	hypertension	renal	injury	improved	the	aortic	relaxation	induced	by	acetylcholine	and	the	vascular	oxidative	stress	RS	and	ITF	treatments	increased	the	proportion	of	acetate-	and	butyrate-producing	bacteria	respectively	improved	colonic	inflammation	and	integrity	endotoxemia	and	decreased	helper	T	Th	17	proportion	in	mesenteric	lymph	nodes	MLNs	blood	and	aorta	in	SLE	mice	However	disease	activity	splenomegaly	and	anti-ds-DNA	was	unaffected	by	both	fibers	T	cell	priming	and	Th17	differentiation	in	MLNs	and	increased	Th17	infiltration	was	linked	to	aortic	endothelial	dysfunction	and	hypertension	after	inoculation	of	fecal	microbiota	from	SLE	mice	to	GF	mice	without	changes	in	proteinuria	and	autoimmunity	All	these	effects	were	lower	in	GF	mice	after	fecal	inoculation	from	fiber-treated	SLE	mice	In	conclusion	these	findings	support	that	fiber	consumption	prevented	the	development	of	hypertension	by	rebalancing	of	dysfunctional	gut-immune	system-vascular	wall	axis	in	SLE
Signaling	driven	by	nucleic	acid	sensors	participates	in	interferonopathy-mediated	autoimmune	diseases	NLRP12	a	pyrin-containing	NLR	protein	is	a	negative	regulator	of	innate	immune	activation	and	type	I	interferon	IFN-I	production	Peripheral	blood	mononuclear	cells	PBMCs	derived	from	systemic	lupus	erythematosus	SLE	patients	expressed	lower	levels	of	NLRP12	with	an	inverse	correlation	with	IFNA	expression	and	high	disease	activity	NLRP12	expression	was	transcriptionally	suppressed	by	runt-related	transcription	factor	1-dependent	RUNX1-dependent	epigenetic	regulation	under	IFN-I	treatment	which	enhanced	a	negative	feedback	loop	between	low	NLRP12	expression	and	IFN-I	production	Reduced	NLRP12	protein	levels	in	SLE	monocytes	was	linked	to	spontaneous	activation	of	innate	immune	signaling	and	hyperresponsiveness	to	nucleic	acid	stimulations	Pristane-treated	Nlrp12-	-	mice	exhibited	augmented	inflammation	and	immune	responses	and	substantial	lymphoid	hypertrophy	was	characterized	in	NLRP12-deficient	lupus-prone	mice	NLRP12	deficiency	mediated	the	increase	of	autoantibody	production	intensive	glomerular	IgG	deposition	monocyte	recruitment	and	the	deterioration	of	kidney	function	These	were	bound	in	an	IFN-I	signature-dependent	manner	in	the	mouse	models	Collectively	we	reveal	a	remarkable	link	between	low	NLRP12	expression	and	lupus	progression	which	suggests	the	impact	of	NLRP12	on	homeostasis	and	immune	resilience
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	and	inflammatory	disease	that	requires	treatment	with	hydroxychloroquine	and	glucocorticoids	Glucocorticoids	are	responsible	for	adverse	effects	such	as	increased	weight	which	can	modify	the	severity	and	chronicity	of	autoimmune	pathologies
The	aim	of	this	study	was	to	investigate	the	characteristics	of	CD4	CD40	T	cells	Th40	cells	in	Chinese	systemic	lupus	erythematosus	SLE	patients	Flow	cytometry	was	used	to	identify	the	percentage	of	Th40	cells	in	peripheral	blood	from	24	SLE	patients	and	24	healthy	individuals	and	the	level	of	IL-2	IL-4	IL-6	IL-10	IFN-r	and	TNF-	in	serum	22	cases	from	the	SLE	patients	Systemic	Lupus	Erythematosus	Disease	Activity	Index	2000	SLEDAI-2000	was	used	to	assess	the	SLE	disease	active	state	The	percentage	of	Th40	cells	in	T	cells	from	SLE	patients	19	37	17	43	was	significantly	higher	than	that	from	healthy	individuals	4	52	3	16	P	0	001	The	percentage	of	Th40	cells	was	also	positively	associated	with	SLEDAI-2000	P	0	001	and	negatively	associated	with	complement	C3	P	0	007	The	Th40	cell	percentage	was	different	in	SLE	patients	with	different	organs	involved	The	Th40	cell	percentage	in	SLE	patients	with	lupus	serositis	29	29	22	19	was	significantly	higher	than	that	in	patients	without	serositis	13	41	10	79	P	0	040	and	the	percentage	in	SLE	patients	with	lupus	pneumonia	involvement	29	11	11	88	was	significantly	higher	than	that	in	patients	without	lupus	pneumonia	16	80	17	99	P	0	043	After	4	weeks	treatment	the	Th40	cell	percentage	decreased	significantly	P	0	005	However	Th40	cell	expression	was	not	related	to	cytokines	IL-2	IL-4	IL-6	IL-10	IFN-r	and	TNF-	P	0	05	A	significantly	higher	percentage	of	Th40	cells	was	found	in	SLE	patients	and	the	Th40	cell	percentage	was	associated	with	SLE	activity	Thus	Th40	cells	may	be	used	as	a	predictor	for	SLE	disease	activity	and	severity	and	therapeutic	efficacy
Objective	We	sought	to	investigate	the	clinical	characteristics	and	risk	factors	of	antiphospholipid	syndrome	APS	complicated	by	autoimmune	hemolytic	anemia	AIHA	Methods	Retrospective	anaysis	Three	hundred	fifteen	consecutive	patients	with	APS	were	enrolled	at	the	Department	of	Rheumatology	of	Peking	Union	Medical	College	Hospital	between	May	2017	to	May	2021	and	their	clinical	manifestations	including	initial	symptoms	time	interval	between	APS	onset	and	diagnosis	systemic	lupus	erythematosus	SLE	thrombotic	events	obstetric	morbidity	and	extra-criteria	manifestations	and	laboratory	test	results	including	blood	routine	antiphospholipid	antibodies	aPLs	blood	lipid	profile	homocysteine	anti-nuclear	antibody	profile	immunoglobulin	levels	and	complement	levels	were	collected	Then	univariate	and	multivariate	logistic	regression	analyses	were	performed	Clinical	features	and	risk	factors	were	analyzed	using	univariable	and	multivariable	logistic	regression	analysis	Results	Among	315	APS	patients	37	cases	11	7	were	complicated	by	AIHA	and	AIHA	was	the	first	manifestation	or	co-occurrence	The	median	time	interval	between	APS	onset	and	diagnosis	was	12	months	The	proportion	of	SLE	in	APS	patients	combined	with	AIHA	was	higher	than	that	in	APS	patients	without	AIHA	62	2	23	37	vs	19	4	54	278	P	0	001	There	was	no	significant	difference	in	the	proportions	of	thrombosis	and	pregnancy	morbidity	between	the	two	groups	In	terms	of	extra-criteria	manifestations	APS	patients	with	AIHA	had	a	significantly	P	0	05	greater	risk	of	thrombocytopenia	OR	6	19	95	CI	2	81-13	65	and	higher	proportions	of	hypocomplementemia	a	positive	lupus	anticoagulant	LA	result	double	aPLs	positivity	i	e	any	two	of	the	following	antibodies	were	positive	LA	anticardilolipin	antibody	aCL	and	anti-	2	glycoprotein	2GP	and	triple	aPLs	positivity	i	e	LA	aCL	and	anti-	2GP	antibodies	were	all	positive	Multivariate	logistic	regression	analysis	showed	that	SLE	OR	3	46	95	CI	1	60-7	48	thrombocytopenia	OR	2	56	95	CI	1	15-5	67	and	hypocomplementemia	OR	4	29	95	CI	2	03-9	04	were	independent	risk	factors	for	the	complication	of	APS	In	the	primary	APS	subgroup	multivariate	logistic	regression	analysis	showed	that	livedo	reticularis	OR	10	51	95	CI	1	06-103	78	thrombocytopenia	OR	3	77	95	CI	1	23-11	57	and	hypocomplementemia	OR	5	92	95	CI	1	95-17	95	were	independent	risk	factors	for	the	complication	of	APS	Conclusions	AIHA	is	not	rare	in	APS	patients	moreover	it	occurs	more	frequently	in	APS	secondary	to	SLE	and	is	more	likely	to	present	with	a	variety	of	extra-criteria	manifestations	Patients	with	AIHA	should	be	promptly	tested	for	antiphospholipid	antibody	profiles	and	alerted	to	the	possibility	of	thrombotic	events
To	character	the	molecular	landscape	of	patients	with	type	1	and	type	2	SLE	by	analysing	gene	expression	profiles	from	peripheral	blood
Coronavirus	Disease	COVID-19	may	cause	a	dysregulation	of	the	immune	system	and	has	complex	relationships	with	multiple	autoimmune	diseases	including	rheumatoid	arthritis	RA	and	systemic	lupus	erythematosus	SLE	However	little	is	known	about	their	common	genetic	architecture	Using	the	latest	data	from	COVID-19	host	genetics	consortium	and	consortia	on	RA	and	SLE	we	conducted	a	genome-wide	cross-trait	analysis	to	examine	the	shared	genetic	etiology	between	COVID-19	and	RA	SLE	and	evaluated	their	causal	associations	using	bidirectional	Mendelian	randomization	MR	The	cross-trait	meta-analysis	identified	23	28	and	10	shared	genetic	loci	for	severe	COVID-19	COVID-19	hospitalization	and	SARS-CoV-2	infection	with	RA	and	14	17	and	7	shared	loci	with	SLE	respectively	Co-localization	analysis	identified	five	causal	variants	in	TYK2	IKZF3	PSORS1C1	and	COG6	for	COVID-19	with	RA	and	four	in	CRHR1	FUT2	and	NXPE3	for	COVID-19	with	SLE	involved	in	immune	function	angiogenesis	and	coagulation	Bidirectional	MR	analysis	suggested	RA	is	associated	with	a	higher	risk	of	COVID-19	hospitalization	and	COVID-19	is	not	related	to	RA	or	SLE	Our	novel	findings	improved	the	understanding	of	the	genetic	etiology	shared	by	COVID-19	RA	and	SLE	and	suggested	an	increased	risk	of	COVID-19	hospitalization	in	people	with	higher	genetic	liability	to	RA
Dendritic	cells	DCs	are	the	most	potent	antigen-presenting	cells	that	have	multifaceted	functions	in	the	control	of	immune	activation	and	tolerance	Hyperresponsiveness	and	altered	tolerogenicity	of	DCs	contribute	to	the	development	and	pathogenesis	of	system	lupus	erythematosus	SLE	therefore	DC-targeted	therapies	aimed	at	inducing	specific	immune	tolerance	have	become	of	great	importance	for	the	treatment	of	SLE	This	study	developed	a	new	nanoparticle	NP	containing	a	biodegradable	PDMAEMA-PLGA	copolymer	for	target-oriented	delivery	to	DCs	in	situ	PDMAEMA-PLGA	NPs	provided	sustained	drug	release	and	exhibited	immunosuppressive	activity	in	FLT3L	and	GM-CSF-derived	bone	marrow	in	conventional	DCs	BM-cDCs	PDMAEMA-PLGA	NPs	improved	dexamethasone	capability	to	convert	wild-type	and	Fcgr2b-	-	BM-cDCs	from	an	immunogenic	to	tolerogenic	state	and	BM-cDCs	treated	with	dexamethasone-incorporated	PDMAEMA-PLGA	NPs	Dex-NPs	efficiently	mediated	regulatory	T	cell	Treg	expansion	in	vitro	Dex-NP	therapy	potentially	alleviated	lupus	disease	in	Fcgr2b-	-	mice	by	mediating	Foxp3	Treg	expansion	in	an	antigen-specific	manner	Our	findings	substantiate	the	superior	efficacy	of	DC-targeted	therapy	using	the	PDMAEMA-PLGA	NP	delivery	system	and	provide	further	support	for	clinical	development	as	a	potential	therapy	for	SLE	Furthermore	PDMAEMA-PLGA	NP	may	be	a	versatile	platform	for	DC-targeted	therapy	to	induce	antigen-specific	immune	tolerance	to	unwanted	immune	responses	that	occur	in	autoimmune	disease	allergy	and	transplant	rejection
The	aim	of	this	study	was	to	investigate	serum	levels	of	soluble	B-cell	maturation	antigen	sBCMA	in	childhood-onset	systemic	lupus	erythematous	cSLE	patients	with	renal	involvement	and	to	elucidate	their	association	with	clinical	characteristics

Age	autoimmunity-associated	B	cells	ABCs	are	a	novel	B	cell	subpopulation	with	a	unique	transcriptional	signature	and	cell	surface	phenotype	They	are	not	sensitive	to	BCR	but	rely	on	TLR7	or	TLR9	in	the	context	of	T	cell-derived	cytokines	for	the	differentiation	It	has	been	established	that	aberrant	expansion	of	ABCs	is	linked	to	the	pathogenesis	of	systemic	autoimmune	diseases	such	as	systemic	lupus	erythematosus	Recently	we	and	other	groups	have	shown	that	increased	ABCs	is	associated	with	rheumatoid	arthritis	RA	disease	activity	and	have	demonstrated	their	pathogenic	role	in	RA	indicating	that	targeting	specific	B	cell	subsets	is	a	promising	strategy	for	the	treatment	of	inflammatory	arthritis	In	this	review	we	summarize	the	current	knowledge	of	ABCs	focusing	on	their	emerging	role	in	the	pathogenesis	of	inflammatory	arthritis	A	deep	understanding	of	the	biology	of	ABCs	in	the	context	of	inflammatory	settings	in	vivo	will	ultimately	contribute	to	the	development	of	novel	targeted	therapies	for	the	treatment	of	inflammatory	arthritis

Jieduquyuziyin	prescription	JP	as	a	traditional	Chinese	medicine	formula	is	extensively	applied	to	treat	systemic	lupus	erythematosus	SLE	Its	prescription	is	based	on	clinical	practice	and	an	evidence-based	application	of	traditional	medicines	It	is	approved	by	use	in	Chinese	hospitals	as	a	clinical	prescription	that	can	be	directly	used
Systemic	lupus	erythematosus	SLE	affects	1	in	537	Black	women	which	is	2-fold	more	than	White	women	Black	patients	develop	the	disease	at	a	younger	age	have	more	severe	symptoms	and	have	a	greater	chance	of	early	mortality	We	used	a	multiomics	approach	to	uncover	ancestry-associated	immune	alterations	in	patients	with	SLE	and	healthy	controls	that	may	contribute	biologically	to	disease	disparities	Cell	composition	signaling	epigenetics	and	proteomics	were	evaluated	by	mass	cytometry	droplet-based	single-cell	transcriptomics	and	proteomics	and	bead-based	multiplex	soluble	mediator	levels	in	plasma	We	observed	altered	whole	blood	frequencies	and	enhanced	activity	in	CD8	T	cells	B	cells	monocytes	and	DCs	in	Black	patients	with	more	active	disease	Epigenetic	modifications	in	CD8	T	cells	H3K27ac	could	distinguish	disease	activity	level	in	Black	patients	and	differentiate	Black	from	White	patient	samples	TLR3	4	7	8	9-related	gene	expression	was	elevated	in	immune	cells	from	Black	patients	with	SLE	and	TLR7	8	9	and	IFN-	phospho-signaling	and	cytokine	responses	were	heightened	even	in	immune	cells	from	healthy	Black	control	patients	compared	with	White	individuals	TLR	stimulation	of	healthy	immune	cells	recapitulated	the	ancestry-associated	SLE	immunophenotypes	This	multiomic	resource	defines	ancestry-associated	immune	phenotypes	that	differ	between	Black	and	White	patients	with	SLE	which	may	influence	the	course	and	severity	of	SLE	and	other	diseases
SLE	is	an	autoimmune	disease	characterised	by	persistent	inflammation	and	autoantibody	production	Genetic	predisposition	and	environmental	factors	such	as	a	high-fat	diet	HFD	may	contribute	to	lupus	development	However	the	immune	cell	profile	and	gender	difference	in	response	to	HFD	in	lupus	have	not	been	reported	Here	we	investigated	the	impact	of	HFD	on	lupus	pathogenesis	and	autoimmunity	using	lupus-prone	mice
The	objective	of	this	cohort	study	was	to	evaluate	the	association	between	the	frequency	of	hospital	admissions	and	disease	activity	as	defined	by	two	different	disease	activity	measurements	the	Systemic	Lupus	Erythematosus	Disease	Activity	Score	SLE-DAS	and	the	Systemic	Lupus	Erythematosus	Disease	Activity	Index	2000	SLEDAI-2K	in	adult	patients	with	systemic	lupus	erythematosus	SLEs	Patients	with	SLE	were	recruited	from	the	rheumatology	outpatient	department	of	a	regional	hospital	in	southern	Taiwan	SLE-DAS	and	SLEDAI-2K	were	used	to	define	SLE	disease	activity	and	the	cause	of	hospital	admissions	was	identified	by	a	rheumatologist	based	on	medical	records	A	generalized	linear	model	GLM	with	gamma	distribution	and	log-linked	function	was	used	to	analyze	variables	associated	with	the	frequency	of	admission	The	mean	frequency	of	hospitalization	was	0	34	times	per	year	for	all-cause	and	0	21	times	per	year	for	SLE-related	admission	Multivariate	GLM	analysis	showed	that	moderate	severe	SLE	disease	activity	defined	by	SLE-DAS	was	associated	with	an	increased	frequency	of	all-cause	and	SLE-related	hospital	admissions	while	adjusting	for	other	covariates	Moderate	severe	SLE	disease	activity	defined	by	SLEDAI-2K	was	only	significantly	associated	with	an	increased	frequency	of	all-cause	hospitalization	When	steroid	dosage	was	included	in	the	model	moderate	severe	SLE	disease	activity	defined	by	the	SLE-DAS	remained	significantly	associated	with	SLE-related	hospital	admissions	p	0	032	In	conclusion	disease	activity	defined	by	the	SLE-DAS	but	not	SLEDAI-2K	was	associated	with	an	increased	frequency	of	SLE-related	hospitalization	Steroid	dosage	a	lower	educational	level	and	smoking	were	associated	with	an	increased	frequency	of	hospital	admissions	whereas	underweight	and	alcohol	use	were	associated	with	a	decreased	frequency	of	hospital	admissions	Rheumatologists	should	promptly	control	SLE	disease	activity	of	their	patients	provide	them	with	adequate	health	education	and	maintain	steroid	doses	to	as	low	as	possible	to	reduce	the	risk	of	hospital	admissions
This	study	aimed	to	evaluate	depression	and	anxiety	in	patients	with	systemic	lupus	erythematosus	SLE	in	the	post-coronavirus	disease-2019	COVID-19	period	and	their	potential	association	with	the	disease	activity	and	related	organ	damage
Several	studies	have	demonstrated	that	anti-carbamylation	protein	antibodies	Anti-CarPA	are	persistent	in	patients	with	rheumatoid	arthritis	RA	systemic	lupus	erythematosus	SLE	systemic	sclerosis	SSC	primary	Sj	gren	s	syndrome	pSS	and	interstitial	lung	disease	associated	with	RA	RA-ILD	However	the	relationship	between	anti-CarPA	and	other	rheumatic	diseases	RDs	and	non-RA-ILD	is	not	known	till	now	This	study	sought	to	examine	the	presence	of	anti-CarPA	in	Chinese	Han	patients	with	RDs	and	its	clinical	significance
Infection	is	a	leading	cause	of	death	in	patients	with	systemic	lupus	erythematosus	SLE	Alt	hough	hydroxychloroquine	HCQ	has	been	reported	to	inhibit	infection	evidence	from	Asian	populations	remains	insufficient	We	investigated	this	effect	in	Japanese	SLE	patients
Hemophagocytic	lymphohistiocytosis	HLH	is	a	rare	and	life-threatening	disorder	characterized	by	systemic	inflammation	and	organ	failure	as	a	result	of	dysregulated	immune	cell	activation	HLH	can	be	induced	by	a	variety	of	factors	including	infection	tumours	and	autoimmune	disease	and	can	also	occur	in	patients	following	solid	organ	transplantation	Occurrence	of	HLH	and	lupus	nephritis	LN	successively	within	a	short	period	of	time	after	renal	transplantation	is	uncommon
Systemic	lupus	erythematosus	is	a	heritable	autoimmune	disease	that	predominantly	affects	young	women	To	improve	our	understanding	of	genetic	etiology	we	conduct	multi-ancestry	and	multi-trait	meta-analysis	of	genome-wide	association	studies	encompassing	12	systemic	lupus	erythematosus	cohorts	from	3	different	ancestries	and	10	genetically	correlated	autoimmune	diseases	and	identify	16	novel	loci	We	also	perform	transcriptome-wide	association	studies	computational	drug	repurposing	analysis	and	cell	type	enrichment	analysis	We	discover	putative	drug	classes	including	a	histone	deacetylase	inhibitor	that	could	be	repurposed	to	treat	lupus	We	also	identify	multiple	cell	types	enriched	with	putative	target	genes	such	as	non-classical	monocytes	and	B	cells	which	may	be	targeted	for	future	therapeutics	Using	this	newly	assembled	result	we	further	construct	polygenic	risk	score	models	and	demonstrate	that	integrating	polygenic	risk	score	with	clinical	lab	biomarkers	improves	the	diagnostic	accuracy	of	systemic	lupus	erythematosus	using	the	Vanderbilt	BioVU	and	Michigan	Genomics	Initiative	biobanks
Pulmonary	Hypertension	PH	is	a	common	manifestation	in	patients	with	Systemic	Lupus	Erythematosus	SLE	and	varies	from	asymptomatic	to	life-threatening	disease	PH	can	result	not	only	from	immune	system	dysregulation	but	also	from	various	conditions	including	cardiorespiratory	disorders	and	thromboembolic	diseases	Most	commonly	SLE-related	PH	presents	with	non-specific	symptoms	such	as	progressive	dyspnea	on	exertion	generalized	fatigue	and	weakness	and	eventually	dyspnea	at	rest	Prompt	diagnosis	of	SLE-related	PH	and	early	identification	of	the	underlying	pathogenetic	mechanisms	is	demanded	in	order	to	introduce	targeted	therapy	to	prevent	irreversible	pulmonary	vascular	damage	In	most	cases	the	management	of	PH	in	SLE	patients	is	similar	to	idiopathic	pulmonary	arterial	hypertension	PAH	Furthermore	specific	diagnostic	tools	like	biomarkers	or	screening	protocols	to	establish	early	diagnosis	seem	to	be	not	available	yet	Although	the	survival	rates	for	patients	with	SLE-related	PH	vary	between	studies	it	is	evident	that	PH	presence	negatively	affects	the	survival	of	SLE	patients
The	objective	is	to	compare	the	clinical	and	laboratory	characteristics	of	systemic	lupus	erythematosus	SLE	patients	with	and	without	lupus	enteritis	LE	and	to	identify	the	factors	associated	with	the	occurrence	of	LE
Calprotectin	CLP	is	a	heterodimeric	complex	formed	by	two	S100	proteins	S100A8	A9	which	plays	a	pivotal	role	in	innate	immunity	Due	to	its	intrinsic	cytotoxic	and	proinflammatory	properties	CLP	controls	cell	differentiation	proliferation	and	NETosis	and	has	been	associated	with	a	wide	range	of	rheumatic	diseases	Our	review	summarizes	the	widespread	interest	in	circulating	CLP	cCLP	as	a	biomarker	of	neutrophil-related	inflammation	in	autoimmune	rheumatic	disease	ARD	and	non-ARD
Depression	is	highly	prevalent	among	systemic	lupus	erythematosus	SLE	patients	Brain	hypoperfusion	in	neuropsychiatric	SLE	patients	might	be	associated	with	emotional	difficulties	However	no	previous	study	examined	possible	associations	of	depression	with	brain	oxygenation	during	a	mild	physical	stress	in	non-neuropsychiatric	SLE	patients	Our	study	aimed	to	identify	possible	differences	in	cerebral	oxygenation	during	exercise	in	SLE	patients	with	and	without	depressive	symptoms	using	near-infrared	spectroscopy	NIRS	and	examine	possible	underlying	mechanisms	through	evaluation	of	vascular	cell	adhesion	molecule	1	VCAM-1	levels
Childhood-onset	systemic	lupus	erythematosus	cSLE	patients	are	unique	with	hallmarks	of	Mendelian	disorders	early-onset	and	severe	disease	and	thus	are	an	ideal	population	for	genetic	investigation	of	SLE	In	this	study	we	use	the	transmission	disequilibrium	test	TDT	a	family-based	genetic	association	analysis	that	employs	robust	methodology	to	analyze	whole	genome	sequencing	data	We	aim	to	identify	novel	genetic	associations	in	an	ancestrally	diverse	international	cSLE	cohort	Forty-two	cSLE	patients	and	84	unaffected	parents	from	3	countries	underwent	whole	genome	sequencing	First	we	performed	TDT	with	single	nucleotide	variant	SNV	-based	common	variants	using	PLINK	1	9	and	gene-based	rare	variants	analyses	using	Efficient	and	Parallelizable	Association	Container	Toolbox	EPACTS	and	rare	variant	TDT	rvTDT	which	applies	multiple	gene-based	burden	tests	adapted	for	TDT	including	the	burden	of	rare	variants	test	Applying	the	GWAS	standard	threshold	5	0	10-8	to	common	variants	our	SNV-based	analysis	did	not	return	any	genome-wide	significant	SNVs	The	rare	variant	gene-based	TDT	analysis	identified	many	novel	genes	significantly	enriched	in	cSLE	patients	including	HNRNPUL2	a	DNA	repair	protein	and	DNAH11	a	ciliary	movement	protein	among	others	Our	approach	identifies	several	novel	SLE	susceptibility	genes	in	an	ancestrally	diverse	childhood-onset	lupus	cohort

The	goal	was	to	characterize	short-term	kidney	status	and	describe	variation	in	early	care	utilization	in	a	multicenter	cohort	of	patients	with	childhood-onset	systemic	lupus	erythematosus	cSLE	and	nephritis
The	severe	acute	respiratory	syndrome	coronavirus	2	SARS-CoV-2	virus	has	become	a	worldwide	pandemic	since	first	discovered	in	2019	Systemic	lupus	erythematosus	SLE	flare	has	been	reported	in	the	post-infectious	period	In	Colombia	the	fourth	pandemic	wave	started	at	the	beginning	of	2022	when	we	observed	flare	of	3	SLE	patients	during	active	infection

No	single	organ	has	received	as	much	attention	in	systemic	lupus	erythematosus	SLE	as	the	kidneys	During	the	period	2019-2022	the	Annals	of	the	Rheumatic	Diseases	published	several	original	papers	brief	reports	and	letters	that	further	elucidate	the	pathogenesis	and	advance	the	management	of	LN	A	selection	of	representative	original	papers	is	highlighted	in	this	review
Systemic	Lupus	Erythematosus	SLE	is	an	autoimmune	disease	characterized	by	the	generation	of	anti-DNA	autoantibodies	due	to	exposure	of	immune	cells	to	excessive	amounts	of	extracellular	DNA	Lack	of	P-selectin	in	mice	induces	the	development	of	a	lupus-like	syndrome	and	patients	with	cutaneous	lupus	have	reduced	P-selectin	expression	in	skin	vessels	Using	flow	cytometry	we	analyzed	in	healthy	donors	and	patients	the	expression	of	P-selectin	Glycoprotein	Ligand-1	PSGL-1	in	circulating	neutrophils	and	the	implication	of	PSGL-1	P-selectin	interaction	in	neutrophil	extracellular	traps	NETs	generation	We	found	a	statistical	significance	that	neutrophils	from	active	SLE	patients	have	a	reduced	expression	of	PSGL-1	and	low	levels	of	PSGL-1	in	neutrophils	from	SLE	patients	associated	with	the	presence	of	anti-dsDNA	antibodies	clinical	lung	involvement	Raynaud	s	phenomenon	and	positive	lupus	anticoagulant	PSGL-1	is	present	along	the	DNA	in	the	NET	In	healthy	donors	neutrophil	interaction	with	immobilized	P-selectin	triggers	Syk	activation	increases	the	NETs	percentage	and	reduces	the	amount	of	DNA	extruded	in	the	NETs	In	active	SLE	patients	neutrophil	interaction	with	P-selectin	does	not	activate	Syk	or	reduce	the	amount	of	DNA	extruded	in	the	NETs	that	might	contribute	to	increase	the	extracellular	level	of	DNA	and	hence	to	disease	pathogenesis
Lupus	nephritis	LN	is	still	a	great	burden	for	patients	with	systemic	lupus	erythematosus	and	also	one	of	the	most	severe	complications	of	SLE	Radix	Paeoniae	Alba	white	peony	WP	is	proved	with	potential	efficacy	in	treating	LN	This	study	was	to	explore	the	effective	ingredients	potential	targets	and	pathways	of	WP	in	treating	LN	based	on	network	pharmacology	and	molecular	docking
Monocytes	-key	regulators	of	the	innate	immune	response-	are	actively	involved	in	the	pathogenesis	of	systemic	lupus	erythematosus	SLE	We	sought	to	identify	novel	compounds	that	might	serve	as	monocyte-directed	targeted	therapies	in	SLE
Systemic	lupus	erythematosus	SLE	is	a	disease	of	immune	complex	deposition	therefore	complement	plays	a	vital	role	in	the	pathogenesis	of	SLE	In	general	complement	levels	in	blood	and	complement	deposition	in	histological	tests	are	used	for	the	management	of	SLE	Thus	the	evaluation	of	complement	status	can	be	useful	in	the	diagnosis	of	SLE	assessment	of	disease	activity	and	prediction	of	treatment	response	and	prognosis	In	addition	novel	complement	biomarkers	such	as	split	products	and	cell-bound	complement	activation	products	are	considered	to	be	more	sensitive	than	traditional	complement	markers	such	as	serum	C3	and	C4	levels	and	total	complement	activity	CH50	which	become	more	widely	used	In	this	review	we	report	the	complement	testing	in	the	management	of	SLE	over	the	last	decade	and	summarize	their	utility
Treat-to-target	T2T	strategies	are	advocated	to	improve	prognosis	in	childhood-onset	SLE	cSLE	Proposed	T2T	states	include	SLEDAI	score	of	4	SLEDAI-LD	limited	corticosteroid	use	low-CS	and	lupus	low	disease	activity	state	LLDAS	We	sought	to	compare	T2T	states	for	their	association	with	cSLE	prognosis	under	consideration	of	relevant	disease	characteristics	such	as	pre-existing	damage	race	and	lupus	nephritis	LN
The	NLRP3	inflammasome	is	an	intracellular	multiprotein	complex	that	promotes	the	auto-catalytic	activation	of	caspase-1	and	the	subsequent	maturation	and	secretion	of	the	pro-inflammatory	cytokines	IL-1	and	IL-18	Persistent	activation	of	the	NLRP3	inflammasome	has	been	implicated	in	the	pathophysiology	of	a	number	of	inflammatory	and	autoimmune	diseases	including	neuroinflammation	cardiovascular	disease	non-alcoholic	steatohepatitis	lupus	nephritis	and	severe	asthma	Here	we	describe	the	preclinical	profile	of	JT002	a	novel	small	molecule	inhibitor	of	the	NLRP3	inflammasome	JT002	potently	reduced	NLRP3-dependent	proinflammatory	cytokine	production	across	a	number	of	cellular	assays	and	prevented	pyroptosis	an	inflammatory	form	of	cell	death	triggered	by	active	caspase-1	JT002	demonstrated	in	vivo	target	engagement	at	therapeutically	relevant	concentrations	when	orally	dosed	in	mice	and	prevented	body	weight	loss	and	improved	inflammatory	and	fibrotic	endpoints	in	a	model	of	Muckle-Wells	syndrome	MWS	In	two	distinct	models	of	neutrophilic	airway	inflammation	JT002	treatment	significantly	reduced	airway	hyperresponsiveness	and	airway	neutrophilia	These	results	provide	a	rationale	for	the	therapeutic	targeting	of	the	NLRP3	inflammasome	in	severe	asthma	and	point	to	the	use	of	JT002	in	a	variety	of	inflammatory	disorders

Hypoxia-inducible	factor-1	HIF-1	is	a	primary	metabolic	sensor	and	is	expressed	in	different	immune	cells	such	as	macrophage	dendritic	cell	neutrophil	T	cell	and	non-immune	cells	for	instance	synovial	fibroblast	and	islet	cell	HIF-1	signaling	regulates	cellular	metabolism	triggering	the	release	of	inflammatory	cytokines	and	inflammatory	cells	proliferation	It	is	known	that	microenvironment	hypoxia	vascular	proliferation	and	impaired	immunological	balance	are	present	in	autoimmune	diseases	To	date	HIF-1	is	recognized	to	be	overexpressed	in	several	inflammatory	autoimmune	diseases	such	as	systemic	lupus	erythematosus	SLE	rheumatoid	arthritis	and	function	of	HIF-1	is	dysregulated	in	these	diseases	In	this	review	we	narrate	the	signaling	pathway	of	HIF-1	and	the	possible	immunopathological	roles	of	HIF-1	in	autoimmune	diseases	The	collected	information	will	provide	a	theoretical	basis	for	the	familiarization	and	development	of	new	clinical	trials	and	treatment	based	on	HIF-1	and	inflammatory	autoimmune	disorders	in	the	future

An	increased	risk	of	pregnancy	complications	is	seen	in	women	with	systemic	lupus	erythematosus	SLE	but	the	specific	immunopathological	drivers	are	still	unclear	Hallmarks	of	SLE	are	granulocyte	activation	type	I	interferon	IFN	overproduction	and	autoantibodies	Here	we	examined	whether	low-density	granulocytes	LDG	and	granulocyte	activation	increase	during	pregnancy	and	related	the	results	to	IFN	protein	levels	autoantibody	profile	and	gestational	age	at	birth
The	purpose	of	this	meta-analysis	is	to	determine	the	efficacy	of	mesenchymal	stromal	stem	cell	MSC	transplantation	therapy	on	lupus	nephritis	LN	and	renal	function	of	patients	with	systemic	lupus	erythematosus	SLE
Systemic	lupus	erythematosus	SLE	is	a	chronic	disease	of	the	autoimmune	system	with	multiple	damages	most	commonly	renal	damage	The	aim	of	the	present	study	is	to	examine	the	therapeutic	ability	of	Qihuang	Jianpi	Zishen	decoction	QJZ	on	MRL	lpr	mice	and	uncover	its	mechanism	preliminarily	Twenty-four	female	MRL	lpr	mice	were	assigned	into	the	model	prednisolone	mycophenolate	mofetil	and	QJZ	groups	randomly	Six	C57BL	6	mice	were	considered	as	controls	Each	group	was	treated	with	corresponding	drugs	for	4	weeks	anti-dsDNA	autoantibodies	C3	and	C4	renal	function	and	renal	histopathological	changes	were	observed	The	expression	of	GAS5	miR-21	sprouty1	axis	and	ERK	CREB	pathway	in	kidney	was	identified	by	western	blotting	and	qRT-PCR	Compared	with	MRL	lpr	mice	anti-dsDNA	autoantibodies	of	mice	treated	with	QJZ	were	significantly	down-regulated	C3	and	C4	were	significantly	up-regulated	QJZ	also	alleviated	proteinuria	decreased	SCr	and	BUN	levels	and	minimized	renal	histopathological	changes	In	addition	QJZ	affected	the	expression	of	GAS5	miR-21	sprouty1	axis	and	the	phosphorylation	of	ERK	CREB	pathway	in	renal	tissues	QJZ	bears	therapeutic	ability	on	healing	renal	injury	in	MRL	lpr	mice	These	effects	may	be	achieved	by	regulating	the	GAS5	miR-21	sprouty1	axis	and	inhibiting	the	ERK	CREB	pathway	thus	improving	the	excessive	proliferation	of	glomerular	mesangial	cells
Lupus	erythematous	panniculitis	LEP	is	a	rare	type	of	chronic	cutaneous	lupus	erythematous	Clinical	characteristics	are	tender	subcutaneous	nodules	erythematous	plaques	Disfigurement	of	face	and	body	might	develop	which	affects	the	patient	s	quality	of	life	LEP	can	be	the	first	sign	of	systemic	lupus	erythematous	SLE

The	aim	of	this	study	is	to	investigate	the	usefulness	which	2-year	trajectories	of	C3	variability	have	in	predicting	clinical	remission	and	systemic	corticosteroids	SCS	use	in	pediatric	patients	with	systemic	lupus	erythematosus	pSLE
N6-methyladenosine	m6A	methylation	modification	is	involved	in	the	regulation	of	various	biological	processes	including	inflammation	antitumor	and	antiviral	immunity	However	the	role	of	m6A	modification	in	the	pathogenesis	of	autoimmune	diseases	has	been	rarely	reported
In	our	study	in	which	the	relationship	between	juvenile	idiopathic	arthritis	JIA	and	particular	environmental	factors	was	evaluated	a	correlation	could	not	be	established	between	the	rate	or	duration	of	breastfeeding	and	the	development	or	severity	of	the	disease	Int	J	Rheum	Dis	25	2022	1376	It	was	determined	that	the	time	of	introduction	to	cow	s	milk	differed	in	JIA	and	juvenile-onset	systemic	lupus	erythematosus	patient	groups	compared	to	healthy	controls	On	the	other	hand	the	fact	that	income	level	and	maternal	literacy	were	associated	with	high	disability	and	damage	scores	and	frequent	recurrence	rates	stood	as	one	of	the	remarkable	results	of	our	study	Kao	et	al	drew	attention	to	the	relationship	between	socioeconomic	status	and	chronic	arthritis	and	quoted	an	adult	study	The	role	of	the	parent	factor	has	been	stressed	and	the	effect	of	maternal	stress	on	disease	development	has	been	discussed	Although	JIA	is	a	heterogeneous	disease	and	the	tribulation	of	measuring	the	direct	impact	of	environmental	elements	are	limiting	factors	it	is	essential	to	determine	the	parts	that	can	be	controlled	to	some	extent	and	the	precautions	to	be	taken
Host	barriers	such	as	the	skin	the	lung	mucosa	the	intestinal	mucosa	and	the	oral	cavity	are	crucial	at	preventing	contact	with	potential	threats	and	are	populated	by	a	diverse	population	of	innate	and	adaptive	immune	cells	Alterations	in	antigen	recognition	driven	by	genetic	and	environmental	factors	can	lead	to	autoimmune	systemic	diseases	such	rheumatoid	arthritis	systemic	lupus	erythematosus	and	food	allergy	Here	we	review	how	different	immune	cells	residing	at	epithelial	barriers	host-derived	signals	and	environmental	signals	are	involved	in	the	initiation	and	progression	of	autoimmune	responses	in	these	diseases	We	discuss	how	regulation	of	innate	responses	at	these	barriers	and	the	influence	of	environmental	factors	such	as	the	microbiota	can	affect	the	susceptibility	to	develop	local	and	systemic	autoimmune	responses	particularly	in	the	cases	of	food	allergy	systemic	lupus	erythematosus	and	rheumatoid	arthritis	Induction	of	pathogenic	autoreactive	immune	responses	at	host	barriers	in	these	diseases	can	contribute	to	the	initiation	and	progression	of	their	pathogenesis

An	18-year-old	Japanese	woman	with	systemic	lupus	erythematosus	experienced	dyspnoea	headache	tinnitus	and	purpura	for	2	weeks	and	was	admitted	to	our	hospital	The	patient	had	been	diagnosed	with	systemic	lupus	erythematosus	and	secondary	immune	thrombocytopenia	8	years	before	and	treated	with	high-dose	prednisolone	and	mycophenolate	mofetil	Since	the	blood	test	on	admission	showed	haemolytic	anaemia	with	a	positive	direct	Coombs	test	and	anti-glycoprotein	IIb	IIIa	antibodies	the	patient	was	initially	diagnosed	with	Evans	syndrome	ES	The	patient	was	treated	with	pulse	intravenous	methylprednisolone	followed	by	45	mg	day	prednisolone	however	the	patient	s	platelet	count	did	not	normalise	Based	on	a	low	level	of	a	disintegrin-like	and	metalloproteinase	with	thrombospondin	type	1	motif	13	ADAMTS-13	activity	and	a	high	level	of	ADAMTS-13	inhibitors	a	diagnosis	of	acquired	thrombotic	thrombocytopenic	purpura	TTP	was	confirmed	After	undergoing	therapeutic	plasma	exchange	for	6	consecutive	days	the	patient	s	platelet	count	recovered	rapidly	Although	concurrent	acquired	TTP	and	ES	have	not	been	reported	previously	the	findings	from	this	case	highlight	the	importance	of	measuring	ADAMTS-13	activity	and	inhibitors	to	rule	out	acquired	TTP	especially	when	ES	is	refractory	to	glucocorticoids
This	study	aimed	to	describe	the	healthcare	resource	utilization	HCRU	and	healthcare	costs	associated	with	systemic	lupus	erythematosus	SLE	management	in	China	from	the	patient	s	and	the	payer	s	perspective
The	aim	of	this	study	was	to	define	the	clinical	histopathologic	and	prognostic	features	associated	with	simultaneous	positivity	for	anti-dsDNA	-nucleosome	and	-histone	antibodies	3-pos	in	Korean	patients	with	biopsy-proven	lupus	nephritis	LN
Systemic	lupus	erythematosus	SLE	is	a	rare	multisystem	autoimmune	disorder	with	a	variable	clinical	phenotype	Pulmonary	hypertension	PHTN	is	a	recognised	and	not	uncommonly	asymptomatic	complication	of	the	condition	with	an	associated	poor	prognosis	in	adults	It	is	relatively	rare	in	juvenile-onset	SLE	JSLE
To	perform	a	systematic	review	with	meta-analysis	to	verify	muscle	strength	muscle	mass	and	physical	function	of	patients	with	systemic	lupus	erythematosus	SLE	and	compare	then	with	healthy	individuals	and	patients	with	rheumatoid	arthritis	RA	A	systematic	review	with	meta-analysis	of	observational	studies	published	in	English	up	to	2022	was	performed	using	MEDLINE	via	PubMed	and	other	relevant	sources	Search	strategies	were	based	on	pre-defined	keywords	and	medical	subject	headings	The	methodological	quality	of	the	studies	was	assessed	using	the	Newcastle-Ottawa	Scale	Mean	difference	MD	or	standardized	mean	difference	SMD	and	95	confidence	intervals	CI	were	combined	using	a	random-effects	model	Sensitivity	analyses	were	performed	when	necessary	The	significance	level	was	set	at	p	0	05	The	systematic	review	included	19	studies	and	the	meta-analysis	included	11	studies	SLE	patients	appear	to	have	less	muscle	strength	assessed	by	handgrip	than	healthy	controls	SLE	21	74	kg	healthy	controls	29	34	kg	p	0	05	SLE	patients	seem	to	have	greater	strength	than	patients	with	RA	but	this	difference	was	not	statistically	significant	RA	17	24	kg	p	0	210	However	in	the	sensitivity	analysis	SLE	group	without	deforming	arthropathy	showed	higher	muscle	strength	than	the	RA	p	0	0001	SLE	patients	with	deforming	arthropathy	have	lower	muscle	strength	compared	to	SLE	patients	without	deforming	arthropathy	p	0	01	Muscle	mass	was	similar	in	SLE	patients	compared	to	the	RA	group	and	healthy	controls	p	0	05	However	RA	patients	have	a	higher	BMI	than	the	two	groups	p	0	05	Patients	with	SLE	have	regular	physical	function	Muscle	strength	is	affected	in	SLE	patients	SLE	patients	with	deforming	arthropathy	have	less	muscle	strength	than	patients	without	deforming	arthropathies
Systemic	lupus	erythematosus	SLE	is	known	to	cause	non-scarring	alopecia	However	histopathological	evaluation	is	uncommon
Hydroxychloroquine	HCQ	is	an	antimalarial	agent	used	to	treat	mucocutaneous	musculoskeletal	constitutional	manifestations	of	systemic	lupus	erythematosus	SLE	This	study	assessed	the	efficacy	and	side	effects	of	HCQ	in	children	with	proliferative	lupus	nephritis	LN	This	double-blind	randomized	placebo-controlled	trial	study	was	conducted	on	60	children	with	proliferative	LN	classes	III	and	IV	treated	with	steroids	and	a	mycophenolate	MMF	regimen	Patients	were	categorized	into	two	groups	the	HCQ	group	n	30	and	the	placebo	group	n	30	They	were	evaluated	initially	at	6-	and	a	12-month	follow-up	by	mucocutaneous	ophthalmological	examination	and	investigations	BUN	creatinine	24	h	proteinuria	triglycerides	TG	cholesterol	Antids-DNA	C3	C4	Disease	activity	was	assessed	using	the	SLE	disease	activity	index	SLEDAI-2	k	After	12	months	TG	cholesterol	24	h	proteinuria	Antids-DNA	and	SLEDAI	score	were	significantly	decreased	in	the	HCQ	group	P	0	002	0	012	0	031	0	001	respectively	After	12	months	the	cumulative	probabilities	of	developing	primary	end-points	LN	partial	and	complete	remission	were	40	and	60	in	the	HCQ	group	versus	53	3	and	36	7	in	the	placebo	group	P	0	002	After	12	months	the	HCQ	group	experienced	mucocutaneous	alopecia	3	3	hyperpigmentation	10	and	ophthalmological	mild	retinal	changes	6	7	but	they	did	not	differ	significantly	from	the	placebo	group	Cunclusion	HCQ	improved	the	disease	and	LN	activity	in	children	with	proliferative	LN	with	documented	skin	hyperpigmentation	and	mild	retinal	changes	following	HCQ	use	in	a	few	cases	This	study	was	registered	on	http	www
The	coronavirus	SARS-CoV-2	which	is	the	cause	of	COVID-19	disease	in	infected	patients	has	led	to	an	ongoing	worldwide	pandemic	Although	SARS-CoV-2	vaccination	had	a	dramatic	positive	effect	on	the	course	of	COVID-19	there	has	been	increasing	evidence	of	adverse	effects	after	SARS-CoV-2	vaccination	This	meta-analysis	highlights	the	association	between	SARS-CoV-2	vaccination	and	de	novo	induction	or	aggravation	of	inflammatory	and	autoimmune	skin	diseases
Genetics	and	gut	microbiota	contribute	to	the	development	of	autoimmune	diseases	SKG	mice	which	harbor	a	point	mutation	in	the	ZAP70	gene	develop	autoimmune	arthritis	in	BALB	c	background	and	systemic	lupus	erythematosus	in	C57BL	6	background	Defective	TCR	signaling	by	ZAP70	mutation	alters	thymic	selection	thresholds	and	allows	the	positive	selection	of	otherwise	negatively	selected	self-reactive	T	cells	On	the	other	hand	defective	TCR	signaling	attenuates	the	positive	selection	of	certain	microbiota-reactive	T	cells	which	lead	to	impaired	IgA	synthesis	at	mucosal	site	and	gut	dysbiosis	Gut	dysbiosis	in	turn	promotes	autoimmunity	via	driving	Th17	differentiation	Thus	defective	TCR	signaling	leads	to	autoimmunity	by	altering	thymic	selection	thresholds	of	self-reactive	T	cells	and	microbiota-reactive	T	cells	In	this	review	genomics-microbiota	interactions	for	the	development	of	autoimmunity	will	be	discussed	with	the	special	focus	on	the	recent	finding	obtained	from	animal	models	of	autoimmunity	with	defective	TCR	signaling
To	clarify	the	controversy	between	systemic	lupus	erythematosus	SLE	and	thyroid	disease	our	study	was	designed	to	determine	whether	or	not	thyroid	problems	are	associated	with	SLE
Patients	with	systemic	lupus	erythematosus	SLE	are	at	elevated	risk	for	Q10	cardiovascular	disease	CVD	due	to	accelerated	atherosclerosis	Compared	to	heathy	control	subjects	lupus	patients	have	higher	volumes	and	densities	of	thoracic	aortic	perivascular	adipose	tissue	PVAT	which	independently	associates	with	vascular	calcification	a	marker	of	subclinical	atherosclerosis	However	the	biological	and	functional	role	of	PVAT	in	SLE	has	not	been	directly	investigated
Despite	how	difficult	the	early	diagnosis	of	systemic	lupus	erythematosus	SLE	is	which	is	mainly	due	to	the	heterogeneity	and	non-specificity	of	its	clinical	manifestations	SLE	is	currently	being	diagnosed	more	frequently	than	in	past	decades	In	fact	there	has	been	an	increase	in	the	incidence	and	prevalence	of	SLE	over	the	last	four	decades	this	can	be	explained	by	a	number	of	reasons	including	a	better	knowledge	of	the	pathogenesis	of	the	disease	which	allows	its	earlier	diagnosis	the	rising	ethnic	and	racial	diversity	of	the	world	population	the	use	of	the	2019	EULAR	ACR	criteria	that	allows	classifying	patients	earlier	and	improvements	in	survival	over	the	last	decades	which	results	in	an	increase	in	the	prevalent	cases	of	SLE	In	this	article	we	will	also	review	the	genetic	environmental	and	lifestyle	factors	that	are	reported	to	increase	the	risk	of	developing	SLE	and	how	preventive	strategies	through	a	clinical	care	pathway	may	prevent	or	delay	the	development	of	SLE	and	improve	these	patients	outcomes
There	is	a	high	prevalence	of	burnout	among	rheumatologists	Grit	which	is	defined	as	possessing	perseverance	and	a	passion	to	achieve	long-term	goals	is	predictive	of	success	in	many	professions	however	whether	grit	is	associated	with	burnout	remains	unclear	especially	among	academic	rheumatologists	who	have	multiple	simultaneous	responsibilities	Thus	the	purpose	of	this	study	was	to	examine	the	associations	between	grit	and	self-reported	burnout	components-professional	efficacy	exhaustion	and	cynicism-in	academic	rheumatologists
Maternal	systemic	lupus	erythematosus	SLE	is	at	greater	risk	of	pregnancy	complications	and	is	associated	with	increased	risk	of	preterm	delivery	However	hardly	any	study	has	looked	at	the	influence	of	SLE	on	the	outcomes	of	preterm	infants	This	study	aimed	to	explore	the	influence	of	SLE	on	the	outcomes	of	preterm	infants
To	determine	vitamin	D	levels	in	patients	with	SLE	and	evaluate	their	relationship	to	bone	mineral	density	BMD	and	the	disease	course
Hemophagocytic	lymphohistiocytosis	HLH	is	a	well-recognized	complication	of	systemic	lupus	erythematosus	SLE	This	study	aims	to	characterize	HLH	with	and	without	SLE	in	the	US	adult	inpatient	population
The	study	aims	to	increase	the	understanding	regarding	the	role	of	regulatory	T	cells	Tregs	in	lupus	nephritis	LN	and	ANCA-associated	vasculitis	AAV	by	comparing	their	localization	in	renal	tissue	and	changes	following	immunosuppressive	therapy	Kidney	biopsies	from	12	patients	with	LN	and	7	patients	with	AAV	were	examined	Kidney	biopsies	had	been	performed	both	at	active	disease	and	following	immunosuppressive	treatment	Clinical	data	was	collected	at	both	biopsy	occasions	Expression	of	Forkhead	Box	P	3	Foxp3	in	renal	tissue	was	assessed	by	immunohistochemistry	An	arbitrary	scale	was	used	to	estimate	the	number	of	Foxp3	cells	In	LN	8	12	67	had	positive	tissue	staining	for	Foxp3	at	baseline	most	pronounced	in	inflammatory	infiltrates	but	also	interstitially	and	in	a	peri-glomerular	pattern	At	second	biopsies	after	immunosuppressive	treatment	4	12	33	still	had	detectable	Foxp3	cells	found	in	persisting	inflammatory	infiltrates	and	some	in	the	interstitium	Patients	with	a	good	clinical	response	to	treatment	had	high	grade	of	Foxp3	cells	in	first	biopsies	In	AAV	only	2	7	29	had	positive	staining	for	Foxp3	at	baseline	in	inflammatory	infiltrates	and	to	a	lesser	extent	in	the	interstitium	despite	large	areas	of	inflammatory	infiltrates	in	all	patients	At	follow-up	2	7	29	biopsies	were	positive	for	Foxp3	Our	data	show	a	higher	presence	of	Foxp3	cells	in	renal	tissue	from	LN	patients	compared	to	AAV	suggesting	that	Tregs	may	be	differently	involved	in	the	control	of	inflammatory	mechanisms	in	these	diseases	These	findings	could	have	further	implication	for	therapeutic	approaches	aiming	at	restoring	the	immunological	tolerance	Key	Points	Foxp3	-cells	are	present	in	larger	amount	in	renal	tissue	in	lupus	nephritis	vs	ANCA-associated	vasculitis	Our	data	suggest	that	Foxp3	regulatory	T	cells	are	involved	in	the	control	of	inflammatory	processes	in	lupus	nephritis
Macrophage	activation	syndrome	MAS	is	a	rare	illness	especially	in	critically	ill	adults	The	diagnosis	of	MAS	is	challenging	requiring	the	expertise	of	multiple	specialists	and	treatments	for	MAS	can	be	associated	with	catastrophic	complications
Observational	studies	have	demonstrated	that	there	was	a	significant	correlation	between	systemic	lupus	erythematosus	SLE	and	anxiety	disorder	but	the	causal	relationship	between	them	is	not	so	clearly	established	This	study	aims	to	reveal	the	potential	causal	link	between	SLE	and	anxiety	disorder
Lupus	nephritis	LN	is	the	most	common	complication	of	systemic	lupus	erythematosus	SLE	This	study	aimed	to	explore	biomarkers	mechanisms	and	potential	novel	agents	regarding	LN	through	bioinformatic	analysis
Lupus	nephritis	LN	is	among	the	most	common	complication	of	systemic	lupus	erythematosus	SLE	with	high	mortality	and	morbidity	The	analysis	of	LN	kidney	s	local	immune	response	through	single-cell	and	spatial	transcriptome	enables	the	study	of	potential	therapeutic	targets
Lupus	nephritis	LN	a	common	manifestation	of	systemic	lupus	erythematosus	is	associated	with	a	higher	risk	of	kidney	failure	and	death	The	renal	pathology	of	LN	helps	elucidate	the	severity	of	inflammation	and	the	extent	of	irreversible	damage	We	aimed	to	identify	histologic	variables	that	correlate	with	risks	of	kidney	failure	and	mortality
Disturbed	lipid	metabolism	was	observed	in	systemic	lupus	erythematosus	SLE	patients	This	study	aimed	to	evaluate	the	relationships	between	dyslipidemia	and	visceral	organ	involvement	disease	severity	inflammatory	factors	and	drug	intake	in	SLE	patients
Systemic	lupus	erythematosus	SLE	is	a	systemic	autoimmune	disease	This	study	aimed	to	investigate	the	role	of	SMAD	specific	E3	ubiquitin	protein	ligase	1	SMURF1	in	the	Th17	and	Th17	1	differentiation	and	Treg	Th17	imbalance	which	are	major	factors	contributing	to	the	pathogenesis	of	SLE	SLE	patients	and	healthy	individuals	were	recruited	to	detect	the	SMURF1	levels	in	na	ve	CD4	cells	from	peripheral	blood	Purified	and	expanded	na	ve	CD4	T	cells	were	employed	to	evaluate	the	effects	of	SMURF1	on	Th17	and	Th17	1	polarization	in	vitro	MRL	lpr	lupus	model	was	employed	to	explore	the	disease	phenotype	as	well	as	Treg	Th17	balance	in	vivo	The	results	showed	that	SMURF1	was	down-regulated	in	na	ve	CD4	T	cells	in	peripheral	blood	of	patients	with	SLE	and	in	spleen	of	MRL	lpr	mice	SMURF1	overexpression	suppressed	the	polarization	of	na	ve	CD4	T	cells	toward	Th17	and	Th17	1	phenotype	and	down-regulated	the	expression	of	retinoid-related	orphan	receptor-gammat	ROR	t	Subsequently	SMURF1	down-regulation	aggravated	the	disease	phenotype	inflammation	and	the	Treg	Th17	imbalance	in	MRL	lpr	mice	Furthermore	we	found	that	SMURF	overexpression	promoted	the	ubiquitination	and	decreases	the	stability	of	ROR	t	In	conclusion	SMURF1	inhibited	the	polarization	of	Th17	and	Th17	1	cells	and	improved	the	Treg	Th17	imbalance	in	SLE	which	was	mediated	as	least	partly	by	the	ubiquitination	of	ROR	t
More	than	10	disease-modifying	therapies	DMT	are	approved	by	the	European	Medicines	Agency	EMA	and	the	US	Food	and	Drug	Administration	FDA	for	the	treatment	of	multiple	sclerosis	MS	and	new	therapeutic	options	are	on	the	horizon	Due	to	different	underlying	therapeutic	mechanisms	a	more	individualized	selection	of	DMTs	in	MS	is	possible	taking	into	account	the	patient	s	current	situation	Therefore	concomitant	treatment	of	various	comorbid	conditions	including	autoimmune	mediated	disorders	such	as	rheumatoid	arthritis	should	be	considered	in	MS	patients	Because	the	pathomechanisms	of	autoimmunity	partially	overlap	DMT	could	also	treat	concomitant	inflammatory	diseases	and	simplify	the	patient	s	treatment	In	contrast	the	exacerbation	and	even	new	occurrence	of	several	autoimmune	diseases	have	been	reported	as	a	result	of	immunomodulatory	treatment	of	MS	To	simplify	treatment	and	avoid	disease	exacerbation	knowledge	of	the	beneficial	and	adverse	effects	of	DMT	in	other	autoimmune	disorders	is	critical	Therefore	we	conducted	a	literature	search	and	described	the	beneficial	and	adverse	effects	of	approved	and	currently	studied	DMT	in	a	large	number	of	comorbid	autoimmune	diseases	including	rheumatoid	arthritis	ankylosing	spondylitis	inflammatory	bowel	diseases	cutaneous	disorders	including	psoriasis	Sj	gren	s	syndrome	systemic	lupus	erythematosus	systemic	vasculitis	autoimmune	hepatitis	and	ocular	autoimmune	disorders	Our	review	aims	to	facilitate	the	selection	of	an	appropriate	DMT	in	patients	with	MS	and	comorbid	autoimmune	diseases
There	has	been	a	cumulative	interest	in	relationships	between	systemic	lupus	erythematosus	SLE	and	cancer	risk	Breast	cancer	is	the	most	common	cancer	among	women	worldwide	However	the	casual	association	and	pathogenesis	between	SLE	and	breast	cancer	remains	incompletely	unknown
Patients	with	SLE	are	at	high	risk	of	various	infections	as	evidenced	by	a	number	of	studies	The	main	determinants	of	infection	in	SLE	are	disease	activity	organ	damage	and	often	inevitable	medication	The	molecular	and	cellular	mechanisms	underlying	infection	remain	unclear	Impaired	immunity	immunosuppressants	and	corticosteroids	clearly	increase	the	risk	of	infection	whereas	some	medications	such	as	low-dose	IL-2	hydroxychloroquine	and	IVIG	are	safe	in	SLE	patients	with	substantial	evidence	It	is	important	to	balance	the	immunosuppression	and	infection	risks	in	practice	This	article	focuses	on	medication-related	infections	in	SLE	and	discusses	the	therapeutic	options	for	the	disease	in	clinical	practice
To	compare	the	risk	of	SARS-CoV-2	infection	and	its	related	severe	sequelae	between	patients	with	systemic	lupus	erythematosus	SLE	and	the	general	population	according	to	COVID-19	vaccination	status
N-acetylcysteine	NAC	has	broadly	been	used	as	an	anti-oxidant	agent	in	various	types	of	diseases	This	study	aimed	to	assess	the	effect	of	NAC	on	the	systemic	lupus	erythematosus	SLE	disease	activity	and	outcome
The	objective	is	to	perform	a	multimodal	ophthalmological	evaluation	including	optical	coherence	angiography	OCTA	asymptomatic	APS	secondary	to	SLE	APS	SLE	and	compare	to	SLE	patients	and	control	group	CG	We	performed	a	complete	structural	functional	ophthalmological	evaluation	using	OCTA	microperimetry	exam	in	all	participants	One	hundred	fifty	eyes	75	asymptomatic	subjects	APS	SLE	n	25	SLE	n	25	and	CG	n	25	were	included	Ophthalmologic	abnormalities	occurred	in	9	36	APS	SLE	11	44	SLE	and	none	of	CG	p	0	001	The	most	common	retinal	finding	was	Drusen-like	deposits	DLDs	exclusively	in	APS	SLE	and	SLE	16	vs	24	p	0	75	whereas	severe	changes	occurred	solely	in	APS	SLE	2	paracentral	acute	middle	maculopathy	PAMM	and	1	homonymous	quadrantanopsia	A	trend	of	higher	frequency	of	antiphospholipid	antibody	aPL	triple	positivity	100	vs	16	p	0	05	and	higher	mean	values	of	adjusted	Global	Antiphospholipid	Syndrome	Score	aGAPSS	14	0	vs	9	69	3	44	p	0	09	was	observed	in	APS	SLE	with	PAMM	vs	those	without	this	complication	We	identified	that	ophthalmologic	retinal	abnormalities	occurred	in	more	than	1	4	of	asymptomatic	APS	SLE	and	SLE	DLDs	are	the	most	frequent	with	similar	frequencies	in	both	conditions	whereas	PAMM	occurred	exclusively	in	APS	SLE	patients	The	possible	association	of	the	latter	condition	with	aPL	triple	positivity	and	high	aGAPSS	suggests	these	two	conditions	may	underlie	the	retinal	maculopathy	Our	findings	in	asymptomatic	patients	reinforce	the	need	for	early	surveillance	in	these	patients	Key	Points	Retinal	abnormalities	occur	in	more	than	1	4	of	asymptomatic	APS	SLE	and	SLE	patients	The	occurrence	of	PAMM	is	possibly	associated	with	APS	and	DLDs	with	SLE	Presence	of	aPL	triple	positivity	and	high	aGAPSS	seem	to	be	risk	factors	for	PAMM
Systemic	lupus	erythematosus	SLE	is	a	chronic	autoimmune	disease	Lupus	nephritis	LN	is	a	common	type	of	organ	damage	which	occurs	in	SLE	patients	and	is	characterized	by	recurrent	proteinuria	Activation	of	B	lymphocytes	can	lead	to	refractory	LN	which	is	an	important	pathogenic	factor	in	SLE	B	lymphocyte	stimulator	BLyS	and	A	proliferation-inducing	ligand	APRIL	are	predominantly	produced	by	myeloid	cells	monocytes	dendritic	cells	neutrophils	etc	to	regulate	B	lymphocyte	function	Telitacicept	was	the	first	dual-targeting	biological	drug	which	targeted	both	BLyS	and	APRIL	Telitacicept	has	passed	a	phase	II	clinical	trial	and	has	since	been	approved	for	the	treatment	of	SLE
We	aimed	to	identify	factors	associated	with	a	significant	reduction	in	SLE	disease	activity	over	12	months	assessed	by	the	BILAG	Index
The	pentraxin	C-reactive	protein	CRP	is	a	pentameric	protein	now	known	to	be	able	to	undergo	dissociation	into	a	monomeric	modified	isoform	referred	to	as	mCRP	In	carefully	assessing	the	bioactivities	of	each	isoform	mCRP	has	strong	pro-inflammatory	activities	while	pCRP	has	mild	anti-inflammatory	activities	Systemic	lupus	erythematosus	SLE	is	a	disease	characterized	by	a	vast	number	of	autoantibodies	including	anti-CRP	autoantibodies	which	have	been	associated	with	SLE	disease	activity	and	lupus	nephritis	The	origin	of	these	autoantibodies	is	currently	unknown	Extracellular	vesicles	EVs	have	been	implicated	in	SLE	pathogenesis	as	they	can	expose	nuclear	antigens	on	their	outside	surface	thereby	being	a	potential	adjuvant	for	the	generation	of	autoantibodies	Herein	we	studied	exposure	of	both	pCRP	and	mCRP	on	EVs	in	SLE	plasma	and	the	implications	of	each	in	disease	activity	organ	damage	and	clinical	manifestations	We	used	flow	cytometry	to	detect	CRP	isoforms	on	EV	surfaces	in	67	well-characterized	SLE	patients	and	60	sex-	and	age-matched	healthy	controls	Autoantibodies	against	mCRP	were	measured	using	ELISA	We	found	an	abundance	of	both	pCRP	and	mCRP	on	SLE	EVs	compared	to	controls	Furthermore	mCRP	but	not	pCRP	EVs	were	elevated	in	patients	with	active	disease	and	in	anti-CRP	positive	patients	The	proportions	of	mCRP	EVs	were	lower	in	patients	with	acquired	organ	damage	especially	in	patients	with	lupus	nephritis	LN	and	displayed	an	inverse	relationship	with	disease	duration	in	LN	and	patients	with	active	disease	Speculatively	these	data	suggest	EV-bound	mCRP	as	a	relevant	factor	in	SLE	pathogenesis	which	could	contribute	to	development	of	anti-CRP	autoantibodies	by	stimulating	an	immune	response
Retiform	purpura-like	lesions	are	rarely	seen	clinically	and	can	be	induced	by	cutaneous	vascular	wall	damage	or	a	lumen-occlusive	disease	arising	from	a	broad	range	of	triggers	including	infection	drugs	emboli	cryoglobulinemia	disseminated	intravascular	coagulation	and	autoimmune	disease	Here	we	present	the	case	of	a	patient	suffering	from	both	systemic	lupus	erythematosus	SLE	and	antiphospholipid	syndrome	APS	with	retiform	purpura	as	the	first	lesion	and	lacking	other	typical	symptoms	of	SLE	such	as	photosensitivity	malar	rash	ulceration	of	the	mouth	and	nose	alopecia	and	joint	pain
Interferon	gamma	IFN	is	a	cytokine	implicated	in	the	pathogenesis	of	autoimmune	diseases	SAM	and	HD	domain-containing	protein	1	SAMHD1	is	an	IFN	-inducible	protein	that	modulates	cellular	dNTP	levels	Mutations	in	the	human	SAMHD1	gene	cause	Aicardi-Gouti	res	AG	syndrome	an	autoimmune	disease	sharing	similar	clinical	features	with	systemic	lupus	erythematosus	SLE	Klotho	is	an	anti-inflammatory	protein	which	suppresses	aging	through	multiple	mechanisms	Implication	of	Klotho	in	autoimmune	response	is	identified	in	rheumatologic	diseases	such	as	SLE	Little	information	exists	regarding	the	effect	of	Klotho	in	lupus	nephritis	one	of	the	prevalent	symptoms	of	SLE	The	present	study	verified	the	effect	of	IFN	on	SAMHD1	and	Klotho	expression	in	MES-13	glomerular	mesangial	cells	a	special	cell	type	in	glomerulus	that	is	critically	involved	in	lupus	nephritis	IFN	upregulated	SAMHD1	expression	in	MES-13	cells	through	the	Janus	kinase-signal	transducer	and	activator	of	transcription	1	JAK-STAT1	and	the	nuclear	factor	kappa	B	NF	B	signaling	pathways	IFN	decreased	Klotho	protein	expression	in	MES-13	cells	Treatment	of	MES-13	cells	with	recombinant	Klotho	protein	inhibited	SAMHD1	expression	by	blocking	IFN	-induced	NF	B	nuclear	translocation	but	showed	no	effect	on	JAK-STAT1	signaling	Collectively	our	findings	support	the	protective	role	of	Klotho	in	attenuating	lupus	nephritis	through	the	inhibition	of	IFN	-induced	SAMHD1	expression	and	IFN	downstream	signaling	in	MES-13	cells
The	segmentation	of	medical	images	is	a	crucial	and	demanding	step	in	medical	image	processing	that	offers	a	solid	foundation	for	subsequent	extraction	and	analysis	of	medical	image	data	Although	multi-threshold	image	segmentation	is	the	most	used	and	specialized	basic	image	segmentation	technique	it	is	computationally	demanding	and	often	produces	subpar	segmentation	results	hence	restricting	its	application	To	solve	this	issue	this	work	develops	a	multi-strategy-driven	slime	mould	algorithm	RWGSMA	for	multi-threshold	image	segmentation	Specifically	the	random	spare	strategy	the	double	adaptive	weigh	strategy	and	the	grade-based	search	strategy	are	used	to	improve	the	performance	of	SMA	resulting	in	an	enhanced	SMA	version	The	random	spare	strategy	is	mainly	used	to	accelerate	the	convergence	rate	of	the	algorithm	To	prevent	SMA	from	falling	towards	the	local	optimum	the	double	adaptive	weights	are	also	applied	The	grade-based	search	approach	has	also	been	developed	to	boost	convergence	performance	This	study	evaluates	the	efficacy	of	RWGSMA	from	many	viewpoints	using	30	test	suites	from	IEEE	CEC2017	to	effectively	demonstrate	the	importance	of	these	techniques	in	RWGSMA	In	addition	numerous	typical	images	were	used	to	show	RWGSMA	s	segmentation	performance	Using	the	multi-threshold	segmentation	approach	with	2D	Kapur	s	entropy	as	the	RWGSMA	fitness	function	the	suggested	algorithm	was	then	used	to	segment	instances	of	lupus	nephritis	The	experimental	findings	demonstrate	that	the	suggested	RWGSMA	beats	numerous	similar	rivals	suggesting	that	it	has	a	great	deal	of	promise	for	segmenting	histopathological	images
Bisphenol	A	BPA	is	a	common	environmental	endocrine	disruptor	which	mimic	the	effect	of	estrogen	The	immunotoxicity	of	BPA	has	attracted	widespread	attention	in	recent	years	However	the	effects	and	mechanism	of	BPA	on	autoimmune	disease	were	rarely	reported	Systemic	lupus	erythematosus	SLE	is	a	typical	autoimmune	disease	and	its	etiology	and	mechanism	are	complex	and	unclear	Currently	inflammation	and	the	production	of	autoantibodies	are	considered	to	be	important	pathological	mechanisms	of	SLE	and	estrogen	contributes	to	the	occurrence	and	development	of	SLE	Therefore	in	order	to	explore	whether	BPA	exposure	can	affect	the	development	of	SLE	and	its	possible	mechanism	we	used	MRL	lpr	lupus-prone	mice	and	C57	BL6	female	mice	exposed	to	0	1	and	0	2	g	mL	BPA	for	6	weeks	We	discovered	that	BPA	exposure	increased	the	concentration	of	serum	anti-dsDNA	antibody	and	IL-17	and	the	level	of	ROR	t	protein	the	transcription	factor	of	Th17	cells	Moreover	there	were	higher	expression	of	p-PI3K	p-AKT	p-mTOR	ULK	Rubicon	P62	Becline1	and	LC3	protein	in	spleen	tissue	of	BPA	exposed	MRL	lpr	mice	compared	with	the	control	However	there	were	no	significant	changes	in	the	expression	of	IL-17	ROR	t	or	mTOR	in	C57	mice	exposed	to	BPA	at	the	same	dose	Our	study	implied	that	BPA	exposure	induced	the	development	of	SLE	which	might	be	related	to	the	up-regulation	of	PI3K	AKT	mTOR	signaling	pathway	and	abnormal	autophagy	Our	study	indicated	that	lupus	mice	were	more	susceptible	to	BPA	and	provided	a	new	insight	into	the	mechanism	by	which	BPA	exacerbated	SLE	Therefore	our	study	suggested	that	autoimmune	patients	and	susceptible	population	should	be	considered	when	setting	thresholds	for	environmental	BPA	exposure
Systemic	lupus	erythematosus	SLE	is	frequently	accompanied	by	neuropsychiatric	NP	manifestations	However	typical	symptoms	of	catatonia	are	uncommon	Neuropsychiatric	SLE	or	its	mimickers	may	cause	NP	symptoms	making	differential	diagnosis	a	significant	challenge	in	clinical	practice
Zetomipzomib	KZR-616	is	a	selective	inhibitor	of	the	immunoproteasome	currently	undergoing	clinical	investigation	in	autoimmune	disorders	Here	we	characterized	KZR-616	in	vitro	and	in	vivo	using	multiplexed	cytokine	analysis	lymphocyte	activation	and	differentiation	and	differential	gene	expression	analysis	KZR-616	blocked	production	of	30	pro-inflammatory	cytokines	in	human	peripheral	blood	mononuclear	cells	PBMCs	polarization	of	T	helper	Th	cells	and	formation	of	plasmablasts	In	the	NZB	W	F1	mouse	model	of	lupus	nephritis	LN	KZR-616	treatment	resulted	in	complete	resolution	of	proteinuria	that	was	maintained	at	least	8	weeks	after	the	cessation	of	dosing	and	was	mediated	in	part	by	alterations	in	T	and	B	cell	activation	including	reduced	numbers	of	short	and	long-lived	plasma	cells	Gene	expression	analysis	of	human	PBMCs	and	tissues	from	diseased	mice	revealed	a	consistent	and	broad	response	focused	on	inhibition	of	T	B	and	plasma	cell	function	and	the	Type	I	interferon	pathway	and	promotion	of	hematopoietic	cell	lineages	and	tissue	remodeling	In	healthy	volunteers	KZR-616	administration	resulted	in	selective	inhibition	of	the	immunoproteasome	and	blockade	of	cytokine	production	following	ex	vivo	stimulation	These	data	support	the	ongoing	development	of	KZR-616	in	autoimmune	disorders	such	as	systemic	lupus	erythematosus	SLE	LN
Resilience	has	been	shown	to	be	associated	with	better	psychological	outcomes	and	ability	to	cope	with	negative	and	traumatic	events	in	the	healthcare	setting	Therefore	in	this	study	we	aimed	to	evaluate	resilience	and	its	association	with	disease	activity	and	health-related	quality	of	life	HRQOL	in	children	with	Systemic	Lupus	Erythematosus	SLE	and	Juvenile	Idiopathic	Arthritis	JIA
Lupus	cystitis	is	a	rare	but	serious	complication	of	systemic	lupus	erythematosus	SLE	that	can	cause	permanent	bladder	dysfunction	leading	to	irreversible	deterioration	of	kidney	function	We	report	two	cases	of	SLE	with	lupus	cystitis	who	showed	different	images	from	the	same	cause	of	disease
Observations	with	rituximab	suggest	B-cell	independent	mechanisms	of	cutaneous	lupus	erythematosus	CLE	in	systemic	lupus	erythematosus	SLE	especially	discoid	lupus	erythematosus	DLE	Type-I	interferon	receptor	blockade	with	anifrolumab	shows	efficacy	in	SLE	but	efficacy	for	cutaneous	disease	of	specific	morphologies	has	not	been	studied	Interferon	has	pleotropic	immune	effects	and	it	is	unknown	which	of	these	are	critical	to	therapeutic	response
Antibodies	to	histone	have	been	associated	in	the	adult	literature	with	systemic	lupus	erythematosus	SLE	and	drug	induced	lupus	DILE	Little	data	is	available	regarding	the	spectrum	of	pathology	that	antibodies	to	histone	encompass	in	the	pediatric	population	Prior	studies	suggest	an	association	with	SLE	juvenile	idiopathic	arthritis	JIA	uveitis	and	linear	scleroderma
Autoantibodies	against	NETs	ANETA	are	present	in	SLE	patients	We	aimed	to	determine	the	clinical	relevance	of	ANETA	in	SLE	Serum	from	129	SLE	patients	161	patients	with	various	rheumatoid	diseases	DC	and	53	healthy	controls	HC	were	tested	by	a	home-made	ANETA	ELISA	platform	ANETA	showed	a	sensitivity	of	35	7	and	a	specificity	of	92	5	respectively	in	the	diagnosis	of	SLE	The	combination	of	ANETA	with	anti-dsDNA	antibody	increased	the	diagnostic	sensitivity	from	49	6	to	62	8	for	SLE	The	presence	of	ANETA	potentiates	the	clinical	utility	of	anti-dsDNA	antibodies	in	identifying	a	subset	of	SLE	patients	with	higher	disease	activity	and	hematological	abnormalities	The	binding	of	ANETA	to	NETs	did	not	inhibit	the	immunostimulatory	effect	of	NETs	Our	findings	suggested	that	ANETA	have	potential	as	clinically	relevant	biomarkers	that	potentiate	the	clinical	performance	of	anti-dsDNA	antibodies	in	the	diagnosis	risk	stratification	and	subtyping	of	patients	with	SLE
1	Background	Immunological	laboratory	testing	is	known	to	be	complex	and	it	is	usually	performed	in	tertiary	referral	centers	Many	criticalities	affect	diagnostic	immunological	testing	such	as	limited	availability	the	need	for	specifically	trained	laboratory	staff	and	potential	difficulties	in	collecting	blood	samples	especially	in	the	most	vulnerable	patients	i	e	the	elderly	and	children	For	this	reason	the	identification	of	a	new	feasible	and	reliable	methodology	for	autoantibody	detection	is	urgently	needed	2	Methods	We	designed	a	systematic	review	to	investigate	the	available	literature	on	the	utilization	of	saliva	samples	for	immunological	testing	3	Results	A	total	of	170	articles	were	identified	Eighteen	studies	met	the	inclusion	criteria	accounting	for	1059	patients	and	671	controls	The	saliva	collection	method	was	mostly	represented	by	passive	drooling	11	18	61	and	the	most	frequently	described	methodology	for	antibody	detection	was	ELISA	12	18	67	The	analysis	included	392	patients	with	rheumatoid	arthritis	161	with	systemic	lupus	erythematosus	131	with	type	1	diabetes	mellitus	116	with	primary	biliary	cholangitis	100	with	pemphigus	vulgaris	50	with	bullous	pemphigoids	49	with	Sjogren	syndrome	39	with	celiac	disease	10	with	primary	antiphospholipid	syndromes	8	with	undifferentiated	connective	tissue	disease	2	with	systemic	sclerosis	and	1	with	autoimmune	thyroiditis	The	majority	of	the	reviewed	studies	involved	adequate	controls	and	saliva	testing	allowed	for	a	clear	distinction	of	patients	10	12	studies	83	More	than	half	of	the	papers	showed	a	correlation	between	saliva	and	serum	results	10	18	55	for	autoantibody	detection	with	varying	rates	of	correlation	sensitivity	and	specificity	Interestingly	many	papers	showed	a	correlation	between	saliva	antibody	results	and	clinical	manifestations	4	Conclusions	Saliva	testing	might	represent	an	appealing	alternative	to	serum-based	testing	for	autoantibody	detection	considering	the	correspondence	with	serum	testing	results	and	the	correlation	with	clinical	manifestations	Nonetheless	standardization	of	sample	collection	processing	maintenance	and	detection	methodology	has	yet	to	be	fully	addressed
Belimumab	is	the	first	biological	agent	approved	for	the	treatment	of	systemic	lupus	erythematosus	SLE	but	the	efficacy	of	belimumab	for	lupus	nephritis	LN	is	not	clear	We	conducted	this	meta-analysis	and	systematic	review	to	compare	the	efficacy	and	safety	of	belimumab	with	those	of	conventional	therapy	for	LN
Cases	of	acute	myocarditis	have	been	after	administration	of	the	BNT162b2	and	Ad26	COV2	S	vaccine
Cognitive	dysfunction	CD	is	detectable	in	approximately	40	of	patients	with	SLE	Despite	this	high	prevalence	there	are	no	approved	pharmacological	treatment	options	for	this	detrimental	condition	Preliminary	murine	studies	show	potential	for	targeting	microglial	activation	as	a	treatment	of	SLE-CD	which	may	be	ameliorated	with	centrally	acting	ACE	inhibitor	cACEi	and	angiotensin	receptor	blocker	cARB	use	The	aim	of	this	study	is	to	determine	if	there	is	an	association	of	cACEi	cARB	use	with	cognitive	function	in	a	human	SLE	cohort
To	characterize	the	antibody	response	to	COVID-19	mRNA	vaccination	in	patients	with	Systemic	Lupus	Erythematosus	SLE	and	identify	predictors	of	poor	response

To	identify	associations	between	mortality	in	cSLE	patients	and	their	characteristics	clinical	and	laboratory	features	disease	activity	and	damage	scores	and	treatment	to	evaluate	risk	factors	associated	with	mortality	in	cSLE	and	to	determine	the	most	frequent	causes	of	death	in	this	group	of	patients
Circulating	T	follicular	helper	cTfh	and	T	peripheral	helper	Tph	subpopulations	are	shown	to	be	higher	in	systemic	lupus	erythematosus	SLE	patients	and	have	been	involved	in	promoting	extrafollicular	B	cell	responses	However	a	possible	association	with	the	B	cell	activating	factor	BAFF	a	cytokine	mainly	related	to	B	cell	responses	and	disease	activity	in	SLE	has	not	been	investigated	Therefore	this	study	aimed	to	evaluate	the	association	of	cTfh	and	Tph	subpopulations	with	the	BAFF	system	expression	and	clinical	activity	in	SLE	patients
Progressive	multifocal	leukoencephalopathy	PML	is	a	central	nervous	system	disease	caused	by	the	human	polyomavirus	2	that	usually	occurs	in	a	setting	of	immunodeficiency	PML	without	overt	immunosuppression	is	considered	a	rare	occurrence	but	has	been	described	in	multiple	previous	case	reports	and	series	Its	prevalence	overall	frequency	and	prognosis	are	largely	unknown	This	is	a	single-center	retrospective	review	of	all	University	of	Florida	cases	with	the	ICD10	PML	diagnosis	code	A81	2	PML	without	overt	immunosuppression	was	defined	as	absence	of	human	immunodeficiency	virus	HIV	infection	hematological	malignancy	immunomodulatory	-suppressive	medications	autoimmune	conditions	with	a	propensity	for	PML	sarcoidosis	systemic	lupus	erythematosus	Cases	that	did	not	fulfill	criteria	for	clinically	or	histologically	definite	PML	were	excluded	Of	52	patients	with	the	ICD10	code	A	81	2	17	fulfilled	definite	diagnostic	criteria	for	PML	Overt	immunosuppression	was	identified	in	15	17	88	2	cases	10	17	58	8	human	immunodeficiency	virus	5	17	29	4	immunomodulatory	-suppressive	medication	Two	seventeen	11	8	cases	were	consistent	with	PML	without	overt	immunosuppression	Possible	contributing	factors	were	a	preceding	dog	bite	and	mild	hypogammaglobulinemia	M	39	mg	dL	in	case	1	and	significant	alcohol	use	without	evidence	for	liver	disease	in	case	2	Both	cases	were	fatal	within	6	case	1	and	2	case	2	months	The	results	suggest	that	PML	without	overt	immunosuppression	may	be	more	common	than	previously	described	Therefore	PML	should	be	considered	even	in	the	absence	of	overt	immunosuppression	if	clinical	and	radiographic	findings	are	suggestive	of	the	diagnosis
Extracellular	microparticles	provide	a	means	of	cell-to-cell	communication	and	can	promote	information	exchanges	between	adjacent	or	distant	cells	Platelets	are	cell	fragments	that	are	derived	from	megakaryocytes	Their	main	functions	are	to	stop	bleeding	regulate	inflammation	and	maintain	the	integrity	of	blood	vessels	When	platelets	are	activated	they	can	perform	related	tasks	by	secreting	platelet-derived	microparticles	that	contain	lipids	proteins	nucleic	acids	and	even	organelles	There	are	differences	in	the	circulating	platelet	levels	in	many	autoimmune	diseases	including	rheumatoid	arthritis	systemic	lupus	erythematosus	antiphospholipid	antibody	syndrome	and	Sjogren	s	syndrome	In	this	paper	the	latest	findings	in	the	research	field	of	platelet-derived	microparticles	are	reviewed	including	the	potential	pathogenesis	of	platelet-derived	microparticles	in	various	types	of	immune	diseases	their	potential	as	related	markers	and	for	monitoring	the	progress	and	prognosis	of	disease	treatment	are	expounded

Platelet-bound	complement	activation	product	C4d	PC4d	levels	correlate	with	history	of	thrombosis	in	patients	with	systemic	lupus	erythematosus	SLE	The	present	study	evaluated	whether	PC4d	levels	could	assess	risk	of	future	thrombosis	events
Despite	considerable	progress	in	our	understanding	of	systemic	lupus	erythematosus	SLE	pathophysiology	patient	diagnosis	is	often	deficient	and	late	and	this	has	an	impact	on	disease	progression	The	aim	of	this	study	was	to	analyze	non-coding	RNA	ncRNA	packaged	into	exosomes	by	next-generation	sequencing	to	assess	the	molecular	profile	associated	with	renal	damage	one	of	the	most	serious	complications	of	SLE	to	identify	new	potential	targets	to	improve	disease	diagnosis	and	management	using	Gene	Ontology	GO	and	the	Kyoto	Encyclopedia	of	Genes	and	Genomes	KEGG	analysis	The	plasma	exosomes	had	a	specific	ncRNA	profile	associated	with	lupus	nephritis	LN	The	three	ncRNA	types	with	the	highest	number	of	differentially	expressed	transcripts	were	microRNAs	miRNAs	long	non-coding	RNAs	lncRNAs	and	piwi-interacting	RNAs	piRNAs	We	identified	an	exosomal	29-ncRNA	molecular	signature	of	which	15	were	associated	only	with	LN	presence	piRNAs	were	the	most	representative	followed	by	lncRNAs	and	miRNAs	The	transcriptional	regulatory	network	showed	a	significant	role	for	four	lncRNAs	LINC01015	LINC01986	AC087257	1	and	AC022596	1	and	two	miRNAs	miR-16-5p	and	miR-101-3p	in	network	organization	targeting	critical	pathways	implicated	in	inflammation	fibrosis	epithelial-mesenchymal	transition	and	actin	cytoskeleton	From	these	a	handful	of	potential	targets	such	as	transforming	growth	factor-	TGF-	superfamily	binding	proteins	activin-A	TGFB	receptors	etc	WNT	-catenin	and	fibroblast	growth	factors	FGFs	have	been	identified	for	use	as	therapeutic	targets	of	renal	damage	in	SLE
Genetic	factors	play	a	crucial	role	in	the	immune	response	of	juvenile	idiopathic	arthritis	JIA	and	juvenile-onset	systemic	lupus	erythematosus	JSLE	This	study	aimed	to	investigate	the	association	of	IL12B	rs3212227	rs6887695	and	IL17	rs2275913	rs763780	gene	polymorphisms	with	the	susceptibility	of	JIA	and	JSLE	in	Chinese	children	A	total	of	303	healthy	controls	and	304	patients	including	160	JIA	and	144	patients	were	analyzed	and	the	genetic	polymorphisms	were	genotyped	by	using	a	Sequenom	MassArray	system	There	was	a	significant	association	between	the	IL12B	rs3212227	genotype	and	the	increased	risk	of	JSLE	P	01	For	rs6887695	the	minor	allele	C	was	significantly	associated	with	the	increased	risk	of	JIA	odds	ratio	1	48	95	confidence	interval	CI	1	12-1	95	P	005	Moreover	rs6887695	genotype	was	significantly	associated	with	both	JIA	and	JSLE	susceptibility	P	05	Besides	IL12B	haplotype	GC	significantly	associated	with	the	increased	risk	of	JIA	P	016	However	no	significant	difference	was	found	between	the	IL17	rs2275913	rs763780	gene	polymorphisms	and	JIA	or	JSLE	susceptibility	P	05	And	similar	genotype	distributions	of	IL12B	and	IL17	polymorphisms	were	found	between	the	patients	with	nephritis	and	without	nephritis	in	JSLE	P	05	Our	results	indicated	that	IL12B	polymorphisms	was	associated	with	an	increased	risk	for	the	development	of	JIA	and	JSLE	in	Chinese	children	highlighting	the	involvement	of	inflammation	in	the	pathogenesis	of	JIA	and	JSLE	Moreover	there	was	a	risk	haplotype	in	IL12B	which	could	increase	the	risk	of	JIA
Lupus	nephritis	LN	is	a	potentially	fatal	autoimmune	disease	The	purpose	of	this	study	was	to	find	potential	key	molecular	markers	of	LN	to	aid	in	the	early	diagnosis	and	management	of	the	disease	Datasets	GSE99967	blood	GSE32591	glomeruli	and	GSE32591	tubulointerstitium	were	included	in	this	study	Differentially	expressed	mRNAs	DEmRNAs	were	identified	between	the	normal	control	and	LN	groups	using	the	limma	package	in	R	Common	DEmRNAs	in	the	three	datasets	were	taken	Subsequently	functional	enrichment	analysis	immune	correlation	analysis	receiver	operating	characteristic	ROC	curve	analysis	and	real-time	polymerase	chain	reaction	RT-PCR	verification	were	performed	In	this	study	11	common	DEmRNAs	were	obtained	and	all	of	them	were	up-regulated	In	protein-protein	interaction	PPI	networks	we	found	that	MX	dynamin	like	GTPase	1	MX1	and	radical	S-adenosyl	methionine	domain	containing	2	RSAD2	had	the	highest	interaction	score	0	997	Functional	enrichment	analysis	revealed	that	MX1	and	RSAD2	were	enriched	in	influenza	A	and	hepatitis	C	signaling	pathways	The	area	under	the	curve	AUC	values	of	interferon-induced	protein	44	IFI44	and	MX1	in	GSE32591	glomeruli	and	GSE32591	tubulointerstitium	datasets	are	1	which	is	worthy	of	further	study	on	their	diagnostic	value	and	molecular	mechanism	The	xCell	analysis	showed	abnormal	distribution	of	granulocyte-macrophage	progenitor	GMP	cells	in	blood	glomeruli	and	tubulointerstitium	Pearson	s	correlation	analysis	found	that	GMP	cells	were	significantly	correlated	with	lactotransferrin	LTF	and	cell	cycle	Identification	of	common	DEmRNAs	and	key	pathways	in	the	blood	glomeruli	and	tubulointerstitium	of	patients	with	LN	provides	potential	research	directions	for	exploring	the	molecular	mechanisms	of	the	disease
Intermittent	fasting	which	includes	periods	of	fasting	and	nutrition	has	been	considered	a	dietary	approach	for	weight	loss	and	metabolic	health	improvement	However	its	potential	benefits	in	autoimmune	diseases	have	not	been	widely	studied	This	study	aims	to	review	the	existing	studies	on	the	role	and	effects	of	intermittent	fasting	on	autoimmune	diseases	A	comprehensive	search	was	conducted	on	electronic	databases	such	as	PubMed	Scopus	Embase	and	Web	of	Science	and	relevant	studies	were	included	based	on	inclusion	criteria	Studies	show	that	intermittent	fasting	may	have	beneficial	effects	on	various	autoimmune	diseases	such	as	type	1	diabetes	rheumatoid	arthritis	and	systemic	lupus	erythematosus	by	reducing	inflammatory	markers	modulating	the	immune	system	altering	and	improving	gut	microbiota	and	enhancing	cellular	repair	mechanisms	through	autophagy	However	evidence	regarding	the	effects	of	intermittent	fasting	on	other	autoimmune	diseases	such	as	multiple	sclerosis	systemic	lupus	erythematosus	thyroid	diseases	and	psoriasis	is	limited	and	inconclusive	Nevertheless	further	research	is	needed	to	determine	optimal	intermittent	fasting	guidelines	and	its	long-term	effects	on	autoimmune	diseases	Overall	this	literature	review	proves	intermittent	fasting	may	be	a	promising	dietary	intervention	for	managing	autoimmune	diseases
Acute	kidney	injury	AKI	with	the	requirement	of	kidney	replacement	therapy	KRT	portends	a	poor	prognosis	for	kidney	function	in	lupus	nephritis	LN	This	study	evaluated	the	kidney	function	recovery	rates	the	rates	of	reinitiation	of	KRT	and	factors	associated	with	these	outcomes	in	LN
Despite	the	continuing	development	of	immunomodulatory	agents	and	supportive	care	the	prognosis	associated	with	lupus	nephritis	LN	has	not	improved	substantially	in	the	past	decade	with	end-stage	kidney	disease	still	developing	in	5-30	of	patients	within	10	years	of	LN	diagnosis	Moreover	inter-ethnic	variation	in	the	tolerance	of	clinical	response	to	and	level	of	evidence	regarding	various	therapeutic	regimens	for	LN	has	led	to	variation	in	treatment	prioritization	in	different	international	recommendations	Modalities	that	better	preserve	kidney	function	and	reduce	the	toxicities	of	concomitant	glucocorticoids	are	unmet	needs	in	the	development	of	therapeutics	for	LN	In	addition	to	the	conventional	recommended	therapies	for	LN	there	are	newly	approved	treatments	as	well	as	investigational	drugs	in	the	pipeline	including	the	newer	generation	calcineurin	inhibitors	and	biologic	agents	In	view	of	the	heterogeneity	of	LN	in	terms	of	clinical	presentation	and	prognosis	the	choice	of	therapies	depends	on	a	number	of	clinical	considerations	Molecular	profiling	gene-signature	fingerprints	and	urine	proteomic	panels	might	enhance	the	accuracy	of	patient	stratification	for	treatment	personalization	in	the	future
We	aimed	to	study	insertion	deletion	I	D	variation	rs4646994	of	ACE	gene	in	a	group	of	SLE	patients	in	west	of	Iran	and	its	possible	relationship	with	oxidative	stress
Sj	gren	syndrome	SjS	is	an	autoimmune	disease	characterized	by	the	destruction	of	the	exocrine	gland	epithelia	causing	a	dryness	of	mucosa	called	sicca	symptoms	and	whose	main	life-threatening	complication	is	lymphoma	There	is	a	need	for	new	biomarkers	in	this	disease	notably	diagnostic	biomarkers	for	patients	with	genuine	sicca	symptoms	that	do	not	meet	current	criteria	and	prognostic	biomarkers	for	patients	at	risk	of	lymphoma	Plasma	extracellular	vesicles	EVs	are	promising	biomarker	candidates	in	several	diseases	but	their	potential	has	not	yet	been	explored	in	SjS	In	this	proof-of-concept	study	we	characterized	EVs	from	primary	SjS	patients	pSS	n	12	at	the	phenotypic	and	proteomic	levels	compared	to	EVs	from	healthy	donor	HD	n	8	and	systemic	lupus	erythematosus	patients	SLE	n	12	Specific	plasma	EVs	subpopulations	derived	from	neutrophils	endothelial	and	epithelial	cells	were	found	increased	in	pSS	We	also	identified	a	pSS	proteomic	signature	in	plasma	EVs	including	neutrophil-	epithelial-	and	endothelial-related	proteins	such	as	integrin	alpha	M	ITGAM	olfactomedin-4	OLFM4	Ras-related	protein	RAB10	and	CD36	Overall	our	results	support	the	relevance	of	plasma	EVs	as	biomarkers	in	SjS
A	32-year-old	woman	with	systemic	lupus	erythematosus	came	to	the	rheumatology	outpatient	clinic	reporting	abdominal	pain	for	a	week	along	with	fever	arthralgias	myalgias	alopecia	asthenia	and	dyspnea	on	exertion	over	the	last	two	months	She	was	hypotensive	and	tachycardic	requiring	admission	to	the	intensive	care	unit	She	was	diagnosed	with	lupus-related	acute	pancreatitis	an	unusual	complication	occurring	in	less	than	1	of	cases	Most	cases	are	mild	and	self-limited	however	severe	and	life-threatening	events	with	multiple	organ	failure	are	possible	This	article	is	a	case	report	of	lupus-related	critical	acute	pancreatitis	and	a	literature	review

Myalgia	myopathy	and	myositis	are	the	most	important	types	of	muscle	impairment	in	immune-mediated	inflammatory	arthropathies	and	connective	tissue	diseases	Multiple	pathogenetic	and	histological	changes	occur	in	the	striated	muscles	of	these	patients	Clinically	the	most	important	muscle	involvement	is	the	one	that	causes	complaints	to	the	patients	In	everyday	practice	insidious	symptoms	present	a	serious	problem	for	the	clinician	in	many	cases	it	is	difficult	to	decide	when	and	how	to	treat	the	muscle	symptoms	that	are	often	present	only	subclinically	In	this	work	authors	review	the	international	literature	on	the	types	of	muscle	problems	in	autoimmune	diseases	In	scleroderma	histopathological	picture	of	muscle	shows	a	very	heterogeneous	picture	necrosis	and	atrophy	are	common	In	rheumatoid	arthritis	and	systemic	lupus	erythematosus	myopathy	is	a	much	less	defined	concept	further	studies	are	needed	to	describe	it	According	to	our	view	overlap	myositis	should	be	recognized	as	a	separate	entity	preferably	with	distinct	histological	and	serological	characteristics	More	studies	are	needed	to	describe	muscle	impairment	in	autoimmune	diseases	which	may	help	to	explore	this	topic	more	in	depth	and	be	of	clinical	use
Numerous	interrelationships	are	known	in	the	literature	that	have	the	final	effect	of	unmasking	or	influencing	various	pathologies	Among	these	the	present	article	aims	to	discuss	the	connection	between	systemic	lupus	erythematosus	SLE	and	the	human	microbiome	The	main	purpose	of	this	work	is	to	popularize	information	about	the	impact	of	dysbiosis	on	the	pathogenesis	and	evolutionary	course	of	pediatric	patients	with	SLE	Added	to	this	is	the	interest	in	knowledge	and	awareness	of	adjunctive	therapeutic	means	that	has	the	ultimate	goal	of	increasing	the	quality	of	life	The	means	by	which	this	can	be	achieved	can	be	briefly	divided	into	prophylactic	or	curative	depending	on	the	phase	of	the	condition	in	which	the	patient	is	We	thus	reiterate	the	importance	of	the	clinician	acquiring	an	overview	of	SLE	and	the	human	microbiome	doubled	by	in-depth	knowledge	of	the	physio-pathogenic	interactions	between	the	two	in	part	achieved	through	the	much-studied	gut-target	organ	axes-brain	heart	lung	skin	with	the	target	objective	being	that	of	obtaining	individualized	multimodal	and	efficient	management	for	each	individual	patient
Systemic	lupus	erythematosus	SLE	is	a	prototypic	autoimmune	disease	mainly	mediated	by	IgG	autoantibody	While	follicular	helper	T	Tfh	cells	are	crucial	for	supporting	IgG	autoantibody	generation	in	human	SLE	underlying	mechanisms	for	Tfh	cell	mal-differentiation	remain	unclear
Although	the	therapeutic	efficacy	of	conventional	core	decompression	CD	for	the	early-stage	osteonecrosis	ON	has	been	widely	investigated	in	the	literature	no	study	to	date	has	specifically	focused	on	its	therapeutic	effect	on	the	long-term	outcome	of	ON	of	the	femoral	head	ONFH	in	systemic	lupus	erythematosus	SLE	This	study	aimed	to	provide	a	long-term	survival	analysis	of	all	hips	that	underwent	conventional	CD	for	the	management	of	ONFH	in	a	consecutive	case	series	of	patients	with	SLE
Lupus	nephritis	is	one	of	the	most	common	and	severe	complications	of	systemic	lupus	erythematosus	and	is	also	a	major	predictor	of	poor	prognosis	and	mortality	Lupus	nephritis	has	the	characteristics	of	insidious	onset	complex	pathological	types	rapid	progression	of	organ	damage	and	easy	recurrence	Currently	kidney	damage	in	lupus	nephritis	is	usually	assessed	based	on	urine	analysis	renal	biopsy	and	glomerular	filtration	rates	However	they	all	have	certain	limitations	making	it	difficult	to	diagnose	lupus	nephritis	early	and	assess	its	severity	and	progression	With	the	rapid	development	of	functional	magnetic	resonance	multiple	functional	imaging	techniques	are	expected	to	provide	more	useful	information	for	the	pathophysiological	development	early	diagnosis	progression	prognosis	and	renal	function	evaluation	of	lupus	nephritis	This	article	reviews	the	principle	of	multiple	functional	magnetic	resonance	imaging	and	the	research	status	of	evaluating	renal	function	in	lupus	nephritis


Collagen	vascular	diseases	such	as	lupus	erythematosus	and	dermatomyositis	DM	occur	2	to	3	times	more	often	among	patients	with	skin	of	color	In	this	article	the	authors	review	DM	and	cutaneous	lupus	erythematosus	including	acute	cutaneous	lupus	erythematosus	subacute	cutaneous	lupus	erythematosus	and	discoid	lupus	erythematosus	They	discuss	the	distinguishing	features	between	these	entities	and	highlight	distinct	presentations	and	management	considerations	in	patients	with	skin	of	color	to	aid	in	prompt	and	correct	diagnoses	in	this	patient	population
This	study	aimed	to	identify	differentially	expressed	genes	DEGs	of	systemic	lupus	erythematosus	SLE	using	gene	expression-based	computational	methodologies	to	analyze	disease-immune	interactions	which	affect	the	development	and	progression	of	SLE
Systemic	lupus	erythematosus	SLE	is	a	chronic	autoimmune	disease	involving	multiple	organs	It	is	often	called	immortal	cancer	due	to	the	difficulties	in	disease	treatment	As	the	cornerstone	of	immune	regulation	the	programmed	cell	death	protein	1	PD-1	has	been	extensively	studied	in	the	context	of	chronic	inflammation	due	to	its	ability	of	regulating	immune	response	and	immunosuppression	Recently	more	and	more	studies	on	rheumatic	immune	related	complications	have	also	focused	on	PD-1	and	proposed	that	the	use	of	PD-1	agonist	could	inhibit	the	activation	of	lymphocytes	and	alleviate	SLE	disease	activity	In	this	review	we	summarized	the	role	of	PD-1	in	SLE	implicating	its	potential	application	as	a	biomarker	to	predict	SLE	disease	activity	we	also	proposed	that	the	combination	of	PD-1	agonist	and	low-dose	IL-2	may	have	better	therapeutic	efficacy	shining	light	on	a	new	direction	for	developing	specific	treatment	approaches
Ferroptosis	resistance	is	vital	for	B	cell	development	especially	in	inflammatory	diseases	yet	the	underlying	mechanism	is	still	unclear	In	this	study	based	on	the	scRNA-seq	technique	and	flow	cytometry	we	discovered	a	proportion	of	neutrophils	exhibited	upregulated	expression	of	the	IL-6	and	correlated	with	the	expression	of	IL-6	receptor	and	SLC7A11	from	B	cells	in	lupus	kidney	Moreover	we	identified	that	in	lupus	kidney	neutrophils	could	provide	IL-6	to	facilitate	ferroptosis	resistance	in	B	cells	via	SLC7A11	and	inhibition	of	SLC7A11	could	significantly	enhance	ferroptosis	in	B	cells	and	could	decrease	B	cell	proliferation	This	study	helps	understand	the	crosstalk	between	neutrophils	and	B	cells	in	the	kidney	in	the	development	of	lupus
Scholars	are	exploring	novel	diagnostic	and	prognostic	biomarkers	with	higher	sensitivity	and	specificity	for	systemic	lupus	erythematosus	SLE	In	this	regard	DNA	methylation	alterations	have	aroused	attention	The	association	between	the	dysfunction	of	MMP9	and	TNFAIP3	genes	and	SLE	has	been	previously	demonstrated	Therefore	in	this	study	we	investigated	the	methylation	level	of	MMP9	and	TNFAIP3	promoters	in	peripheral	blood	mononuclear	cells	PBMCs	of	SLE	patients	and	healthy	controls
Baricitinib	is	an	oral	selective	inhibitor	of	Janus	kinase	1	and	2	approved	for	the	treatment	of	rheumatoid	arthritis	atopic	dermatitis	and	alopecia	areata	In	a	24-week	phase	2	study	in	patients	with	systemic	lupus	erythematosus	SLE	baricitinib	4	mg	significantly	improved	SLE	disease	activity	compared	with	placebo	In	this	Article	we	report	the	evaluation	of	efficacy	and	safety	of	baricitinib	in	patients	with	SLE	in	a	52-week	phase	3	study
Infections	are	a	major	cause	of	morbidity	and	mortality	in	systemic	lupus	erythematosus	SLE	We	assessed	the	incidence	and	risk	factors	for	major	infections	in	SLE	in	India
Our	group	has	previously	demonstrated	elevated	serum-soluble	ST2	in	patients	with	active	systemic	lupus	erythematosus	suggesting	a	role	of	IL-33	in	the	underlying	pathogenesis	However	inconsistent	results	have	been	reported	on	the	effect	of	exogenous	IL-33	on	murine	lupus	activity	which	may	be	mediated	by	concerted	actions	of	various	immune	cells	in	vivo	This	study	aimed	to	examine	the	function	of	IL-33	on	macrophage	polarization	and	regulatory	T	cells	Treg	and	their	interactive	effects	in	the	lupus	setting	by	in	vitro	coculture	experiments	of	macrophages	and	T	cells	that	were	performed	in	the	presence	or	absence	of	IL-33-containing	medium	Compared	to	IL-4-polarized	bone	marrow-derived	macrophages	BMDM	from	MRL	MpJ	mice	adding	IL-33	enhanced	mRNA	expression	of	markers	of	alternatively	activated	macrophages	including	CD206	and	Arg1	IL-33	and	IL-4	copolarized	BMDM	produced	higher	TGF-	but	not	IL-6	upon	inflammatory	challenge	These	BMDM	induced	an	increase	in	the	Foxp3	CD25	Treg	population	in	cocultured	allogeneic	T	cells	from	MRL	MpJ	and	predisease	MRL	lpr	mice	These	copolarized	BMDM	also	showed	an	enhanced	suppressive	effect	on	T	cell	proliferation	with	reduced	IFN-	and	IL-17	release	but	increased	TGF-	production	In	the	presence	of	TGF-	and	IL-2	IL-33	also	directly	promoted	inducible	Treg	that	expressed	a	high	level	of	CD25	and	more	sustained	Foxp3	Unpolarized	BMDM	cocultured	with	these	Treg	displayed	higher	phagocytosis	In	conclusion	TGF-	was	identified	as	a	key	cytokine	produced	by	IL-4	and	IL-33	copolarized	alternatively	activated	macrophages	and	the	induced	Treg	which	may	contribute	to	a	positive	feedback	loop	potentiating	the	immunoregulatory	functions	of	IL-33
Recent	studies	have	shown	substantial	progress	in	understanding	the	association	between	epigenetics	and	autoimmune	diseases	However	there	is	a	lack	of	comprehensive	bibliometric	analysis	in	this	research	area	This	article	aims	to	present	the	current	status	and	hot	topics	of	epigenetic	research	in	autoimmune	diseases	ADs	from	a	bibliometric	perspective	as	well	as	explore	the	frontier	hotspots	and	trends	in	epigenetic	studies	related	to	ADs
Diffuse	alveolar	haemorrhage	DAH	is	a	rapidly	developing	condition	owing	to	a	lack	of	effective	treatment	and	resulting	in	a	high	mortality	rate	in	systemic	lupus	erythematosus	SLE	Neutrophil	extracellular	traps	NETs	contain	numerous	antigens	and	proinflammatory	substances	that	directly	damage	the	vascular	endothelium	and	aggravate	vascular	inflammation	which	is	considered	an	important	pathogenic	factor	of	DAH	in	SLE	Therefore	blocking	the	release	of	NETs	from	neutrophils	is	an	important	target	for	the	treatment	of	DAH	in	SLE	In	this	study	we	investigated	whether	the	inhibition	of	neutrophils	releasing	NETs	could	relieve	DAH	in	SLE	Necrostatin-1	Nec-1	a	small	molecule	has	been	reported	to	inhibit	the	release	of	NETs	by	neutrophils	In	vitro	experiments	revealed	that	Nec-1	inhibited	alveolar	epithelial	cell	damage	by	preventing	the	release	of	NETs	Furthermore	vivo	studies	showed	that	Nec-1	alleviated	lupus	pulmonary	haemorrhage	in	mice	by	reducing	lung	pathology	severity	body	weight	and	serum	inflammatory	cytokine	levels	Mechanistically	Nec-1	prevented	NET	release	by	inhibiting	neutrophil	elastase	NE	activation	and	N-Gasdermin	D	N-GSDMD	expression	Additionally	immunohistochemistry	and	immunofluorescence	findings	showed	that	Nec-1	decreased	NE	expression	in	the	lung	tissues	of	mice	with	lupus	pulmonary	haemorrhage	Thus	NETs	released	by	neutrophils	contributed	to	the	pathogenesis	of	DAH	in	SLE	and	Nec-1	showed	protective	effects	by	the	inhibition	of	NET	production	via	the	reduction	of	NE	activation	and	N-GSDMD	expression
Recent	developments	in	mass	spectrometry	MS	have	revealed	target	antigens	for	membranous	nephropathy	MN	including	phospholipase	A2	receptor	and	exostosin	1	exostosin	2	EXT1	2	EXT1	2	are	known	antigens	of	autoimmune	disease-related	MN	especially	membranous	lupus	nephritis	We	describe	the	case	of	an	elderly	man	who	developed	nephrotic	syndrome	followed	by	progressive	renal	dysfunction
Systemic	lupus	erythematosus	SLE	is	a	chronic	rheumatic	disorder	Endothelin-1	a	vasoconstrictor	belongs	to	the	endothelin	family	and	is	associated	with	vascular-related	damages	To	date	association	between	ET-1	and	pathogenesis	of	SLE	remains	unclear	This	case-control	study	was	carried	out	by	314	SLE	252	non-SLE	diseases	patients	and	500	healthy	controls	Serum	ET-1	CCN3	IL-28B	levels	were	detected	by	ELISA	and	ET-1	gene	polymorphisms	rs5369	rs5370	rs1476046	rs2070699	rs2071942	rs2071943	rs3087459	rs4145451	rs6458155	rs9369217	were	genotyped	with	Kompetitive	Allele-Specific	PCR	SLE	patients	had	high	levels	of	ET-1	which	were	correlated	with	some	clinical	laboratory	features	Serum	CCN3	IL-28B	levels	were	higher	in	SLE	patients	and	ET-1	levels	were	positively	correlated	with	the	two	cytokines	Rs5370	rs1476046	rs2070699	rs2071942	rs2071943	rs3087459	rs6458155	and	rs2070699	were	associated	with	SLE	risk	Rs2070699	T	TT	was	related	to	SLE	patients	with	alopecia	Rs5370	T	TT	TG	rs1476046	G	GA	rs2071942	G	GA	and	rs2071943	G	GA	were	associated	with	SLE	patients	with	pericarditis	pyuria	and	fever	manifestation	respectively	Rs3087459	CC	and	rs9369217	TC	were	related	to	SLE	patients	with	positive	anti-SSB	antibody	Rs5369	AA	was	associated	with	IgG	and	CRP	levels	in	SLE	patients	In	conclusion	elevated	serum	ET-1	in	SLE	patients	may	be	a	potential	disease	marker	and	its	gene	polymorphisms	were	related	to	SLE	susceptibility
Neutrophil	extracellular	traps	NETs	is	an	important	process	involved	in	the	pathogenesis	of	systemic	lupus	erythematosus	SLE	but	the	potential	mechanisms	of	NETs	contributing	to	SLE	at	the	genetic	level	have	not	been	clearly	investigated	This	investigation	aimed	to	explore	the	molecular	characteristics	of	NETs-related	genes	NRGs	in	SLE	based	on	bioinformatics	analysis	and	identify	associated	reliable	biomarkers	and	molecular	clusters	Dataset	GSE45291	was	acquired	from	the	Gene	Expression	Omnibus	repository	and	used	as	a	training	set	for	subsequent	analysis	A	total	of	1006	differentially	expressed	genes	DEGs	were	obtained	most	of	which	were	associated	with	multiple	viral	infections	The	interaction	of	DEGs	with	NRGs	revealed	8	differentially	expressed	NRGs	DE-NRGs	The	correlation	and	protein-protein	interaction	analyses	of	these	DE-NRGs	were	performed	Among	them	HMGB1	ITGB2	and	CREB5	were	selected	as	hub	genes	by	random	forest	support	vector	machine	and	least	absolute	shrinkage	and	selection	operator	algorithms	The	significant	diagnostic	value	for	SLE	was	confirmed	in	the	training	set	and	three	validation	sets	GSE81622	GSE61635	and	GSE122459	Additionally	three	NETs-related	sub-clusters	were	identified	based	on	the	hub	genes	expression	profiles	analyzed	by	unsupervised	consensus	cluster	assessment	Functional	enrichment	was	performed	among	the	three	NETs	subgroups	and	the	data	revealed	that	cluster	1	highly	expressed	DEGs	were	prevalent	in	innate	immune	response	pathways	while	that	of	cluster	3	were	enriched	in	adaptive	immune	response	pathways	Moreover	immune	infiltration	analysis	also	revealed	that	innate	immune	cells	were	markedly	infiltrated	in	cluster	1	while	the	adaptive	immune	cells	were	upregulated	in	cluster	3	As	per	our	knowledge	this	investigation	is	the	first	to	explore	the	molecular	characteristics	of	NRGs	in	SLE	identify	three	potential	biomarkers	HMGB1	ITGB2	and	CREB5	and	three	distinct	clusters	based	on	these	hub	biomarkers
The	goal	was	to	characterize	short-term	kidney	status	and	describe	variation	in	early	care	utilization	in	a	multicenter	cohort	of	patients	with	childhood-onset	systemic	lupus	erythematosus	cSLE	and	nephritis
A	preliminary	definition	of	disease	modification	DM	in	lupus	nephritis	LN	was	recently	developed	focusing	on	long-term	remission	and	damage	prevention	with	minimal	treatment-associated	toxicity	We	aimed	to	further	specify	aspects	of	DM	criteria	in	LN	assess	DM	achievement	in	a	real-world	setting	and	examine	potential	DM	predictors	and	long-term	outcomes
To	assess	whether	a	healthy	lifestyle	is	associated	to	beneficial	effects	on	various	systemic	lupus	erythematosus	SLE	health	domains
The	FDA	approved	the	anti-BAFF	monoclonal	antibody	belimumab	in	2011	for	adult	systemic	lupus	erythematosus	SLE	in	2019	for	pediatric	SLE	in	2020	for	adult	lupus	nephritis	LN	and	in	2022	for	pediatric	LN
We	aim	to	quantify	the	risk	of	maternal	and	fetal	complications	in	patients	with	SLE	in	order	to	identify	the	impact	of	SLE	on	pregnancy	and	of	pregnancy	on	SLE
Primary	adrenal	insufficiency	PAI	is	a	rare	disease	which	represents	the	end	stage	of	a	destructive	process	involving	the	adrenal	cortex	Occasionally	it	may	be	caused	by	bilateral	adrenal	hemorrhagic	infarction	in	patients	with	antiphospholipid	syndrome	APS	We	herein	report	the	challenging	case	of	a	30-year-old	female	patient	with	systemic	lupus	erythematosus	SLE	and	secondary	APS	who	was	admitted	to	the	emergency	department	ED	due	to	fever	lethargy	and	syncopal	episodes	Hyponatremia	hyperkalemia	hyperpigmentation	shock	altered	mental	status	and	clinical	response	to	glucocorticoid	administration	were	features	highly	suggestive	of	an	acute	adrenal	crisis	The	patient	s	clinical	status	required	admission	to	the	intensive	care	unit	ICU	where	steroid	replacement	anticoagulation	and	supportive	therapy	were	provided	with	a	good	outcome	Imaging	demonstrated	bilateral	adrenal	enlargement	attributed	to	recent	adrenal	hemorrhage	This	case	highlights	the	fact	that	bilateral	adrenal	vein	thrombosis	and	subsequent	hemorrhage	can	be	part	of	the	thromboembolic	complications	seen	in	both	primary	and	secondary	APS	and	which	if	misdiagnosed	may	lead	to	a	life-threatening	adrenal	crisis	High	clinical	suspicion	is	required	for	its	prompt	diagnosis	and	management	A	literature	search	of	past	clinical	cases	with	adrenal	insufficiency	AI	in	the	setting	of	APS	and	SLE	was	conducted	using	major	electronic	databases	Our	aim	was	to	retrieve	information	about	the	pathophysiology	diagnosis	and	management	of	similar	conditions
The	aim	of	this	study	was	to	explore	the	effect	of	depression	on	pain	disease	activity	functional	disability	and	health-related	quality	of	life	measured	by	Visual	Analogue	Scale	Systemic	Lupus	Erythematosus	Disease	Activity	Index	Health	Assessment	Questionnaire	and	Short	Form-36	in	patients	with	systemic	lupus	erythematosus
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	disease	characterized	by	loss	of	tolerance	to	self-antigen	autoantibody	production	and	abnormal	immune	response	Cuproptosis	is	a	recently	reported	cell	death	form	correlated	with	the	initiation	and	development	of	multiple	diseases	This	study	intended	to	probe	cuproptosis-related	molecular	clusters	in	SLE	and	constructed	a	predictive	model
I	have	been	a	scientific	grasshopper	throughout	my	career	moving	from	question	to	question	within	the	domain	of	lupus	This	has	proven	to	be	immensely	gratifying	Scientific	exploration	is	endlessly	fascinating	and	succeeding	in	studies	you	care	about	with	colleagues	and	trainees	leads	to	strong	and	lasting	bonds	Science	isn	t	easy	being	a	woman	in	science	presents	challenges	but	the	drive	to	understand	a	disease	remains	strong
Lupus	nephritis	LN	is	a	crucial	complication	of	systemic	lupus	erythematosus	SLE	and	has	important	clinical	implications	in	guiding	treatment	N-glycosylation	of	immunoglobulin	G	IgG	plays	a	key	role	in	the	development	of	SLE	by	affecting	the	balance	of	anti-inflammatory	and	proinflammatory	responses	This	study	aimed	to	evaluate	the	performance	of	IgG	N-glycosylation	for	diagnosing	LN	in	a	sample	of	female	SLE	patients
Antiphospholipid	Syndrome	APS	is	an	autoimmune	disease	which	was	defined	in	the	early	1980s	The	principal	features	include	thromboembolic	events	and	or	pregnancy	losses	in	association	with	antiphospholipid	antibodies	aPL	As	an	historical	note	the	full-blown	picture	of	the	syndrome	resembles	the	illness	suffered	by	Anne	Stuart	Queen	of	England	in	the	XVIII	century	whose	repeated	miscarriages	caused	the	end	of	the	royal	Stuart	line	and	the	Hanoverian	succession	The	identification	of	aPL	started	in	the	early	XX	century	and	was	linked	to	the	introduction	of	the	serological	test	for	the	diagnosis	of	syphilis	This	involves	a	reaction	between	an	antibody	reagin	and	a	phospholipid	antigen	derived	from	bovine	heart	cardiolipin	Later	on	it	was	observed	that	not	all	subjects	with	a	positive	test	had	syphilis	and	that	the	so	called	false	positive	reaction	was	often	reported	in	patients	with	systemic	lupus	erythematosus	Different	tests	for	the	identification	of	aPL	were	subsequently	developed	first	lupus	anticoagulant	1971	and	then	immunoassays	for	anticardiolipin	1983	and	anti-beta2	glycoprotein	I	1990	antibodies	In	the	same	period	the	association	between	the	presence	of	circulating	aPL	and	thrombotic	and	obstetric	events	was	established	both	in	patients	with	autoimmune	diseases	and	in	otherwise	healthy	subjects	leading	to	the	identification	of	APS	as	a	distinct	autoimmune	disease	This	has	allowed	better	diagnosis	and	more	targeted	treatment	for	many	patients
There	is	an	unmet	need	to	improve	the	efficacy	of	therapeutic	regimens	in	lupus	nephritis	LN	Cocktail	immunosuppressive	therapy	for	the	synergistic	effect	of	individual	drugs	may	enhance	efficacy	and	enable	dosage	reduction	However	the	potential	increase	in	the	risk	of	serious	and	opportunistic	infections	is	a	concern	Moreover	the	timing	of	combination	therapy	adoption	of	a	step-up	or	step-down	approach	and	the	choice	of	drugs	is	still	controversial	partly	related	to	the	cost-effectiveness	issue
BACKGROUND	Anticardiolipin	antibodies	in	patients	with	Libman-Sacks	endocarditis	LS	are	indicative	of	comorbid	antiphospholipid	syndrome	APS	and	can	result	in	cerebral	infarctions	We	describe	a	case	of	LS	and	primary	APS	with	recurrent	cerebral	infarctions	despite	anticoagulation	treatment	The	patient	underwent	surgery	for	enlarged	LS	vegetation	with	high	titers	of	antiphospholipid	antibodies	CASE	REPORT	A	41-year-old	Japanese	man	was	admitted	to	hospital	for	small	cerebral	infarction	recurrence	in	a	left	parietal	lesion	At	age	35	the	patient	had	suffered	multiple	cerebral	infarctions	He	was	found	to	have	high	serum	titers	of	all	3	antiphospholipid	antibodies	Transesophageal	echocardiography	TEE	findings	were	normal	Differential	diagnosis	ruled	out	other	autoimmune	diseases	and	a	clinical	diagnosis	of	primary	APS	was	made	Warfarin	anticoagulation	was	started	When	cerebral	infarction	recurred	6	years	after	the	first	episode	serum	titers	of	antiphospholipid	antibodies	remained	high	and	TEE	showed	a	7	8	mm	area	of	mitral	vegetation	A	TEE	results	from	his	first	admission	revealed	a	5	6	mm	area	of	mitral	vegetation	which	was	believed	to	be	related	to	the	current	vegetation	As	anticoagulation	produced	no	improvement	the	mitral	valve	was	replaced	with	a	mechanical	valve	Examination	of	the	excised	vegetation	found	it	to	be	consistent	with	LS	The	patient	made	good	progress	within	3	years	after	surgery	CONCLUSIONS	LS	size	can	increase	despite	anticoagulation	in	cases	with	high	titers	of	all	3	antiphospholipid	antibodies	and	cerebral	infarction	Such	patients	require	ongoing	TEE	follow-up	and	surgical	treatment	should	be	considered
Patients	with	systemic	lupus	erythematosus	SLE	are	at	risk	of	cardiac	disease	including	antimalarial-induced	cardiomyopathy	AMIC	The	purpose	of	this	study	is	to	evaluate	cardiac	magnetic	resonance	imaging	parametric	mapping	findings	in	SLE	patients	with	AMIC	and	investigate	the	relationship	of	T1	T2	mapping	to	antimalarial	AM	treatment	duration
B	cells	expressing	the	transcription	factor	T-bet	are	found	to	have	a	protective	role	in	viral	infections	but	are	also	considered	major	players	in	the	onset	of	different	types	of	autoimmune	diseases	Currently	the	exact	mechanisms	driving	such	atypical	memory	B	cells	to	contribute	to	protective	immunity	or	autoimmunity	are	unclear	In	addition	to	general	autoimmune-related	factors	including	sex	and	age	the	ways	T-bet	B	cells	instigate	autoimmune	diseases	may	be	determined	by	the	close	interplay	between	genetic	risk	variants	and	Epstein-Barr	virus	EBV	The	impact	of	EBV	on	T-bet	B	cells	likely	relies	on	the	type	of	risk	variants	associated	with	each	autoimmune	disease	which	may	affect	their	differentiation	migratory	routes	and	effector	function	In	this	hypothesis-driven	review	we	discuss	the	lines	of	evidence	pointing	to	such	genetic	and	or	EBV-mediated	influence	on	T-bet	B	cells	in	a	range	of	autoimmune	diseases	including	systemic	lupus	erythematosus	SLE	and	multiple	sclerosis	MS	We	provide	examples	of	how	genetic	risk	variants	can	be	linked	to	certain	signaling	pathways	and	are	differentially	affected	by	EBV	to	shape	T-bet	B-cells	Finally	we	propose	options	to	improve	current	treatment	of	B	cell-related	autoimmune	diseases	by	more	selective	targeting	of	pathways	that	are	critical	for	pathogenic	T-bet	B-cell	formation
Systemic	lupus	erythematosus	SLE	is	a	chronic	autoimmune	disease	that	often	involves	abnormal	activation	of	regulatory	IFN	genes	and	regulation	of	B	cells	by	CD4	T	cells	Radical	S-adenosyl	methionine	domain	containing	2	RSAD2	is	a	viral	suppressor	protein	regulated	by	type	I	IFN	and	it	has	been	proven	to	play	an	important	regulatory	role	in	SLE	However	the	mechanism	by	which	RSAD2	participates	in	the	pathogenesis	of	SLE	is	unclear	In	this	study	we	observed	higher	expression	levels	of	RSAD2	in	CD4	T-cell	subsets	from	the	peripheral	blood	of	SLE	patients	than	in	those	from	healthy	controls	by	bioinformatics	analysis	and	validation	experiments	We	analyzed	the	expression	of	RSAD2	in	CD4	T	cells	of	patients	with	SLE	and	other	autoimmune	diseases	In	addition	we	found	that	the	expression	of	RSAD2	in	CD4	T	cells	might	be	regulated	by	IFN-	and	RSAD2	significantly	affected	the	differentiation	of	Th17	cells	and	T	follicular	helper	Tfh	cells	Our	findings	underlined	that	RSAD2	may	promote	B-cell	activation	by	promoting	the	differentiation	of	Th17	and	Tfh	cells	in	SLE	patients	a	process	that	is	regulated	by	IFN-
Nephrolithiasis	as	a	feature	of	rheumatologic	diseases	is	under	recognized	Understanding	presenting	features	diagnostic	testing	is	crucial	to	proper	management
There	is	a	limited	understanding	of	racial	disparities	in	adverse	pregnancy	outcomes	APO	among	women	with	rheumatic	diseases	The	aim	of	our	study	was	to	conduct	a	systematic	literature	review	to	evaluate	the	impact	of	race	on	APO	in	women	with	rheumatic	diseases
Children-onset	lupus	nephritis	cLN	occurs	50	of	patients	with	systemic	lupus	erythematosus	Mycophenolic	acid	MPA	is	the	first-line	agent	for	the	induction	and	maintenance	treatment	of	LN	This	study	was	to	explore	the	predictors	of	renal	flare	in	cLN
EZH2	regulates	B	cell	development	and	differentiation	We	previously	demonstrated	increased	EZH2	expression	in	peripheral	blood	mononuclear	cells	from	lupus	patients	The	goal	of	this	study	was	to	evaluate	the	role	of	EZH2	expression	in	B	cells	in	the	pathogenesis	of	lupus
Hypoxia-inducible	factor-1	HIF-1	is	a	primary	metabolic	sensor	and	is	expressed	in	different	immune	cells	such	as	macrophage	dendritic	cell	neutrophil	T	cell	and	non-immune	cells	for	instance	synovial	fibroblast	and	islet	cell	HIF-1	signaling	regulates	cellular	metabolism	triggering	the	release	of	inflammatory	cytokines	and	inflammatory	cells	proliferation	It	is	known	that	microenvironment	hypoxia	vascular	proliferation	and	impaired	immunological	balance	are	present	in	autoimmune	diseases	To	date	HIF-1	is	recognized	to	be	overexpressed	in	several	inflammatory	autoimmune	diseases	such	as	systemic	lupus	erythematosus	SLE	rheumatoid	arthritis	and	function	of	HIF-1	is	dysregulated	in	these	diseases	In	this	review	we	narrate	the	signaling	pathway	of	HIF-1	and	the	possible	immunopathological	roles	of	HIF-1	in	autoimmune	diseases	The	collected	information	will	provide	a	theoretical	basis	for	the	familiarization	and	development	of	new	clinical	trials	and	treatment	based	on	HIF-1	and	inflammatory	autoimmune	disorders	in	the	future
To	accelerate	the	onset	of	systemic	lupus	erythematosus	in	C57BL	6	mice	by	injecting	cadmium	chloride	nanoemulsion	and	shorten	the	traditional	modeling	time
Female	sexual	dysfunction	SD	is	an	under-recognized	and	undertreated	problem	in	patients	with	systemic	autoimmune	rheumatic	disorders	SARDs
Diffuse	alveolar	haemorrhage	DAH	is	a	rare	but	life-threatening	complication	of	systemic	lupus	erythematosus	SLE	We	describe	the	clinical	characteristics	treatment	and	survival	outcomes	of	SLE	patients	with	DAH	in	Singapore
In	this	study	we	proposed	a	biological	model	explaining	the	progress	of	autoimmune	activation	along	different	stages	of	systemic	lupus	erythematosus	SLE	For	any	upcoming	stage	of	SLE	any	new	component	is	introduced	when	it	is	added	to	the	model	Particularly	the	interaction	of	mesenchymal	stem	cells	with	the	components	of	the	model	is	specified	in	a	way	that	both	the	inflammatory	and	anti-inflammatory	functions	of	these	cells	would	be	covered	The	biological	model	is	then	recapitulated	to	a	model	with	less	complexity	that	explains	the	main	features	of	the	problem	Later	a	7th-order	mathematical	model	for	SLE	is	proposed	based	on	this	simplified	model	Finally	the	range	of	validity	of	the	proposed	mathematical	model	was	assessed	For	this	purpose	we	simulated	the	model	and	analyzed	the	simulation	results	in	case	of	some	known	behaviors	of	the	disease	such	as	tolerance	breach	the	appearance	of	systemic	inflammation	development	of	clinical	signs	and	occurrence	of	flares	and	improvements	The	model	was	able	to	reproduce	these	events	qualitatively
Exploring	the	human	microbiome	in	multiple	body	niches	is	beneficial	for	clinicians	to	determine	which	microbial	dysbiosis	should	be	targeted	first	We	aimed	to	study	whether	both	the	fecal	and	vaginal	microbiomes	are	disrupted	in	SLE	patients	and	whether	they	are	correlated	as	well	as	their	associations	with	immunological	features
This	study	aimed	to	explore	risk	factors	for	lupus	nephritis	LN	in	systemic	lupus	erythematosus	SLE	patients	and	establish	a	Nomogram	prediction	model	based	on	LASSO-logistic	regression
To	compare	the	risk	of	SARS-CoV-2	infection	and	its	related	severe	sequelae	between	patients	with	systemic	lupus	erythematosus	SLE	and	the	general	population	according	to	COVID-19	vaccination	status
Neutrophil	extracellular	traps	NETs	are	web-like	structures	composed	of	nuclear	and	granular	components	The	primary	role	of	NETS	is	to	prevent	the	dissemination	of	microbes	and	facilitate	their	elimination	However	this	process	is	accompanied	by	collateral	proinflammatory	adverse	effects	when	the	NET	release	becomes	uncontrollable	or	clearance	is	impaired	Although	NET-induced	organ	damage	is	conducted	primarily	and	indirectly	via	immune	complexes	and	the	subsequent	release	of	cytokines	their	direct	effects	on	cells	are	also	remarkable	NETosis	plays	a	critical	pathogenic	role	in	several	renal	disorders	such	as	the	early	phase	of	acute	tubular	necrosis	anti-neutrophil	cytoplasmic	antibody-mediated	renal	vasculitis	lupus	nephritis	thrombotic	microangiopathies	anti-glomerular	basement	membrane	disease	and	diabetic	nephropathy	Their	substantial	contribution	in	the	course	of	these	disorders	makes	them	a	desirable	target	in	the	therapeutic	armamentarium	This	article	gives	an	in-depth	review	of	the	heterogeneous	pathogenesis	and	physiological	regulations	of	NETosis	and	its	pivotal	role	in	renal	diseases	Based	on	the	pathogenesis	the	article	also	outlines	the	current	therapeutic	options	and	possible	molecular	targets	in	the	treatment	of	NET-related	renal	disorders
Haemophagocytic	lymphohistiocytosis	HLH	is	an	immune-mediated	disease	driven	by	abnormal	macrophage	activation	and	regulatory	cell	dysfunction	HLH	can	be	primary	due	to	genetic	mutations	or	secondary	due	to	infection	malignancy	or	autoimmune	conditions	We	describe	a	woman	in	her	early	30s	who	developed	HLH	while	being	treated	for	newly	diagnosed	systemic	lupus	erythematosus	SLE	complicated	by	lupus	nephritis	as	well	as	concomitant	cytomegalovirus	CMV	reactivation	from	a	dormant	infection	The	trigger	for	this	secondary	form	of	HLH	may	have	been	either	aggressive	SLE	and	or	CMV	reactivation	Despite	prompt	treatment	with	immunosuppressive	therapies	for	SLE	consisting	of	high-dose	corticosteroids	mycophenolate	mofetil	tacrolimus	etoposide	for	HLH	and	ganciclovir	for	CMV	infection	the	patient	developed	multiorgan	failure	and	passed	away	We	demonstrate	the	difficulty	in	identifying	a	specific	cause	for	secondary	HLH	when	multiple	conditions	are	present	SLE	and	CMV	and	the	fact	that	despite	aggressive	treatment	for	both	conditions	the	mortality	for	HLH	remains	high
Epidemiological	and	toxicological	studies	have	shown	that	inhalation	of	particulate	matter	PM	is	associated	with	development	of	cardiovascular	diseases	Long-term	exposure	to	PM	may	increase	the	risk	of	cardiovascular	events	and	reduce	life	expectancy	Systemic	lupus	erythematosus	SLE	is	a	chronic	inflammatory	disease	autoimmune	in	nature	that	is	characterized	by	the	production	of	autoantibodies	that	affects	several	organs	including	the	heart	Air	pollution	-	which	can	be	caused	by	several	different	factors	-	may	be	one	of	the	most	important	points	both	at	the	onset	and	the	natural	history	of	SLE	Therefore	this	study	aims	to	investigate	whether	exposure	to	air	pollution	promotes	increased	inflammation	and	cardiac	remodelling	in	animals	predisposed	to	SLE	Female	NZBWF1	mice	were	exposed	to	an	environmental	particle	concentrator	Aspects	related	to	cardiac	remodelling	inflammation	and	apoptosis	were	analysed	in	the	myocardium	Body	weight	gain	cardiac	trophism	by	heart	body	weight	ratio	relative	area	of	cardiomyocytes	and	the	fibrotic	area	of	cardiac	tissue	were	evaluated	during	the	exposure	period	Animals	exposed	to	PM2	5	showed	increased	area	of	cardiomyocytes	and	area	of	fibrosis	in	addition	we	observed	an	increase	in	IL-1	and	C3	in	the	cardiac	tissue	demonstrating	increased	inflammation	We	suggest	that	air	pollution	is	capable	of	promoting	cardiac	remodelling	and	increased	inflammation	in	animals	predisposed	to	SLE
Hydroxychloroquine	HCQ	is	one	of	the	most	used	drugs	in	patients	with	systemic	lupus	erythematosus	SLE	In	these	patients	where	heart	involvement	is	common	cardiac	HCQ	toxicity	may	lead	to	fatal	outcomes	The	aim	of	this	work	is	to	study	the	influence	of	cumulative	HCQ	cHCQ	in	a	selected	group	of	patients	with	SLE	and	its	association	with	electrocardiographic	EKG	abnormalities
Remission	in	systemic	lupus	erythematosus	SLE	or	Lupus	Low	Disease	Activity	State	LLDAS	are	associated	with	less	organ	damage	and	thus	create	new	perspectives	for	effective	damage-limiting	treatment	The	aim	of	this	study	was	to	assess	the	occurrence	of	remission	defined	by	The	Definition	of	Remission	In	SLE	DORIS	and	of	LLDAS	as	well	as	their	predictors	in	the	Polish	SLE	cohort

Systemic	lupus	erythematosus	SLE	is	a	heterogeneous	autoimmune	disease	characterised	by	unpredictable	flares	Many	patients	with	SLE	are	unable	to	achieve	the	recommended	treatment	goal	of	remission	or	the	intermediate	yet	still	clinically	beneficial	goal	of	Lupus	Low	Disease	Activity	State	LLDAS	with	standard	of	care	SoC	treatments	LLDAS	is	an	emerging	treat-to-target	goal	in	SLE	with	the	aim	of	reducing	organ	damage	and	mortality	A	high	unmet	need	remains	in	SLE	and	mainstay	glucocorticoid	treatment	is	associated	with	unacceptable	toxicity	The	recently	approved	type	I	interferon	receptor	antagonist	anifrolumab	is	a	new	treatment	option	for	this	historically	underserved	patient	population	In	phase	3	trials	a	higher	percentage	of	patients	on	anifrolumab	achieved	remission	as	defined	by	the	Definition	Of	Remission	In	SLE	DORIS	and	LLDAS	compared	with	placebo	Real-world	clinical	experience	with	anifrolumab	use	is	still	limited	Until	real-world	study	results	and	updated	treatment	guidelines	are	available	personal	expert	clinical	experience	supported	by	data	may	inform	clinical	decision-making	This	viewpoint	article	discusses	four	example	patient	types	that	could	be	considered	for	anifrolumab	treatment	based	on	1	high-risk	features	early	in	the	disease	course	2	inability	to	achieve	and	3	maintain	at	least	LLDAS	or	4	a	desire	to	reduce	or	stop	SoC	These	patients	with	high	unmet	need	may	benefit	from	the	addition	of	anifrolumab	to	SoC	to	achieve	or	maintain	the	therapeutic	goals	of	LLDAS	or	DORIS	remission
Macrophage	activation	syndrome	MAS	is	a	rare	illness	especially	in	critically	ill	adults	The	diagnosis	of	MAS	is	challenging	requiring	the	expertise	of	multiple	specialists	and	treatments	for	MAS	can	be	associated	with	catastrophic	complications
NLRC4	gain-of-function	variants	are	known	to	cause	various	autoinflammatory	phenotypes	including	familial	cold	autoinflammatory	syndrome	FCAS4	and	NLRC4	macrophage	activation	syndrome	NLRC4-MAS	However	to	date	no	study	has	linked	NLRC4	gain-of-function	variants	to	systemic	lupus	erythematosus	SLE	In	this	study	we	identified	a	novel	NLRC4	W655S	variant	in	an	SLE	patient	and	her	son	who	had	neonatal	lupus	complicated	with	macrophage	activation	syndrome	Our	in	vitro	experiments	demonstrated	that	the	W655S	NLRC4	increased	ASC	speck	formation	and	mature	IL-1	secretion	compared	to	the	wild-type	NLRC4	In	addition	the	patient	had	elevated	levels	of	IL-1	and	IL-18	in	both	serum	and	PBMCs	RNA	sequencing	showed	that	NF-	B	and	interferon	signaling	pathways	were	significantly	activated	in	the	patient	compared	to	healthy	controls	Furthermore	gene	set	enrichment	analysis	revealed	upregulation	of	NLRC4-related	pathways	in	patient	PBMCs	In	conclusion	our	study	identified	the	NLRC4	W655S	variant	in	a	patient	with	SLE	This	is	the	first	report	linking	inflammasomopathy	to	monogenic	SLE	Our	findings	suggest	that	inflammasome	activation	may	be	a	critical	driver	in	the	pathogenicity	of	lupus	and	autoinflammatory	pathways	may	play	important	roles	in	the	development	of	the	disease
Abnormal	infiltration	and	activation	of	neutrophils	play	a	pathogenic	role	in	the	development	of	lupus	nephritis	LN	Myeloid-related	proteins	MRPs	MRP-8	and	-14	also	known	as	the	damage-associated	molecular	patterns	DAMPs	are	mainly	secreted	by	activated	neutrophils	in	systemic	lupus	erythematosus	SLE	Mesenchymal	stem	cells	MSCs	regulate	a	variety	of	immune	cells	to	treat	LN	but	it	is	not	clear	whether	MSCs	can	regulate	neutrophils	and	the	expression	of	MRP-8	14	in	LN	Here	we	demonstrated	that	neutrophil	infiltration	and	MRP-8	14	expression	were	increased	in	the	kidney	of	MRL	lpr	mice	and	both	decreased	after	MSCs	transplantation	Further	the	results	showed	that	tumor	necrosis	factor-	TNF	stimulated	gene-6	TSG-6	in	MSCs	is	necessary	for	MSCs	to	inhibit	MRP-8	14	expression	in	neutrophils	and	neutrophil	migration	In	addition	small-molecule	immunosuppressant	had	no	significant	effect	on	the	expression	of	MRP-8	14	in	neutrophils	Therefore	our	results	suggest	that	MSCs	inhibited	MRP-8	14	expression	and	neutrophil	migration	by	secreting	TSG-6	in	the	treatment	of	LN
The	77th	Annual	Meeting	of	the	Canadian	Rheumatology	Association	was	held	both	in	person	at	the	Quebec	City	Convention	Centre	in	Quebec	City	Quebec	Canada	and	virtually	on	February	8-11	2023	The	program	consisted	of	presentations	covering	original	research	symposia	awards	and	lectures	Highlights	of	the	meeting	include	the	following	2023	Award	Winners	Distinguished	Rheumatologist	Gilles	Boire	Distinguished	Investigator	Murray	Baron	Distinguished	Teacher-Educator	Janet	Pope	Emerging	Investigator	Lihi	Eder	Emerging	Teacher-Educator	Steven	Thomson	Ian	Watson	Award	for	the	Best	Abstract	on	SLE	Research	by	a	Trainee	Laura	Whittall-Garcia	Phil	Rosen	Award	for	the	Best	Abstract	on	Clinical	or	Epidemiology	Research	by	a	Trainee	Timothy	Kwok	Best	Abstract	on	Research	by	a	Rheumatology	Resident	Mats	Junek	Best	Abstract	on	Basic	Science	Research	by	a	Trainee	Marie-H	l	ne	Normand	Best	Abstract	by	a	Post-Graduate	Research	Trainee	Leah	Flatman	Best	Abstract	on	Quality	Care	Initiatives	in	Rheumatology	Amanda	Steiman	Best	Abstract	by	a	Medical	Student	Shakeel	Subdar	Best	Abstract	by	an	Undergraduate	Student	Jeremiah	Tan	Best	Abstract	by	a	Rheumatology	Post-Graduate	Research	Trainee	Nicole	Andersen	Best	Abstract	on	Research	by	Young	Faculty	Alexandra	Legge	Best	Abstract	on	Spondyloarthritis	Research	Patricia	Remalante-Rayco	Practice	Reflection	Award	Gold	Carrie	Ye	and	Janet	Roberts	Practice	Reflection	Award	Silver	Lillian	Lim	Lectures	and	other	events	included	Keynote	Lecture	by	Fiona	Rawle	Communicating	Science	to	Patients	Complexities	Caveats	Keynote	Address	by	Murray	Baron	Distinguished	Investigator	Awardee	New	Outcome	Measures	for	Systemic	Sclerosis	State	of	the	Art	Lecture	by	John	Isaacs	Precision	Medicine	in	RA	-	The	Precision	Gap	Dunlop-Dottridge	Lecture	by	Rae	Yeung	What	s	in	a	Name	That	Which	We	Call	JIA	By	Any	Other	Name	Would	It	Still	Be	the	Same	Childhood	Arthritis	and	the	Great	Debate	Be	it	Resolved	that	Canadians	With	New	Inflammatory	Arthritis	Should	Have	Access	to	All	Therapeutic	Options	at	Disease	Onset	to	Induce	Remission	Arguing	for	Cory	Baillie	and	Anne	MacLeod	and	against	Michelle	Batthish	and	Louis	Bessette	Topics	including	rheumatoid	arthritis	systemic	lupus	erythematosus	systemic	sclerosis	Sj	gren	syndrome	psoriatic	arthritis	spondyloarthritis	vasculitis	osteoarthritis	fibromyalgia	and	their	respective	diagnoses	treatments	and	outcomes	are	reflected	in	the	abstracts	which	we	are	pleased	to	publish	in	this	issue	of	The	Journal	of	Rheumatology
About	15	to	28	of	patients	treated	with	thiopurines	experienced	adverse	drug	reactions	such	as	haematological	and	hepatic	toxicities	Some	of	these	related	to	the	polymorphic	activity	of	the	thiopurine	S-methyltransferase	TPMT	the	key	detoxifying	enzyme	of	thiopurine	metabolism	We	report	here	a	case	of	thiopurine-induced	ductopenia	with	a	comprehensive	pharmacological	analysis	on	thiopurine	metabolism	A	34-year-old	woman	with	a	medical	history	of	severe	systemic	lupus	erythematosus	with	recent	introduction	of	azathioprine	therapy	presented	with	mild	fluctuating	transaminase	blood	levels	consistent	with	a	hepatocellular	pattern	which	evolved	to	a	cholestatic	pattern	over	the	next	weeks	A	blood	thiopurine	metabolite	assay	revealed	low	6-thioguanine	nucleotides	6-TGN	level	and	a	dramatically	increased	6-methylmercaptopurine	ribonucleotides	6-MMPN	level	together	with	an	unfavourable	6-MMPN	6-TGN	metabolite	ratio	and	a	high	TPMT	activity	After	a	total	of	about	6	months	of	thiopurine	therapy	a	transjugular	liver	biopsy	revealed	a	ductopenia	and	azathioprine	discontinuation	led	to	further	clinical	improvement	In	line	with	previous	reports	from	the	literature	our	case	supports	the	fact	that	ductopenia	is	a	rare	adverse	drug	reaction	of	azathioprine	The	mechanism	of	reaction	is	unknown	but	may	involve	high	6-MMPN	blood	level	due	to	unusual	thiopurine	metabolism	switched	metabolism	Early	therapeutic	drug	monitoring	with	measurement	of	6-TGN	and	6-MMPN	blood	levels	may	help	physicians	to	identify	patients	at	risk	of	similar	duct	injury
Glomerulonephritis	are	renal	disorders	resulting	from	different	pathogenic	mechanisms	i	e	autoimmunity	complement	inflammatory	activation	etc	Clarifying	details	of	the	pathogenic	cascade	is	basic	to	limit	the	progression	from	starting	inflammation	to	degenerative	stages	The	balance	between	tissue	injury	activation	of	protective	systems	and	renal	tissue	repair	determines	the	final	outcome	Induction	of	an	oxidative	stress	is	part	of	glomerular	inflammation	and	activation	of	protective	antioxidant	systems	has	a	crucial	role	in	reducing	tissue	effects	The	generation	of	highly	reactive	oxygen	species	can	be	evaluated	in	vivo	by	tracing	the	inner-layer	content	of	phosphatidyl	ethanolamine	and	phosphatidyl	serine	in	cell	membranes	Albumin	is	the	major	antioxidant	in	serum	and	the	level	of	oxidized	albumin	is	another	indirect	sign	of	oxidative	stress	Studies	performed	in	Gn	specifically	in	FSGS	showed	a	high	degree	of	oxidation	in	most	contexts	High	levels	of	circulating	anti-SOD2	antibodies	limiting	the	detoxyfing	activity	of	SOD2	have	been	detected	in	autoimmune	Gn	lupus	nephritis	and	membranous	nephropathy	in	association	with	persistence	of	proteinuria	and	worsening	of	renal	function	In	renal	transplant	high	levels	of	circulating	anti-Glutathione	S-transferase	antibodies	have	been	correlated	with	chronic	antibody	rejection	and	progressive	loss	of	renal	function	Annexins	mainly	ANXA1	and	ANXA2	play	a	general	anti-inflammatory	effect	by	inhibiting	neutrophil	functions	Cytosolic	ANXA1	is	decreased	in	apoptotic	neutrophils	of	patients	with	glomerular	polyangitis	in	association	with	delayed	apoptosis	that	is	considered	the	mechanism	for	polyangitis	High	circulating	levels	of	anti-ANXA1	and	anti-ANXA2	antibodies	characterize	lupus	nephritis	implying	a	reduced	anti-inflammatory	effect	High	circulating	levels	of	antibodies	targeting	Macrophages	anti-FMNL1	have	been	detected	in	Gn	in	association	with	proteinuria	They	potentially	modify	the	intra-glomerular	presence	of	protective	macrophages	M2a	M2c	thus	acting	on	the	composition	of	renal	infiltrate	and	on	tissue	repair
Neurological	involvement	can	occur	in	systemic	lupus	erythematosus	SLE	due	to	co-existing	neuromyelitis	optica	spectrum	disorder	NMOSD	The	symptoms	can	mimic	those	of	neuropsychiatric	manifestations	of	SLE	Pathogenic	anti-aquaporin-4	AQP4	antibodies	commonly	found	in	NMOSD	are	responsible	for	the	neuroinflammatory	response	and	secondary	demyelinating	lesions	These	anti-AQP4	antibodies	can	be	the	drivers	of	neuroinflammatory	process	in	SLE	patients	which	is	distinct	from	the	immunopathogenesis	seen	in	traditional	neuropsychiatric	SLE	The	clinical	course	is	often	a	relapsing	one	and	is	managed	differently	In	this	review	we	describe	and	outline	the	clinical	course	and	outcomes	of	AQP4	NMOSD	SLE	overlap	cases
Glucocorticoid	receptor	GR	is	expressed	in	normal	renal	podocytes	however	its	expression	differs	among	renal	diseases	The	expression	of	GR	as	well	as	its	epigenetic	regulators	microRNA	miR	30a	miR24	and	miR370	was	studied	in	the	renal	tissues	of	patients	with	systemic	lupus	nephritis	LN	minimal	changes	disease	MCD	and	pauci-immune	glumeronephritis	PIN	A	total	of	51	patients	undergoing	renal	biopsy	and	22	nephrectomised	controls	with	no	history	of	parenchymal	renal	disease	were	recruited	from	the	Clinic	of	Nephrology	and	Renal	Transplantation	of	General	Laikon	hospital	between	November	2016	and	March	2019	All	patients	were	newly-diagnosed	and	they	were	na	ve	of	any	treatment	The	mRNA	and	protein	expression	were	analyzed	through	reverse	transcription-quantitative	PCR	and	immunohistochemistry	respectively	Written	consent	was	obtained	from	all	participants	GR	mRNA	expression	was	significantly	reduced	in	all	pathological	samples	compared	with	the	normal	renal	tissues	used	as	controls	P	0	023	for	LN	P	0	05	for	MCD	and	P	0	004	for	PIN	Similarly	GR	protein	expression	was	lower	in	all	pathological	samples	6	GR	positive	podocytes	glomerulus	in	50	of	patients	with	LN	and	MCD	and	18	with	PIN	compared	with	controls	6	positive	podocytes	glomerulus	in	all	the	controls	PIN	samples	presented	significantly	lower	GR	mRNA	and	protein	expression	compared	with	LN	and	MCD	samples	No	significant	differences	were	observed	in	the	miR30a	expression	when	comparing	pathological	with	normal	renal	samples	miR24	and	miR370	expression	demonstrated	statistically	significant	difference	in	all	pathological	compared	with	normal	tissues	Moreover	GR	expression	was	not	significantly	associated	with	either	LN	disease	activity	score	or	the	response	to	the	treatment	GR	and	miR24	expression	was	significantly	reduced	whereas	miR370	significantly	increased	in	all	pathological	compared	with	normal	renal	tissues	implying	their	protentional	role	in	nephritis	pathogenesis	and	treatment	Analysis	of	larger	samples	are	required	for	more	robust	statistical	analysis
Triggering	receptors	expressed	on	myeloid	cells-1	TREM-1	has	been	shown	to	participate	in	inflammatory	autoimmune	diseases	Nevertheless	the	detailed	underlying	mechanisms	and	therapeutic	benefits	by	targeting	TREM-1	remain	elusive	especially	in	myeloid	dendritic	cells	mDCs	and	systemic	lupus	erythematosus	SLE	Disorders	of	epigenetic	processes	including	non-coding	RNAs	give	rise	to	SLE	resulting	in	complicated	syndromes	Here	we	aim	to	address	this	issue	and	explore	the	miRNA	to	inhibit	the	activation	of	mDCs	and	alleviate	the	progress	of	SLE	by	targeting	TREM-1	signal	axis
Osteoporosis	OP	and	fragility	fractures	FF	are	common	comorbidities	in	patients	with	systemic	lupus	erythematosus	SLE	This	study	aimed	to	1	assess	the	prevalence	of	these	conditions	in	a	cohort	of	SLE	patients	2	evaluate	the	risk	factors	associated	with	FF	and	3	compare	the	accuracy	of	four	different	FF	risk	assessment	algorithms	to	determine	which	performs	better	in	this	specific	rheumatologic	population

Systemic	lupus	erythematosus	SLE	is	characterized	by	an	imbalance	between	proinflammatory	and	anti-inflammatory	mediators	Single-nucleotide	polymorphisms	SNPs	in	genes	coding	IL10RA	IL10RB	and	IL22RA	could	affect	their	expression	or	function	and	disrupt	immune	homeostasis	We	aimed	to	analyze	the	associations	of	IL10RA	IL10RB	and	IL22RA	polymorphisms	haplotypes	with	patients	susceptibility	to	and	clinical	manifestations	of	SLE	Our	study	included	103	SLE	patients	and	99	healthy	controls	The	genotypes	of	the	selected	polymorphisms	within	IL10RA	rs10892202	rs4252270	rs3135932	rs2228055	rs2229113	and	rs9610	IL10RB	rs999788	rs2834167	and	rs1058867	and	IL22RA	rs3795299	and	rs16829204	genes	were	determined	by	TaqMan	Assays	IL10RB	rs1058867	G	allele	carriers	were	significantly	more	frequent	among	the	controls	than	among	the	SLE	patients	76	8	vs	61	2	p	0	017	OR	0	477	95	CI	0	258-0	879	The	IL10RB	CAA	haplotype	was	more	frequent	among	the	SLE	patients	than	in	the	control	group	42	7	vs	30	7	p	0	027	The	IL22RA	rs3795299	C	allele	and	rs16829204	CC	genotype	were	associated	with	Hashimoto	thyroiditis	in	the	SLE	patients	n	103	p	0	002	and	p	0	026	respectively	and	in	all	the	included	participants	n	202	p	0	000	and	p	0	007	respectively	and	the	IL22RA	CC	haplotype	was	more	frequent	in	the	SLE	patients	with	Hashimoto	thyroiditis	p	0	047	and	in	the	overall	participants	with	Hashimoto	thyroiditis	n	32	p	0	004	The	IL10RA	IL10RB	and	IL22RA	polymorphisms	haplotypes	could	be	associated	with	SLE	susceptibility	and	various	clinical	manifestations	and	the	IL22RA	CC	haplotype	could	be	associated	with	Hashimoto	thyroiditis
We	aimed	to	compare	the	clinical	and	laboratory	characteristics	of	patients	with	SLE	according	to	the	weighted	complement	status	of	the	EULAR	ACR	criteria	and	investigate	whether	different	weighting	of	the	complement	status	at	disease	onset	is	associated	with	outcomes
Over	95	of	healthy	subjects	develop	anti-COVID	IgG	antibodies	after	receiving	two	doses	of	BNT162b2	COVID-19	vaccine	In	comparison	20	-30	of	SLE	patients	do	not	seroconvert	following	1-2	doses	of	COVID	vaccines	potentially	due	to	immunosuppression	The	aim	of	this	study	was	to	assess	immunogenicity	and	safety	of	BNT	vaccine	in	SLE	patients	treated	with	Belimumab	and	especially	the	yield	of	a	booster	third	dose	in	this	population
Systemic	lupus	erythematosus	SLE	is	one	of	the	most	common	autoimmune	diseases	in	China	At	present	there	are	hundreds	of	autoantibodies	in	SLE	patients	however	only	a	dozen	of	the	autoantibodies	can	be	routinely	detected	and	the	available	diagnostic	antibodies	are	not	sufficient	for	diagnosis	or	differential	diagnosis	of	SLE	patients	with	atypical	clinical	manifestations	or	other	autoimmune	diseases	Therefore	it	is	necessary	to	find	new	diagnostic	markers	to	improve	the	diagnostic	effect	of	SLE


To	evaluate	the	usefulness	of	urine	SERPINC1	and	ORM1	as	biomarkers	for	early	detection	of	lupus	nephritis	LN
Cluster	of	differentiation	38	CD38	is	a	multifunctional	cell	surface	protein	involved	in	nicotinamide	adenine	dinucleotide	NAD	homeostasis	in	types	of	cells	and	tissues	which	can	be	found	in	many	immune	cells	and	non-immune	cells	Previous	studies	have	shown	that	CD38	plays	an	important	role	in	regulating	innate	immunity	Recently	many	studies	have	revealed	the	importance	of	CD38	in	autoimmune	diseases	such	as	rheumatoid	arthritis	RA	systemic	lupus	erythematosus	SLE	multiple	sclerosis	MS	type	1	diabetes	T1D	and	inflammatory	bowel	disease	among	others	In	this	report	we	will	briefly	discuss	the	complex	immunological	functions	of	CD38	and	focus	on	recent	advances	in	the	role	of	CD38	in	the	development	and	pathogenesis	of	autoimmune	diseases	as	well	as	their	potential	as	therapeutic	targets	for	systemic	diseases	intending	to	make	a	comprehensive	understanding	of	CD38	and	its	promising	therapeutic	potential	in	these	systemic	diseases
Patients	diagnosed	with	systemic	lupus	erythematosus	SLE	suffer	from	a	decreased	quality	of	life	an	increased	risk	of	medical	complications	and	an	increased	risk	of	death	In	particular	approximately	50	of	SLE	patients	progress	to	develop	lupus	nephritis	which	oftentimes	leads	to	life-threatening	end	stage	renal	disease	ESRD	and	requires	dialysis	or	kidney	transplant1	The	challenge	is	that	lupus	nephritis	is	diagnosed	via	a	kidney	biopsy	which	is	typically	performed	only	after	noticeable	decreased	kidney	function	leaving	little	room	for	proactive	or	preventative	measures	The	ability	to	predict	which	patients	are	most	likely	to	develop	lupus	nephritis	has	the	potential	to	shift	lupus	nephritis	disease	management	from	reactive	to	proactive	We	present	a	clinically	useful	prediction	model	to	predict	which	patients	with	newly	diagnosed	SLE	will	go	on	to	develop	lupus	nephritis	in	the	next	five	years
Therapy	of	childhood-onset	systemic	lupus	erythematosus	cSLE	with	drugs	is	unsatisfactory	Some	new	drugs	such	as	belimumab	and	rituximab	may	improve	the	course	of	severe	cSLE	although	there	are	few	reports	on	treatment	efficiency	for	these	new	drugs	especially	belimumab
To	estimate	the	annual	direct	costs	and	cost-drivers	associated	with	systemic	lupus	erythematosus	SLE	patients	in	China
To	determine	vitamin	D	levels	in	patients	with	SLE	and	evaluate	their	relationship	to	bone	mineral	density	BMD	and	the	disease	course
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	illness	marked	by	the	loss	of	immune	tolerance	and	the	production	of	autoantibodies	against	nucleic	acids	and	other	nuclear	antigens	Ags	B	lymphocytes	are	important	in	the	immunopathogenesis	of	SLE	Multiple	receptors	control	abnormal	B-cell	activation	in	SLE	patients	including	intrinsic	Toll-like	receptors	TLRs	B-cell	receptors	BCRs	and	cytokine	receptors	The	role	of	TLRs	notably	TLR7	and	TLR9	in	the	pathophysiology	of	SLE	has	been	extensively	explored	in	recent	years	When	endogenous	or	exogenous	nucleic	acid	ligands	are	recognized	by	BCRs	and	internalized	into	B	cells	they	bind	TLR7	or	TLR9	to	activate	related	signalling	pathways	and	thus	govern	the	proliferation	and	differentiation	of	B	cells	Surprisingly	TLR7	and	TLR9	appear	to	play	opposing	roles	in	SLE	B	cells	and	the	interaction	between	them	is	still	poorly	understood	In	addition	other	cells	can	enhance	TLR	signalling	in	B	cells	of	SLE	patients	by	releasing	cytokines	that	accelerate	the	differentiation	of	B	cells	into	plasma	cells	Therefore	the	delineation	of	how	TLR7	and	TLR9	regulate	the	abnormal	activation	of	B	cells	in	SLE	may	aid	the	understanding	of	the	mechanisms	of	SLE	and	provide	directions	for	TLR-targeted	therapies	for	SLE
Despite	the	introduction	of	novel	treatment	strategies	management	of	rheumatic	disorders	remains	associated	with	substantial	unmet	clinical	need	Of	interest	therefore	it	has	recently	become	apparent	that	there	is	a	global	inverse	relationship	between	the	incidence	of	such	conditions	and	parasitic	helminth	infection	with	striking	examples	involving	rheumatoid	arthritis	RA	systemic	lupus	erythematosus	SLE	patients	and	filarial	nematode	worm	infection	in	studies	in	India	Such	findings	reflect	that	helminths	are	master	manipulators	of	the	immune	system	particularly	in	being	able	to	modulate	proinflammatory	responses	The	aim	of	this	article	is	thus	to	consider	findings	to	date	on	this	exciting	and	intriguing	research	area	to	form	an	opinion	on	whether	parasitic	worms	may	be	exploited	to	generate	novel	therapies	for	rheumatic	diseases
This	study	aimed	to	identify	which	disease	activity	parameters	may	be	risk	factors	for	preterm	birth	PB	and	low	birth	weight	LBW	in	patients	with	systemic	lupus	erythematosus	SLE	We	also	analyzed	the	extent	to	which	these	parameters	affected	PB	and	LBW
Systemic	lupus	erythematosus	SLE	is	a	systemic	autoimmune	disease	This	study	aimed	to	investigate	the	role	of	SMAD	specific	E3	ubiquitin	protein	ligase	1	SMURF1	in	the	Th17	and	Th17	1	differentiation	and	Treg	Th17	imbalance	which	are	major	factors	contributing	to	the	pathogenesis	of	SLE	SLE	patients	and	healthy	individuals	were	recruited	to	detect	the	SMURF1	levels	in	na	ve	CD4	cells	from	peripheral	blood	Purified	and	expanded	na	ve	CD4	T	cells	were	employed	to	evaluate	the	effects	of	SMURF1	on	Th17	and	Th17	1	polarization	in	vitro	MRL	lpr	lupus	model	was	employed	to	explore	the	disease	phenotype	as	well	as	Treg	Th17	balance	in	vivo	The	results	showed	that	SMURF1	was	down-regulated	in	na	ve	CD4	T	cells	in	peripheral	blood	of	patients	with	SLE	and	in	spleen	of	MRL	lpr	mice	SMURF1	overexpression	suppressed	the	polarization	of	na	ve	CD4	T	cells	toward	Th17	and	Th17	1	phenotype	and	down-regulated	the	expression	of	retinoid-related	orphan	receptor-gammat	ROR	t	Subsequently	SMURF1	down-regulation	aggravated	the	disease	phenotype	inflammation	and	the	Treg	Th17	imbalance	in	MRL	lpr	mice	Furthermore	we	found	that	SMURF	overexpression	promoted	the	ubiquitination	and	decreases	the	stability	of	ROR	t	In	conclusion	SMURF1	inhibited	the	polarization	of	Th17	and	Th17	1	cells	and	improved	the	Treg	Th17	imbalance	in	SLE	which	was	mediated	as	least	partly	by	the	ubiquitination	of	ROR	t
To	characterise	the	safety	and	efficacy	of	anifrolumab	in	active	lupus	nephritis	LN	through	year	2	of	the	phase	II	randomised	double-blind	Treatment	of	Uncontrolled	Lupus	via	the	Interferon	Pathway	TULIP	-LN	trial	NCT02547922	of	2	anifrolumab	dosing	regimens	versus	placebo



Neutrophils	have	been	implicated	in	initiating	and	perpetuating	systemic	lupus	erythematosus	and	the	resultant	kidney	damage	in	lupus	nephritis	LN	patients	in	part	through	an	excessive	release	of	neutrophil	serine	proteases	NSPs	NSP	zymogens	are	activated	by	dipeptidyl	peptidase	1	DPP1	during	neutrophil	maturation	and	released	by	mature	neutrophils	in	response	to	inflammatory	stimuli	Thus	a	potential	strategy	to	attenuate	disease	progression	in	LN	would	be	to	inhibit	DPP1	We	tested	whether	brensocatib	a	highly	selective	and	reversible	DPP1	inhibitor	could	mitigate	LN	progression	in	an	interferon-alpha	IFN	-accelerated	NZB	W	F1	mouse	model	To	confirm	brensocatib	s	pharmacodynamic	effect	on	NSPs	in	this	mouse	strain	repeated	dose	studies	were	conducted	for	7	and	14	days	in	na	ve	NZB	W	F1	mice	via	oral	gavage	twice	a	day	Brensocatib	at	2	and	20	mg	kg	day	achieved	a	significant	reduction	in	bone	marrow	NSP	activities	after	7	days	of	daily	administration	To	initiate	LN	disease	progression	the	mice	were	injected	with	an	IFN	-expressing	adenovirus	After	2	weeks	three	brensocatib	doses	or	vehicle	were	administered	for	6	more	weeks	Throughout	the	8-week	study	brensocatib	treatment	20	mg	kg	day	significantly	reduced	the	occurrence	of	severe	proteinuria	compared	to	the	vehicle	control	Brensocatib	treatment	also	entailed	a	significant	reduction	in	the	urine	albumin-to-creatinine	ratio	indicating	decreased	kidney	damage	as	well	as	a	significant	reduction	in	blood	urea	nitrogen	level	suggesting	improved	renal	function	Based	on	kidney	histopathology	analysis	brensocatib	treatment	significantly	lowered	both	the	renal	tubular	protein	score	and	the	nephropathy	score	compared	to	the	vehicle	group	A	trend	towards	reduced	glomerulonephritis	score	with	brensocatib	treatment	was	also	observed	Lastly	brensocatib	significantly	reduced	LN	mouse	kidney	infiltration	by	various	inflammatory	cells	In	conclusion	these	results	suggest	that	brensocatib	alters	disease	progression	in	LN	mice	and	warrant	further	evaluation	of	DPP1	inhibition	in	LN
Renal	involvement	is	a	common	occurrence	in	subjects	with	systemic	autoimmune	diseases	The	renal	manifestation	and	its	severity	depend	on	the	underlying	condition	and	may	reversely	complicate	the	clinical	course	of	autoimmune	diseases	Renal	function	markers	have	been	widely	used	in	the	assessment	of	normal	functioning	of	kidneys	including	glomerular	filtration	rate	and	concentrating	and	diluting	capacity	of	the	kidney	An	increase	or	decrease	in	the	values	of	these	markers	may	indicate	kidney	dysfunction	In	this	study	a	number	of	critical	renal	markers	were	examined	in	seropositive	autoimmune	diseases	including	systemic	lupus	erythematosus	SLE	connective	tissue	disorder	CTD	and	rheumatoid	arthritis	RA	The	data	from	three	cohorts	of	subjects	enrolled	in	renal	markers	and	autoimmune	antibody	testing	between	January	2015	to	August	2019	were	retrospectively	studied	The	prevalence	of	renal	markers	that	were	out	of	the	reference	range	and	their	average	levels	in	female	and	male	subgroups	across	SLE	CTD	and	RA	cohorts	were	compared	and	analyzed	The	levels	of	renal	markers	are	significantly	affected	by	the	presence	of	autoantibodies	in	particular	eGFR	cystatin	C	and	albumin	Autoantibodies	were	also	more	frequent	in	subjects	with	severe	renal	function	damage	Close	follow-up	of	both	renal	markers	and	autoantibodies	may	potentially	assist	in	the	early	diagnosis	of	kidney	diseases	and	improve	the	survival	and	life	expectancy	of	autoimmune	patients

The	objectives	of	this	study	were	to	screen	for	latent	tuberculosis	infection	LTBI	among	patients	with	systemic	lupus	erythematosus	SLE	using	the	T-SPOT	TB	assay	and	to	identify	factors	affecting	the	assay	results	SLE	patients	were	enrolled	from	13	tertiary	hospitals	in	eastern	central	and	western	China	from	September	2014	to	March	2016	and	were	screened	using	the	T-SPOT	TB	assay	to	detect	LTBI	Basic	information	about	the	subjects	was	collected	including	gender	age	body	mass	index	BMI	course	of	disease	evidence	of	previous	tuberculosis	Systemic	Lupus	Erythematosus	Disease	Activity	Index	2000	SLEDAI-2K	score	and	the	use	of	glucocorticoids	and	immunosuppressants	Univariate	analysis	and	multivariable	logistic	regression	were	performed	to	identify	factors	affecting	the	results	of	the	T-SPOT	TB	assay	In	all	2	229	SLE	patients	were	screened	using	the	T-SPOT	TB	assay	of	whom	334	patients	tested	positive	yielding	a	positivity	rate	of	15	95	confidence	interval	CI	13	5	to	16	5	The	positivity	rate	was	higher	in	male	than	female	patients	and	had	an	increasing	trend	with	age	Multivariable	logistic	regression	analysis	showed	that	patients	over	40	odds	ratio	OR	1	65	95	CI	1	29	to	2	10	and	with	evidence	of	previous	tuberculosis	OR	4	43	95	CI	2	81	to	6	99	were	more	likely	to	have	positive	T-SPOT	TB	results	while	patients	with	a	SLEDAI-2K	score	of	10	OR	0	61	95	CI	0	43	to	0	88	a	glucocorticoid	dose	of	60	mg	d	OR	0	62	95	CI	0	39	to	0	98	leflunomide	LEF	treatment	OR	0	51	95	CI	0	29	to	0	88	or	tacrolimus	FK506	treatment	OR	0	40	95	CI	0	16	to	1	00	were	more	likely	to	have	negative	T-SPOT	TB	results	The	frequencies	of	CFP-10-specific	gamma	interferon	IFN-	-secreting	T	cells	were	significantly	lower	in	SLE	patients	with	severe	disease	activity	or	high-dose	glucocorticoids	P	0	05	The	positivity	rate	of	the	T-SPOT	TB	assay	was	15	among	SLE	patients	Severe	active	SLE	disease	and	the	use	of	high-dose	glucocorticoids	and	some	types	of	immunosuppressants	are	likely	to	result	in	negative	T-SPOT	TB	results	For	SLE	patients	with	the	above	conditions	diagnosing	LTBI	based	on	a	positive	T-SPOT	TB	result	may	lead	to	underestimation	of	the	prevalence	IMPORTANCE	The	burden	of	tuberculosis	and	systemic	lupus	erythematosus	in	China	ranks	among	the	top	three	in	the	world	Therefore	active	screening	for	LTBI	and	preventive	intervention	in	SLE	patients	are	of	great	significance	in	China	In	view	of	the	lack	of	relevant	data	in	a	large	sample	we	conducted	a	multicenter	cross-sectional	study	using	T-SPOT	TB	as	a	screening	method	for	LTBI	to	investigate	the	prevalence	of	LTBI	and	analyze	the	factors	affecting	the	results	of	the	T-SPOT	TB	assay	in	SLE	patients	Our	study	showed	that	the	overall	positivity	rate	of	the	T-SPOT	TB	assay	in	SLE	patients	was	15	0	which	was	lower	than	the	estimated	LTBI	prevalence	in	the	general	population	in	China	20	For	SLE	patients	with	severe	active	disease	high-dose	glucocorticoids	and	some	types	of	immunosuppressants	a	diagnosis	of	LTBI	based	on	only	positive	T-SPOT	TB	results	may	lead	to	underestimation	of	the	prevalence
Systemic	lupus	erythematosus	SLE	is	a	heterogeneous	multisystem	inflammatory	disease	with	wide	variability	in	clinical	manifestations	Natural	arising	CD4	regulatory	T	cells	Tregs	play	a	critical	role	in	maintaining	peripheral	tolerance	by	suppressing	inflammation	and	preventing	autoimmune	responses	in	SLE	Additionally	CD8	regulatory	T	cells	type	1	regulatory	T	cells	Tr1	and	B	regulatory	cells	also	have	a	less	well-defined	role	in	the	pathogenesis	of	SLE	Elucidation	of	the	roles	of	various	Treg	subsets	dedicated	to	immune	homeostasis	will	provide	a	novel	therapeutic	approach	that	governs	immune	tolerance	for	the	remission	of	active	lupus	Diminished	interleukin	IL	-2	production	is	associated	with	a	depleted	Treg	cell	population	and	its	reversibility	by	IL-2	therapy	provides	important	reasons	for	the	treatment	of	lupus	This	review	focuses	on	the	pathogenesis	and	new	therapeutics	of	human	Treg	subsets	and	low-dose	IL-2	therapy	in	clinical	benefits	with	SLE
More	than	10	disease-modifying	therapies	DMT	are	approved	by	the	European	Medicines	Agency	EMA	and	the	US	Food	and	Drug	Administration	FDA	for	the	treatment	of	multiple	sclerosis	MS	and	new	therapeutic	options	are	on	the	horizon	Due	to	different	underlying	therapeutic	mechanisms	a	more	individualized	selection	of	DMTs	in	MS	is	possible	taking	into	account	the	patient	s	current	situation	Therefore	concomitant	treatment	of	various	comorbid	conditions	including	autoimmune	mediated	disorders	such	as	rheumatoid	arthritis	should	be	considered	in	MS	patients	Because	the	pathomechanisms	of	autoimmunity	partially	overlap	DMT	could	also	treat	concomitant	inflammatory	diseases	and	simplify	the	patient	s	treatment	In	contrast	the	exacerbation	and	even	new	occurrence	of	several	autoimmune	diseases	have	been	reported	as	a	result	of	immunomodulatory	treatment	of	MS	To	simplify	treatment	and	avoid	disease	exacerbation	knowledge	of	the	beneficial	and	adverse	effects	of	DMT	in	other	autoimmune	disorders	is	critical	Therefore	we	conducted	a	literature	search	and	described	the	beneficial	and	adverse	effects	of	approved	and	currently	studied	DMT	in	a	large	number	of	comorbid	autoimmune	diseases	including	rheumatoid	arthritis	ankylosing	spondylitis	inflammatory	bowel	diseases	cutaneous	disorders	including	psoriasis	Sj	gren	s	syndrome	systemic	lupus	erythematosus	systemic	vasculitis	autoimmune	hepatitis	and	ocular	autoimmune	disorders	Our	review	aims	to	facilitate	the	selection	of	an	appropriate	DMT	in	patients	with	MS	and	comorbid	autoimmune	diseases
Long	noncoding	RNAs	LncRNAs	play	key	roles	in	the	regulation	of	gene	expression	and	subsequently	in	the	pathogenesis	of	several	autoimmune	diseases	This	study	aimed	to	explore	the	peripheral	expression	levels	of	T-cells-specific	LncRNAs	and	transcription	factors	in	systemic	lupus	erythematosus	SLE	patients	carrying	either	human	leukocyte	antigens	HLA	risk	or	non-risk	alleles
Recent	population-based	cohort	studies	suggest	that	the	incidence	of	systemic	lupus	erythematosus	SLE	is	increased	in	patients	with	immune	thrombocytopenic	purpura	ITP	We	performed	a	systematic	review	and	meta-analysis	to	evaluate	the	development	of	SLE	in	patients	with	ITP
Among	systemic	lupus	erythematosus	SLE	patients	neuropsychiatric	symptoms	are	highly	prevalent	being	observed	in	up	to	80	of	adult	and	95	of	pediatric	patients	Type	1	interferons	particularly	interferon	alpha	IFN	have	been	implicated	in	the	pathogenesis	of	SLE	and	its	associated	neuropsychiatric	symptoms	NPSLE	However	it	remains	unclear	how	type	1	interferon	signaling	in	the	central	nervous	system	CNS	might	result	in	neuropsychiatric	sequelae	In	this	study	we	validate	an	NPSLE	mouse	model	and	find	an	elevated	peripheral	type	1	interferon	signature	alongside	clinically	relevant	NPSLE	symptoms	such	as	anxiety	and	fatigue	Unbiased	single-nucleus	sequencing	of	the	hindbrain	and	hippocampus	revealed	that	interferon-stimulated	genes	ISGs	were	among	the	most	highly	upregulated	genes	in	both	regions	and	that	gene	pathways	involved	in	cellular	interaction	and	neuronal	development	were	generally	repressed	among	astrocytes	oligodendrocytes	and	neurons	Using	image-based	spatial	transcriptomics	we	found	that	the	type	1	interferon	signature	is	enriched	as	spatially	distinct	patches	within	the	brain	parenchyma	of	these	mice	Our	results	suggest	that	type	1	interferon	in	the	CNS	may	play	an	important	mechanistic	role	in	mediating	NPSLE	behavioral	phenotypes	by	repressing	general	cellular	communication	pathways	and	that	type	1	interferon	signaling	modulators	are	a	potential	therapeutic	option	for	NPSLE
Systemic	lupus	erythematosus	SLE	is	characterized	by	poor	regulation	of	the	immune	response	leading	to	chronic	inflammation	and	multiple	organ	dysfunction	Glucocorticoid	GC	is	currently	one	of	the	main	treatments	However	a	high	dose	or	prolonged	use	of	GC	may	result	in	glucocorticoid-induced	osteoporosis	GIOP	Jiedu	Quyu	Ziyin	decoction	JP	is	effective	in	treating	SLE	and	previous	clinical	studies	have	proved	that	JP	can	prevent	and	treat	SLE	steroid	osteoporosis	SLE-GIOP	We	aim	to	examine	JPs	main	mechanism	on	SLE-GIOP	through	network	pharmacology	and	molecular	docking
Transforming	growth	factor	beta	TGF-	1	is	a	multifunctional	cytokine	that	has	anti-inflammatory	and	immunosuppressive	effects	TGF-	1	has	been	linked	to	cardiovascular	disease	in	the	general	population	The	immunosuppressive	effect	of	TGF-	1	is	believed	to	be	dysregulated	in	patients	with	systemic	lupus	erythematosus	SLE	In	the	present	work	we	aimed	to	study	the	relationship	of	serum	levels	of	TGF-	1	with	subclinical	carotid	atherosclerosis	in	patients	with	SLE
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	disease	that	has	diverse	clinical	manifestations	ranging	from	restricted	cutaneous	involvement	to	life-threatening	systemic	organ	involvement	The	heterogeneity	of	pathomechanisms	that	lead	to	SLE	contributes	to	between-patient	variation	in	clinical	phenotype	and	treatment	response	Ongoing	efforts	to	dissect	cellular	and	molecular	heterogeneity	in	SLE	could	facilitate	the	future	development	of	stratified	treatment	recommendations	and	precision	medicine	which	is	a	considerable	challenge	for	SLE	In	particular	some	genes	involved	in	the	clinical	heterogeneity	of	SLE	and	some	phenotype-related	loci	STAT4	IRF5	PDGF	genes	HAS2	ITGAM	and	SLC5A11	have	an	association	with	clinical	features	of	the	disease	An	important	part	is	also	played	by	epigenetic	varation	in	DNA	methylation	histone	modifications	and	microRNAs	that	influences	gene	expression	and	affects	cell	function	without	modifying	the	genome	sequence	Immune	profiling	can	help	to	identify	an	individual	s	specific	response	to	a	therapy	and	can	potentially	predict	outcomes	using	techniques	such	as	flow	cytometry	mass	cytometry	transcriptomics	microarray	analysis	and	single-cell	RNA	sequencing	Furthermore	the	identification	of	novel	serum	and	urinary	biomarkers	would	enable	the	stratification	of	patients	according	to	predictions	of	long-term	outcomes	and	assessments	of	potential	response	to	therapy
From	the	pathogenic	mechanism	point	of	view	systemic	lupus	erythematosus	SLE	features	prominently	in	T	lymphocyte	apoptosis	Yet	the	regulatory	mechanism	underlying	SLE	cell	apoptosis	remains	to	be	explored	This	research	intends	to	clarify	the	role	played	by	miR-137	in	SLE	and	the	underlying	mechanisms
Both	TLR7	and	NF-	B	hyperactivity	are	known	to	contribute	to	pathogenesis	in	Systemic	Lupus	Erythematosus	SLE	driving	a	pro-interferon	response	autoreactive	B	cell	expansion	and	autoantibody	production	UBE2L3	is	an	SLE	susceptibility	gene	which	drives	plasmablast	plasma	cell	expansion	in	SLE	but	its	role	in	TLR7	signalling	has	not	been	elucidated	We	aimed	to	investigate	the	role	of	UBE2L3	in	TLR7-mediated	NF-	B	activation	and	the	effect	of	UBE2L3	inhibition	by	Dimethyl	Fumarate	DMF	on	SLE	B	cell	differentiation	in	vitro	Our	data	demonstrate	that	UBE2L3	is	critical	for	activation	of	NF-	B	downstream	of	TLR7	stimulation	via	interaction	with	LUBAC	DMF	which	directly	inhibits	UBE2L3	significantly	inhibited	TLR7-induced	NF-	B	activation	differentiation	of	memory	B	cells	and	plasmablasts	and	autoantibody	secretion	in	SLE	DMF	also	downregulated	interferon	signature	genes	and	plasma	cell	transcriptional	programmes	These	results	demonstrate	that	UBE2L3	inhibition	could	potentially	be	used	as	a	therapy	in	SLE	through	repurposing	of	DMF	thus	preventing	TLR7-driven	autoreactive	B	cell	maturation
Endocytic	recycling	regulates	the	cell	surface	receptor	composition	of	the	plasma	membrane	The	surface	expression	levels	of	the	T	cell	receptor	TCR	in	concert	with	signal	transducing	co-receptors	regulate	T	cell	responses	such	as	proliferation	differentiation	and	cytokine	production	Altered	TCR	expression	contributes	to	pro-inflammatory	skewing	which	is	a	hallmark	of	autoimmune	diseases	such	as	systemic	lupus	erythematosus	SLE	defined	by	a	reduced	function	of	regulatory	T	cells	Tregs	and	the	expansion	of	CD4	helper	T	Th	cells	The	ensuing	secretion	of	inflammatory	cytokines	such	as	interferon-	and	interleukin	IL	-4	IL-17	IL-21	and	IL-23	trigger	autoantibody	production	and	tissue	infiltration	by	cells	of	the	adaptive	and	innate	immune	system	that	induce	organ	damage	Endocytic	recycling	influences	immunological	synapse	formation	by	CD4	T	lymphocytes	signal	transduction	from	crosslinked	surface	receptors	through	recruitment	of	adaptor	molecules	intracellular	traffic	of	organelles	and	the	generation	of	metabolites	to	support	growth	cytokine	production	and	epigenetic	control	of	DNA	replication	and	gene	expression	in	the	cell	nucleus	This	review	will	delineate	checkpoints	of	endosome	traffic	that	can	be	targeted	for	therapeutic	interventions	in	autoimmune	and	other	disease	conditions
The	severity	of	the	2019	coronavirus	disease	COVID-19	and	its	effects	remain	unpredictable	Certain	factors	such	as	obesity	hypertension	and	type	2	diabetes	mellitus	may	increase	the	severity	of	the	disease	Rheumatology	experts	suggest	that	patients	with	active	autoimmune	conditions	and	controlled	autoimmune	diseases	on	immunosuppressive	therapy	may	be	at	higher	risk	of	developing	severe	COVID-19	In	this	retrospective	observational	study	we	aimed	to	examine	the	patterns	of	COVID-19	in	patients	with	underlying	rheumatological	diseases	and	their	association	with	disease	severity	and	hospital	outcomes	A	total	of	34	patients	with	underlying	rheumatological	diseases	who	tested	positive	for	severe	acute	respiratory	syndrome	coronavirus-2	SARS-CoV-2	by	polymerase	chain	reaction	PCR	were	included	between	March	2020	and	April	2021	at	King	Fahd	Hospital	of	the	University	The	study	population	consisted	of	76	47	female	and	23	53	male	patients	with	a	mean	age	ranging	from	20	to	40	years	Female	gender	p	0	0001	and	younger	age	p	0	004	were	associated	with	milder	disease	The	most	frequent	rheumatological	disease	was	systemic	lupus	erythematosus	SLE	38	24	which	was	associated	with	a	milder	infection	p	0	045	Patients	treated	with	mycophenolate	mofetil	MMF	had	a	milder	disease	course	p	0	0037	Hypertension	was	significantly	associated	with	severe	COVID-19	disease	p	0	037	There	was	no	significant	relationship	between	SLE	and	the	need	for	ICU	admission	Patients	on	hydroxychloroquine	and	MMF	tended	to	develop	milder	disease	and	there	was	no	association	between	the	severity	of	the	infection	and	the	treatment	with	steroids
To	generate	comparative	efficacy	evidence	of	belimumab	versus	anifrolumab	in	SLE	that	can	inform	treatment	practices
Systemic	lupus	erythematosus	SLE	is	a	chronic	autoimmune	disease	At	present	the	mechanism	of	non-coding	RNA	in	renal	injury	in	SLE	patients	is	still	unclear	A	total	of	64	DEcircRNAs	75	DEmiRNAs	and	249	DEmRNAs	were	identified	We	integrated	10	circRNAs	10	miRNAs	and	88	target	mRNAs	into	a	circRNA-miRNA-mRNA	network	and	obtained	9	hub	genes	circ-0000006	miR-766-3p	miR-409-3p	miR-339-3p	miR-331-3p	miR-140-3p	miR-186-5p	miR-149-5p	PSME3	The	ROC	curve	results	showed	that	the	diagnostic	efficiency	of	6	hub	miRNA	was	higher	than	that	of	has	circ	0000006	and	PSEME3	SsGSEA	analysis	revealed	immune	cell	composition	in	SLE	and	control	renal	tissues	including	3	types	of	immune	cells	up-regulated	gamma	delta	T	cell	effector	memory	CD4	T	cell	central	memory	CD8	T	cell	and	4	types	down-regulated	memory	B	cell	mast	cell	macrophage	immature	dendritic	cell	eosinophil	in	SLE	patients	In	addition	PSME3	was	negatively	correlated	with	3	up-regulated	immune	cells	and	positively	correlated	with	4	down-regulated	immune	cells	in	SLE	patients	Our	study	provides	a	deeper	understanding	of	the	circRNA-related	competing	endogenous	RNA	regulatory	mechanism	in	the	renal	injury	of	systemic	lupus	erythematosus

This	study	aimed	to	identify	differentially	expressed	genes	DEGs	of	systemic	lupus	erythematosus	SLE	using	gene	expression-based	computational	methodologies	to	analyze	disease-immune	interactions	which	affect	the	development	and	progression	of	SLE
SLE	is	a	global	health	concern	that	unevenly	affects	certain	ethnic	racial	groups	Individuals	of	Asian	Black	Hispanic	and	Indigenous	ethnicity	race	are	amongst	those	who	experience	increased	prevalence	incidence	morbidity	and	mortality	Population-based	surveillance	studies	from	many	regions	are	few	and	often	still	in	nascent	stages	Many	of	these	areas	are	challenged	by	restricted	access	to	diagnostics	and	therapeutics	Without	accurately	capturing	the	worldwide	burden	and	distribution	of	SLE	appropriately	dedicating	resources	to	improve	global	SLE	outcomes	may	be	challenging	This	review	discusses	recent	SLE	epidemiological	studies	highlighting	the	challenges	and	emerging	opportunities	in	low-	and	middle-income	countries	We	suggest	means	of	closing	these	gaps	to	better	address	the	global	health	need	in	SLE
The	relationship	between	viral	infection	and	onset	of	autoimmune	diseases	such	as	systemic	lupus	erythematosus	remains	uncertain	During	the	COVID-19	pandemic	organ-specific	and	multisystemic	autoimmune	phenomena	temporally	related	to	the	viral	infection	have	been	described	Immune	dysregulation	triggered	by	the	SARS-CoV-2	virus	leading	to	hyperactivation	of	both	the	innate	and	adaptive	immune	systems	contributes	to	the	excessive	production	of	pro-inflammatory	cytokines	autoantibodies	and	subsequent	autoimmune	manifestations	We	report	two	patients	without	known	autoimmune	diseases	who	developed	lupus	nephritis	shortly	after	a	documented	mild	SARS-CoV-2	infection	Together	with	other	similar	cases	in	the	literature	the	observation	supports	a	viral	trigger	of	the	development	of	systemic	lupus	erythematosus	in	susceptible	individuals
To	conduct	a	systematic	review	with	meta-analysis	to	determine	the	effects	of	immunosuppression	on	Group	1	Pulmonary	Arterial	Hypertension	in	patients	with	systemic	lupus	erythematosus	SLE
Shikonin	is	an	anti-inflammatory	natural	herbal	drug	extracted	from	Lithospermum	erythrorhizon	and	its	therapeutic	effect	on	neuropsychiatric	systemic	lupus	erythematosus	NPSLE	is	yet	unknown	In	our	study	Shikonin	significantly	reversed	the	cognitive	impairment	and	alleviated	the	brain	tissue	damage	in	NPSLE	mice	The	permeability	of	blood-brain	barrier	was	also	verified	to	be	repaired	in	Shikonin-treated	NPSLE	mice	In	particular	we	found	that	Shikonin	alleviated	neuroinflammation	through	inhibiting	-catenin	signaling	pathway	thereby	depressing	the	activation	of	microglia	and	the	loss	of	neuronal	synapses	Overall	Shikonin	may	be	a	promising	candidate	drug	for	NPSLE	through	diminishing	neuroinflammation	and	repairing	neuron	damage
Since	the	improvement	in	management	and	the	reduction	of	mortality	caused	by	the	disease	activity	infections	have	represented	the	main	cause	of	morbidity	and	mortality	in	systemic	lupus	erythematosus	patients	We	aimed	to	determine	the	prevalence	and	identify	risk	factors	of	severe	infections	in	systemic	lupus	erythematosus	patients	We	conducted	a	retrospective	study	on	93	Tunisian	lupus	patients	followed	between	2010	and	2019	The	mean	age	of	the	disease	was	33	63	13	76	years	Fifty-two	patients	had	118	infections	and	16	of	the	infections	were	serious	The	bivariate	analysis	revealed	a	positive	correlation	between	the	total	cumulative	doses	of	corticosteroids	and	the	number	of	serious	infections	p	0	009	The	multivariate	study	has	shown	that	the	number	of	flares	p	0	03	pulmonary	manifestations	p	0	01	pleuritis	p	0	001	and	the	total	cumulative	dose	of	corticosteroids	p	0	04	were	independent	risk	factors	of	severe	infections	p	0	001	The	use	of	antimalarials	exerted	a	protective	effect	from	severe	infection	OR	0	19	95	CI	0	03-0	9	p	0	03
Cardiac	wall	rupture	CWR	is	a	serious	and	often	fatal	complication	of	myocardial	infarction	MI	Despite	an	increase	in	the	incidence	of	MI	in	patients	with	systemic	lupus	erythematosus	SLE	cases	of	CWR	in	these	patients	have	been	reported	rarely	This	study	reports	an	SLE	patient	with	CWR	and	pseudoaneurysm	formation	and	reviews	previously	reported	cases	of	CWR	in	SLE	patients	An	English	language	literature	review	of	from	the	PubMed	EMBASE	and	Scopus	databases	on	published	cases	of	CWR	in	SLE	up	until	January	2023	was	performed	and	analyzed	The	search	identified	4	patients	including	the	present	one	5	cases	altogether	All	of	them	were	female	aged	27-40	years	and	3	of	them	had	had	SLE	for	10	years	or	more	Chest	pain	and	dyspnea	were	the	common	presentations	All	had	left	ventricular	LV	wall	rupture	Three	patients	had	LV	wall	rupture	with	pseudoaneurysm	formation	one	had	MI	with	normal	coronary	artery	one	myocardial	necrosis	secondary	from	small	coronary	artery	vasculitis	and	one	MI	from	uncertain	cause	The	other	2	patients	had	LV	free	wall	rupture	one	had	MI	with	extensive	coronary	atherosclerosis	with	coronary	arteritis	and	the	other	septic	myocarditis	with	septic	coronary	arteritis	and	these	2	patients	died	before	the	diagnosis	was	made	Three	patients	with	pseudoaneurysm	received	surgical	correction	with	good	clinical	outcomes	in	all	Cardiac	wall	rupture	is	a	serious	and	often	fatal	cardiac	complication	Emergency	diagnosis	and	appropriate	management	with	an	experienced	cardiology	team	is	crucial	Surgical	correction	is	the	treatment	of	choice	Key	Points	Cardiac	wall	rupture	a	serious	and	often	fatal	cardiac	complication	has	rarely	been	described	in	SLE	patients	Emergency	diagnosis	and	appropriate	management	with	an	experienced	cardiology	team	is	crucial	Surgical	correction	is	the	treatment	of	choice
Pulmonary	involvement	in	childhood-onset	systemic	lupus	erythematosus	cSLE	contributes	to	significant	morbidity	and	mortality	Manifestations	include	chronic	interstitial	pneumonitis	pneumonia	pleuritis	alveolar	hemorrhage	and	shrinking	lung	syndrome	However	many	patients	can	be	asymptomatic	from	a	respiratory	standpoint	and	still	have	pulmonary	function	test	PFT	abnormalities	Our	aim	is	to	describe	PFT	abnormalities	in	patients	with	cSLE
MicroRNAs	miRNAs	are	crucial	post-transcriptional	regulators	of	gene	expression	in	ubiquitous	biological	processes	including	immune-related	pathways	This	review	focuses	on	the	miR-183	96	182	cluster	miR-183C	which	contains	three	miRNAs	miR-183	-96	and	-182	having	almost	identical	seed	sequences	with	minor	differences	The	similarity	among	seed	sequences	allows	these	three	miRNAs	to	act	cooperatively	In	addition	their	minor	differences	permit	them	to	target	distinct	genes	and	regulate	unique	pathways	The	expression	of	miR-183C	was	initially	identified	in	sensory	organs	Subsequently	abnormal	expression	of	miR-183C	miRNAs	in	various	cancers	and	autoimmune	diseases	has	been	reported	implying	their	potential	role	in	human	diseases	The	regulatory	effects	of	miR-183C	miRNAs	on	the	differentiation	and	function	of	both	innate	and	adaptive	immune	cells	have	now	been	documented	In	this	review	we	have	discussed	the	complex	role	of	miR-183C	in	the	immune	cells	in	both	normal	and	autoimmune	backgrounds	We	highlighted	the	dysregulation	of	miR-183C	miRNAs	in	several	autoimmune	diseases	including	systemic	lupus	erythematosus	SLE	multiple	sclerosis	MS	and	ocular	autoimmune	disorders	and	discussed	the	potential	for	utilizing	miR-183C	as	biomarkers	and	therapeutic	targets	of	specific	autoimmune	diseases
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	disease	causing	significant	morbidity	and	mortality	despite	important	improvements	in	its	management	in	the	last	decades	The	objective	of	this	work	is	to	investigate	the	role	of	IFN-	in	the	pathogenesis	of	childhood-onset	systemic	lupus	erythematosus	cSLE	evaluating	the	crosstalk	between	IFN-	and	IFN-	and	the	expression	of	T-bet	a	transcription	factor	induced	by	IFN-	in	B	cells	of	patients	with	cSLE	Expression	levels	of	both	IFN-	and	IFN-	-induced	genes	were	upregulated	in	patients	with	cSLE	We	found	increased	serum	levels	of	CXCL9	and	CXCL10	in	patients	with	cSLE	Type	I	IFN	score	decreased	with	initiation	of	immunosuppressive	treatment	conversely	type	II	IFN	score	and	levels	of	CXCL9	were	not	significantly	affected	by	immunosuppressive	treatment	Type	II	IFN	score	and	CXCL9	were	significantly	higher	in	patients	with	lupus	nephritis	We	observed	the	expansion	of	a	population	of	na	ve	B	cells	expressing	T-bet	in	a	cluster	of	patients	with	cSLE	IFN-	but	not	IFN-	induced	the	expression	of	T-bet	in	B	cells	Our	data	suggest	that	IFN-	is	hyperactive	in	cSLE	especially	in	patients	with	lupus	nephritis	and	it	is	not	modulated	by	therapy	Our	data	reinforce	the	potential	of	IFN-	as	a	therapeutic	target	in	SLE
Anti-Ro60	and	anti-Ro52	antibodies	are	associated	with	different	connective	tissue	diseases	CTDs	However	the	clinical	significance	of	anti-Ro	antibodies	is	not	always	consistent	among	different	global	regions	The	aim	of	this	study	was	to	investigate	the	clinical	characteristics	of	patients	with	anti-Ro	antibodies
Positive	antineutrophil	cytoplasmic	antibody	ANCA	serology	in	adult-onset	lupus	nephritis	LN	is	associated	with	more	active	disease	and	distinct	renal	pathology	but	data	with	respect	to	childhood-onset	LN	remain	scarce	Here	we	aimed	to	determine	the	impact	of	positive	ANCA	serology	on	clinical	and	histopathologic	features	and	renal	outcomes	in	children	with	LN	from	multiple	centers
Patients	with	systemic	lupus	erythematosus	SLE	are	at	increased	risk	of	tuberculosis	TB	infection	due	to	immune	dysfunction	and	immunosuppressive	therapy	We	present	a	case	study	of	a	40-year-old	woman	with	systemic	lupus	erythematosus	SLE	Initially	she	was	diagnosed	with	a	lupus	flare	based	on	her	clinical	symptoms	and	laboratory	results	However	upon	further	investigation	positive	polymerase-chain	reaction	results	for	M	tuberculosis	in	the	cerebrospinal	fluid	and	lung	parenchymal	changes	on	chest	computed	tomography	scan	were	indicative	of	TB	infection	There	was	initial	uncertainty	regarding	whether	TB	had	triggered	a	flare-up	of	SLE	or	if	TB	was	merely	mimicking	the	symptoms	of	a	SLE	flare-up	However	as	increasing	the	prednisolone	dose	did	not	have	a	positive	effect	and	the	patient	s	condition	improved	significantly	with	anti-TB	treatment	alone	it	became	clearer	that	the	deterioration	observed	upon	admission	was	primarily	due	to	TB	progression	rather	than	an	SLE	flare-up	Additionally	we	review	the	current	literature	on	TB	and	SLE	including	risk	factors	diagnostic	challenges	and	treatment	considerations	highlighting	the	importance	of	considering	TB	infection	in	patients	with	SLE	who	present	with	overlapping	manifestations	Prompt	diagnosis	and	treatment	are	essential	for	improving	outcomes	in	these	patients
Sj	gren	syndrome	SjS	is	an	autoimmune	disease	characterized	by	the	destruction	of	the	exocrine	gland	epithelia	causing	a	dryness	of	mucosa	called	sicca	symptoms	and	whose	main	life-threatening	complication	is	lymphoma	There	is	a	need	for	new	biomarkers	in	this	disease	notably	diagnostic	biomarkers	for	patients	with	genuine	sicca	symptoms	that	do	not	meet	current	criteria	and	prognostic	biomarkers	for	patients	at	risk	of	lymphoma	Plasma	extracellular	vesicles	EVs	are	promising	biomarker	candidates	in	several	diseases	but	their	potential	has	not	yet	been	explored	in	SjS	In	this	proof-of-concept	study	we	characterized	EVs	from	primary	SjS	patients	pSS	n	12	at	the	phenotypic	and	proteomic	levels	compared	to	EVs	from	healthy	donor	HD	n	8	and	systemic	lupus	erythematosus	patients	SLE	n	12	Specific	plasma	EVs	subpopulations	derived	from	neutrophils	endothelial	and	epithelial	cells	were	found	increased	in	pSS	We	also	identified	a	pSS	proteomic	signature	in	plasma	EVs	including	neutrophil-	epithelial-	and	endothelial-related	proteins	such	as	integrin	alpha	M	ITGAM	olfactomedin-4	OLFM4	Ras-related	protein	RAB10	and	CD36	Overall	our	results	support	the	relevance	of	plasma	EVs	as	biomarkers	in	SjS
Systemic	lupus	erythematosus	SLE	pregnancies	are	considered	high-risk	due	to	risk	of	disease	flare	and	pregnancy	complications	A	more	in-depth	understanding	of	the	immunological	alterations	in	SLE	patients	during	pregnancy	and	identification	of	predictive	biomarkers	may	help	to	achieve	stable	disease	and	to	avoid	pregnancy	complications	Lipocalin-2	LCN2	has	been	implicated	as	a	potential	biomarker	for	rheumatic	diseases	and	preeclampsia	but	remains	unexplored	in	SLE	pregnancies
There	is	an	urgent	need	for	novel	biomarkers	in	lupus	nephritis	LN	We	report	a	non-invasive	urinary	biomarker	L-selectin	in	two	independent	multi-ethnic	cohorts

Autoimmune	diagnostics	plays	a	central	role	in	the	detection	of	various	acute	and	or	chronic	diseases	in	both	nephrology	and	rheumatology	which	are	associated	with	high	morbidity	and	mortality	if	left	untreated	or	not	detected	in	time	Patients	are	threatened	with	significant	limitations	in	everyday	skills	and	quality	of	life	due	to	loss	of	kidney	function	and	dialysis	immobilizing	and	destructive	joint	processes	or	also	significant	damage	of	organ	systems	In	all	of	these	autoimmune	diseases	early	diagnosis	and	treatment	is	of	central	importance	for	the	further	course	and	prognosis	of	disease	Antibodies	play	an	essential	role	in	the	pathogenesis	of	autoimmune	diseases	Antibodies	are	either	directed	against	organ	or	tissue-specific	antigens	such	as	in	primary	membranous	glomerulonephritis	or	Goodpasture	s	syndrome	or	they	lead	to	a	systemic	disease	such	as	systemic	lupus	erythematosus	SLE	or	rheumatoid	arthritis	Knowledge	of	the	sensitivity	and	specificity	of	antibodies	is	crucial	for	the	interpretation	of	antibody	diagnostics	results	Antibody	detection	can	precede	the	clinical	onset	of	the	disease	and	antibody	titers	often	reflect	disease	activity	However	there	are	also	false	positive	results	Detection	of	antibodies	in	the	absence	of	disease	symptoms	often	leads	to	uncertainty	and	unnecessary	further	diagnostics	Therefore	an	unfounded	antibody	screening	is	not	recommended	A	rational	antibody	diagnostics	is	an	integral	part	of	the	diagnostics	and	during	treatment	of	nephrological	and	rheumatological	diseases	like	glomerulonephrititis	pulmorenal	syndrome	SLE	and	other	collagenosis	thrombotic	microangiopathy	HUS	TTP	and	rheumatoid	arthritis
The	aim	of	this	study	was	to	define	the	clinical	histopathologic	and	prognostic	features	associated	with	simultaneous	positivity	for	anti-dsDNA	-nucleosome	and	-histone	antibodies	3-pos	in	Korean	patients	with	biopsy-proven	lupus	nephritis	LN
The	short-term	and	long-term	outcome	of	inflammatory	neuropsychiatric	SLE	NPSLE	with	immunosuppressive	treatment	is	largely	unknown	We	used	clinical	data	from	our	tertiary	referral	centre	for	NPSLE	to	investigate	the	type	of	inflammatory	NPSLE	manifestations	type	of	immunosuppressive	treatment	prescribed	for	these	manifestations	and	clinical	outcomes
Systemic	lupus	erythematosus	SLE	is	reported	to	produce	anti-HLA	antibodies	We	report	a	case	of	chronic	active	antibody-mediated	rejection	caused	by	pre-existing	donor-specific	antibody	DSA	in	a	patient	with	SLE	without	a	history	of	sensitization
Systemic	lupus	erythematosus	SLE	is	a	chronic	autoimmune	illness	with	an	unclear	etiology	and	a	range	of	clinical	manifestations	The	therapeutic	results	of	current	conventional	treatments	are	frequently	unsatisfactory	Many	B-cell-directed	immunotherapies	have	recently	been	discovered	as	B	cells	play	a	key	role	in	the	pathogenesis	of	SLE	However	large-scale	rituximab	trials	found	that	the	antibody	against	CD20	was	no	better	than	a	placebo	Autologous	CAR	T-cell	therapy	has	garnered	considerable	interest	and	is	considered	a	potential	treatment	option	for	SLE	CD19	CD20-	B	cells	are	thought	to	play	an	essential	role	in	the	onset	and	progression	of	SLE	CD19-targeted	CAR	T-cells	destroy	B	cells	without	requiring	an	accessory	cell	type	thereby	decreasing	B	cells	more	efficiently	Preclinical	trials	of	CAR	T-cells	in	mice	have	shown	promising	results	against	SLE	The	review	aimed	to	shed	light	on	autologous	CD19-targeted	CAR	T-cells	as	a	potential	treatment	for	SLE
The	HLA-DRB1	gene	encodes	a	protein	that	is	essential	for	the	immune	system	This	gene	is	important	in	organ	transplant	rejection	and	acceptance	as	well	as	multiple	sclerosis	systemic	lupus	erythematosus	Addison	s	disease	rheumatoid	arthritis	caries	susceptibility	and	Aspirin-exacerbated	respiratory	disease	The	following	Homo	sapiens	variants	were	investigated	single-nucleotide	variants	SNVs	multi-nucleotide	variants	MNVs	and	small	insertions-deletions	Indels	in	the	HLA-DRB1	gene	via	coding	and	untranslated	regions	The	current	study	sought	to	identify	functional	variants	that	could	affect	gene	expression	and	protein	product	function	structure	ALL	target	variants	available	until	April	14	2022	were	obtained	from	the	Single	Nucleotide	Polymorphism	database	dbSNP	Out	of	all	the	variants	in	the	coding	region	91	nsSNVs	were	considered	highly	deleterious	by	seven	prediction	tools	and	instability	index	25	of	them	are	evolutionary	conserved	and	located	in	domain	regions	Furthermore	31	indels	were	predicted	as	harmful	potentially	affecting	a	few	amino	acids	or	even	the	entire	protein	Last	within	the	coding	sequence	CDS	23	stop-gain	variants	SNVs	indels	were	predicted	as	high	impact	High	impact	refers	to	the	assumption	that	the	variant	will	have	a	significant	disruptive	effect	on	the	protein	likely	leading	to	protein	truncation	or	loss	of	function	For	untranslated	regions	functional	55	single-nucleotide	polymorphisms	SNPs	and	16	indels	located	within	microRNA	binding	sites	furthermore	10	functionally	verified	SNPs	were	predicted	at	transcription	factor-binding	sites	The	findings	demonstrate	that	employing	in	silico	methods	in	biomedical	research	is	extremely	successful	and	has	a	major	influence	on	the	capacity	to	identify	the	source	of	genetic	variation	in	diverse	disorders	In	conclusion	these	previously	functional	identified	variants	could	lead	to	gene	alteration	which	may	directly	or	indirectly	contribute	to	the	occurrence	of	many	diseases	The	study	s	results	could	be	an	important	guide	in	the	research	of	potential	diagnostic	and	therapeutic	interventions	that	require	experimental	mutational	validation	and	large-scale	clinical	trials


It	is	inevitable	that	artificial	intelligence	applications	will	be	used	as	a	source	of	information	in	the	field	of	health	in	the	near	future	For	this	reason	we	aimed	to	evaluate	whether	ChatGPT	a	new	Large	Language	Model	can	be	used	to	obtain	information	about	common	rheumatic	diseases
Fifteen-year-old	female	patient	previously	healthy	referred	to	our	center	for	presenting	abdominal	pain	vomiting	diarrhea	malar	erythema	palpebral	and	lower	limb	edema	arthralgia	morning	stiffness	and	bilateral	blurred	vision	Laboratory	and	imaging	studies	together	with	the	clinic	allowed	the	diagnosis	of	nephrotic	syndrome	secondary	to	systemic	lupus	erythematosus	Ophthalmology	examination	revealed	a	visual	acuity	of	8	10	in	both	eyes	and	bilateral	disc	edema	with	partial	macular	star	findings	compatible	with	bilateral	neuroretinitis	Renal	biopsy	established	the	diagnosis	of	membranous	lupus	nephritis	Immunosuppressive	treatment	was	started	obtaining	gradual	clinical	improvement	Although	systemic	lupus	erythematosus	with	membranous	lupus	nephritis	and	neuroretinitis	is	a	very	infrequent	association	when	faced	with	a	patient	with	bilateral	neuroretinitis	we	must	consider	systemic	lupus	erythematosus	within	the	differential	diagnoses
Although	extracellular	DNA	is	known	to	form	immune	complexes	ICs	with	autoantibodies	in	systemic	lupus	erythematosus	SLE	the	mechanisms	leading	to	the	release	of	DNA	from	cells	remain	poorly	characterized	Here	we	show	that	the	pore-forming	protein	gasdermin	D	GSDMD	is	required	for	nuclear	DNA	and	mitochondrial	DNA	mtDNA	release	from	neutrophils	and	lytic	cell	death	following	ex	vivo	stimulation	with	serum	from	patients	with	SLE	and	IFN-	Mechanistically	the	activation	of	Fc	R	downregulated	Serpinb1	following	ex	vivo	stimulation	with	serum	from	patients	with	SLE	leading	to	spontaneous	activation	of	both	caspase-1	caspase-11	and	cleavage	of	GSDMD	into	GSDMD-N	Furthermore	mtDNA	oxidization	promoted	GSDMD-N	oligomerization	and	cell	death	In	addition	GSDMD	but	not	peptidyl	arginine	deiminase	4	is	necessary	for	extracellular	mtDNA	release	from	low-density	granulocytes	from	SLE	patients	or	healthy	human	neutrophils	following	incubation	with	ICs	Using	the	pristane-induced	lupus	model	we	show	that	disease	severity	is	significantly	reduced	in	mice	with	neutrophil-specific	Gsdmd	deficiency	or	following	treatment	with	the	GSDMD	inhibitor	disulfiram	Altogether	our	study	highlights	an	important	role	for	oxidized	mtDNA	in	inducing	GSDMD	oligomerization	and	pore	formation	These	findings	also	suggest	that	GSDMD	might	represent	a	possible	therapeutic	target	in	SLE
Systemic	lupus	erythematosus	SLE	is	a	multisystemic	autoimmune	disease	with	a	complex	etiopathogenesis	Renal	involvement	is	the	most	common	and	devastating	complication	of	the	disease	Renal	resistive	index	RRI	was	suggested	as	a	noninvasive	biomarker	for	lupus	nephritis	in	previous	studies	This	is	the	first	study	to	investigate	the	role	of	RRI	measurement	in	juvenile	SLE	patients

Childhood-onset	systemic	lupus	erythematosus	cSLE	patients	are	unique	with	hallmarks	of	Mendelian	disorders	early-onset	and	severe	disease	and	thus	are	an	ideal	population	for	genetic	investigation	of	SLE	In	this	study	we	use	the	transmission	disequilibrium	test	TDT	a	family-based	genetic	association	analysis	that	employs	robust	methodology	to	analyze	whole	genome	sequencing	data	We	aim	to	identify	novel	genetic	associations	in	an	ancestrally	diverse	international	cSLE	cohort	Forty-two	cSLE	patients	and	84	unaffected	parents	from	3	countries	underwent	whole	genome	sequencing	First	we	performed	TDT	with	single	nucleotide	variant	SNV	-based	common	variants	using	PLINK	1	9	and	gene-based	rare	variants	analyses	using	Efficient	and	Parallelizable	Association	Container	Toolbox	EPACTS	and	rare	variant	TDT	rvTDT	which	applies	multiple	gene-based	burden	tests	adapted	for	TDT	including	the	burden	of	rare	variants	test	Applying	the	GWAS	standard	threshold	5	0	10-8	to	common	variants	our	SNV-based	analysis	did	not	return	any	genome-wide	significant	SNVs	The	rare	variant	gene-based	TDT	analysis	identified	many	novel	genes	significantly	enriched	in	cSLE	patients	including	HNRNPUL2	a	DNA	repair	protein	and	DNAH11	a	ciliary	movement	protein	among	others	Our	approach	identifies	several	novel	SLE	susceptibility	genes	in	an	ancestrally	diverse	childhood-onset	lupus	cohort
Cutaneous	lupus	erythematosus	can	manifest	with	or	without	systemic	involvement	resulting	in	a	broad	clinical	spectrum	Disease	pathogenesis	is	often	characterized	by	a	loss	of	tolerance	to	endogenous	antigens	and	a	chronic	relapsing	activation	of	the	innate	and	adaptive	immune	system	Research	in	recent	years	has	expanded	our	pathogenic	understanding	of	the	disease	However	therapeutic	options	remain	limited	Biologics	directed	against	BLyS	or	the	type	I	interferon	receptor	can	be	used	for	patients	with	cutaneous	involvement	and	systemic	lupus	erythematosus	sometimes	with	an	excellent	response	Clinical	trials	are	difficult	to	conduct	due	to	the	symptomatic	variability	of	the	disease	However	as	cutaneous	manifestations	are	increasingly	recorded	as	a	primary	endpoints	we	hope	that	multiple	therapeutic	targets	will	lead	to	better	treatment	options	for	SLE	in	the	near	future
To	assess	if	high	quality	of	care	QOC	in	SLE	results	in	improved	outcomes	of	quality	of	life	QOL	and	non-routine	health	care	utilization	HCU
We	aimed	to	reveal	a	spatial	proteomic	and	immune	signature	of	kidney	function	regions	in	lupus	nephritis	LN
The	kidney	is	a	comparatively	hostile	microenvironment	characterized	by	highsodium	concentrations	however	lymphocytes	infiltrate	and	survive	therein	in	autoimmune	diseases	such	as	lupus	The	effects	of	sodium-lymphocyte	interactions	on	tissue	injury	in	autoimmune	diseases	and	the	mechanisms	used	by	infiltrating	lymphocytes	to	survive	the	highsodium	environment	of	the	kidney	are	not	known	Here	we	show	that	kidney-infiltrating	B	cells	in	lupus	adapt	to	elevated	sodium	concentrations	and	that	expression	of	sodium	potassium	adenosine	triphosphatase	Na	-K	-ATPase	correlates	with	the	ability	of	infiltrating	cells	to	survive	Pharmacological	inhibition	of	Na	-K	-ATPase	and	genetic	knockout	of	Na	-K	-ATPase	subunit	resulted	in	reduced	B	cell	infiltration	into	kidneys	and	amelioration	of	proteinuria	B	cells	in	human	lupus	nephritis	biopsies	also	had	high	expression	of	Na	-K	-ATPase	Our	study	reveals	that	kidney-infiltrating	B	cells	in	lupus	initiate	a	tissue	adaption	program	in	response	to	sodium	stress	and	identifies	Na	-K	-ATPase	as	an	organ-specific	therapeutic	target
To	characterize	the	antibody	response	to	COVID-19	mRNA	vaccination	in	patients	with	Systemic	Lupus	Erythematosus	SLE	and	identify	predictors	of	poor	response
Systemic	lupus	erythematosus	SLE	is	a	chronic	systemic	autoimmune	disease	characterized	by	genetic	heterogeneity	and	an	interferon	IFN	signature	The	overall	landscapes	of	the	heritability	of	SLE	remains	unclear
In	this	study	we	aimed	to	investigate	Bregs	their	regulatory	effects	on	Th17	Treg	cell	balance	and	the	release	of	downstream	inflammatory	factors	in	a	mouse	model	of	low-density	lipoprotein	receptor	LDLr	-	-	Pristane
Kunxian	capsule	KXC	is	a	new	traditional	Chinese	medicine	drug	included	in	The	key	science	and	technology	achievements	in	the	Ninth	Five	Year	Plan	of	China	KXC	has	been	clinically	used	for	more	than	10	years	in	the	treatment	of	lupus	nephritis	LN	However	the	underlying	role	and	molecular	mechanism	of	KXC	in	LN	remain	unclear
Ferroptosis	resistance	is	vital	for	B	cell	development	especially	in	inflammatory	diseases	yet	the	underlying	mechanism	is	still	unclear	In	this	study	based	on	the	scRNA-seq	technique	and	flow	cytometry	we	discovered	a	proportion	of	neutrophils	exhibited	upregulated	expression	of	the	IL-6	and	correlated	with	the	expression	of	IL-6	receptor	and	SLC7A11	from	B	cells	in	lupus	kidney	Moreover	we	identified	that	in	lupus	kidney	neutrophils	could	provide	IL-6	to	facilitate	ferroptosis	resistance	in	B	cells	via	SLC7A11	and	inhibition	of	SLC7A11	could	significantly	enhance	ferroptosis	in	B	cells	and	could	decrease	B	cell	proliferation	This	study	helps	understand	the	crosstalk	between	neutrophils	and	B	cells	in	the	kidney	in	the	development	of	lupus
The	recognition	that	cytosolic	mitochondrial	DNA	mtDNA	activates	cyclic	GMP-AMP	synthase-stimulator	of	interferon	genes	cGAS-STING	innate	immune	signaling	has	unlocked	novel	disease	mechanisms	Here	an	uncharacterized	variant	predicted	to	affect	TOP1MT	function	P193L	was	discovered	in	a	family	with	multiple	early	onset	autoimmune	diseases	including	Systemic	Lupus	Erythematosus	SLE	Although	there	was	no	previous	genetic	association	between	TOP1MT	and	autoimmune	disease	the	role	of	TOP1MT	as	a	regulator	of	mtDNA	led	us	to	investigate	whether	TOP1MT	could	mediate	the	release	of	mtDNA	to	the	cytosol	where	it	could	then	activate	the	cGAS-STING	innate	immune	pathway	known	to	be	activated	in	SLE	and	other	autoimmune	diseases	Through	analysis	of	cells	with	reduced	TOP1MT	expression	we	show	that	loss	of	TOP1MT	results	in	release	of	mtDNA	to	the	cytosol	which	activates	the	cGAS-STING	pathway	We	also	characterized	the	P193L	variant	for	its	ability	to	rescue	several	TOP1MT	functions	when	expressed	in	TOP1MT	knockout	cells	We	show	that	the	P193L	variant	is	not	fully	functional	as	its	re-expression	at	high	levels	was	unable	to	rescue	mitochondrial	respiration	deficits	and	only	showed	partial	rescue	for	other	functions	including	repletion	of	mtDNA	replication	following	depletion	nucleoid	size	steady	state	mtDNA	transcripts	levels	and	mitochondrial	morphology	Additionally	expression	of	P193L	at	endogenous	levels	was	unable	to	rescue	mtDNA	release-mediated	cGAS-STING	signaling	Overall	we	report	a	link	between	TOP1MT	and	mtDNA	release	leading	to	cGAS-STING	activation	Moreover	we	show	that	the	P193L	variant	has	partial	loss	of	function	that	may	contribute	to	autoimmune	disease	susceptibility	via	cGAS-STING	mediated	activation	of	the	innate	immune	system
The	aim	of	the	study	was	to	investigate	whether	the	IRAK1	JAK2	Flt3	inhibitor	pacritinib	prevents	disease	development	in	the	lupus-prone	ABIN1	D485N	knock-in	mouse

We	have	developed	a	new	conceptual	model	to	characterise	the	signs	and	symptoms	of	SLE	the	Type	1	and	2	SLE	Model	Within	the	original	model	Type	1	SLE	consists	of	inflammatory	manifestations	like	arthritis	nephritis	and	rashes	Type	2	SLE	includes	symptoms	of	fatigue	myalgia	mood	disturbance	and	cognitive	dysfunction	Through	in-depth	interviews	we	explored	how	the	Type	1	and	2	SLE	Model	fits	within	the	lived	experience	of	patients	with	SLE	with	a	focus	on	the	connection	between	Type	1	and	Type	2	SLE	symptoms
Inhalation	of	silica	not	only	directly	leads	to	silicosis	locally	but	also	results	in	various	types	of	autoimmune	diseases	systemically	most	commonly	systemic	lupus	erythematosus	SLE	Little	is	known	about	the	etiopathogenesis	of	silica-aggravated	SLE	to	date	however	abnormal	apoptosis	and	impaired	apoptotic	clearance	have	been	reported	to	be	closely	related	to	the	occurrence	of	SLE	LC3-associated	phagocytosis	LAP	is	a	non-canonical	form	of	autophagy	which	plays	a	crucial	role	in	mediating	the	clearance	of	apoptotic	cells	Here	we	showed	that	the	excessive	accumulation	of	apoptotic	debris	in	MRL	lpr	mice	exposed	to	silica	might	be	due	to	the	increased	cell	apoptosis	and	defective	LAP	caused	by	silica	thus	accelerating	the	occurrence	and	progression	of	silica-aggravated	SLE	Dioscin	is	an	active	ingredient	in	the	family	of	Dioscoreaceae	and	is	reported	to	possess	multiple	pharmacological	activities	including	anti-inflammatory	anti-apoptotic	and	autophagy-promoting	properties	However	its	role	in	SLE	aggravated	by	silica	exposure	has	not	been	investigated	In	our	study	we	confirmed	that	dioscin	decreased	the	accumulation	of	apoptotic	debris	by	suppressing	the	excessive	cell	apoptosis	and	improving	the	LAP	of	immune	cells	in	lung	and	spleen	leading	to	subsequent	dramatically	ameliorated	lupus-like	symptoms	in	silica-exposed	MRL	lpr	mice
Autoimmune	diseases	are	life-threatening	disorders	that	cause	increasing	disability	over	time	Systemic	lupus	erythematosus	SLE	and	other	autoimmune	diseases	arise	when	immune	stimuli	override	mechanisms	of	self-tolerance	Accumulating	evidence	has	demonstrated	that	protein	glycosylation	is	substantially	altered	in	autoimmune	disease	development	but	the	mechanisms	by	which	glycans	trigger	these	autoreactive	immune	responses	are	still	largely	unclear	In	this	study	we	found	that	presence	of	microbial-associated	mannose	structures	at	the	surface	of	the	kidney	triggers	the	recognition	of	DC-SIGN-expressing	T	cells	inducing	a	pathogenic	interleukin-17a	IL-17a	-mediated	autoimmune	response	Mice	lacking	Mgat5	which	have	a	higher	abundance	of	mannose	structures	in	the	kidney	displayed	increased	T	cell	infiltration	into	the	kidney	that	was	associated	with	spontaneous	development	of	lupus	in	older	mice	N-acetylglucosamine	supplementation	which	promoted	biosynthesis	of	tolerogenic	branched	N-glycans	in	the	kidney	was	found	to	inhibit	T	cell	infiltration	and	control	disease	development	Together	this	work	reveals	a	mannose-	T	cell-IL-17a	axis	in	SLE	immunopathogenesis	and	highlights	glycometabolic	reprogramming	as	a	therapeutic	strategy	for	autoimmune	disease	treatment
The	etiology	of	systemic	lupus	erythematosus	SLE	remains	unclear	with	both	genetic	and	environmental	factors	potentially	contributing	This	study	aimed	to	explore	the	relationship	among	gut	microbiota	GM	intestinal	permeability	and	food	intake	with	inflammatory	markers	in	inactive	SLE	patients	A	total	of	22	women	with	inactive	SLE	and	20	healthy	volunteers	were	enrolled	and	dietary	intake	was	assessed	through	24-h	dietary	recalls	Plasma	zonulin	was	used	to	evaluate	intestinal	permeability	while	GM	was	determined	by	16S	rRNA	sequencing	Regression	models	were	used	to	analyze	laboratory	markers	of	lupus	disease	C3	and	C4	complement	and	C-reactive	protein	Our	results	showed	that	the	genus	Megamonas	was	significantly	enriched	in	the	iSLE	group	p	0	001	with	Megamonas	funiformis	associated	with	all	evaluated	laboratory	tests	p	0	05	Plasma	zonulin	was	associated	with	C3	levels	p	0	016	and	sodium	intake	was	negatively	associated	with	C3	and	C4	levels	p	0	05	A	combined	model	incorporating	variables	from	each	group	GM	intestinal	permeability	and	food	intake	demonstrated	a	significant	association	with	C3	complement	levels	p	0	01	These	findings	suggest	that	increased	Megamonas	funiformis	abundance	elevated	plasma	zonulin	and	higher	sodium	intake	may	contribute	to	reduced	C3	complement	levels	in	women	with	inactive	SLE
Age-associated	B	cells	ABCs	are	formed	under	inflammatory	conditions	and	are	considered	a	type	of	memory	B	cell	MBC	expressing	the	transcription	factor	T-bet	In	SLE	ABC	frequency	is	correlated	with	disease	and	they	are	thought	to	be	the	source	of	autoantibody-secreting	cells	However	in	inflammatory	conditions	whether	autoreactive	B	cells	can	become	resting	MBCs	is	uncertain	Further	the	phenotypic	identity	of	ABCs	and	their	relationship	to	other	B	cell	subsets	such	as	plasmablasts	is	unclear	Whether	ABCs	directly	promote	disease	is	untested	Here	we	report	in	the	MRL	lpr	SLE	model	unexpected	heterogeneity	among	ABC-like	cells	for	expression	of	the	integrins	CD11b	and	CD11c	T-bet	and	memory	or	plasmablast	markers	Transfer	and	labeling	studies	demonstrated	that	ABCs	are	dynamic	rapidly	turning	over	scRNA-seq	identified	B	cell	clones	present	in	multiple	subsets	revealing	that	ABCs	can	be	plasmablast	precursors	or	undergo	cycles	of	reactivation	Deletion	of	CD11c-expressing	B	cells	revealed	a	direct	role	for	ABC-like	B	cells	in	lupus	pathogenesis
To	evaluate	and	quantify	the	indicators	of	fetal	and	maternal	morbidity	in	deliveries	for	patients	with	systemic	lupus	erythematosus	SLE	compared	with	deliveries	in	patients	without	SLE
Lupus	nephritis	LN	is	a	common	and	severe	manifestation	of	pediatric-onset	systemic	lupus	erythematosus	pSLE	It	is	one	of	the	major	causes	of	long-term	glucocorticoid	immune	suppressants	use	in	pSLE	It	causes	long-term	glucocorticoid	immune	suppressants	use	and	even	end-stage	renal	disease	ESRD	in	pSLE	It	is	now	well	known	that	high	chronicity	especially	the	tubulointerstitial	components	in	the	renal	biopsy	predicts	a	poor	renal	outcome	Interstitial	inflammation	II	a	component	of	activity	in	LN	pathology	can	be	an	early	predictor	for	the	renal	outcome	With	the	advent	of	3D	pathology	and	CD19-targeted	CAR-T	cell	therapy	in	the	2020s	the	present	study	focuses	on	detailed	pathology	and	B	cell	expression	in	II	We	recruited	48	pSLE	patients	with	class	III	IV	LN	to	analyze	the	risk	of	ESRD	based	on	different	II	scores	We	also	studied	3D	renal	pathology	and	immunofluorescence	IF	staining	of	CD3	19	20	and	138	in	patients	with	a	high	II	score	but	low	chronicity	Those	pSLE	LN	patients	with	II	scores	of	2	or	3	showed	a	higher	risk	for	ESRD	p	0	003	than	those	with	II	scores	of	0	or	1	Excluding	patients	with	chronicity	3	high	II	scores	still	carried	a	higher	risk	for	ESRD	p	0	005	Checking	the	average	scores	from	the	renal	specimens	from	different	depths	the	II	and	chronicity	showed	good	consistency	between	3D	and	2D	pathology	interclass	correlation	coefficient	ICC	II	0	91	p	0	0015	chronicity	0	86	p	0	024	However	the	sum	of	tubular	atrophy	plus	interstitial	fibrosis	showed	no	good	consistency	ICC	0	79	p	0	071	The	selected	LN	patients	with	negative	CD19	20	IF	stains	showed	scattered	CD3	infiltration	and	a	different	IF	pattern	of	Syndecan-1	expression	Our	study	provides	unique	data	in	LN	including	3D	pathology	and	different	in	situ	Syndecan-1	patterns	in	LN	patients
Bisphenol	A	BPA	is	a	common	environmental	endocrine	disruptor	which	mimic	the	effect	of	estrogen	The	immunotoxicity	of	BPA	has	attracted	widespread	attention	in	recent	years	However	the	effects	and	mechanism	of	BPA	on	autoimmune	disease	were	rarely	reported	Systemic	lupus	erythematosus	SLE	is	a	typical	autoimmune	disease	and	its	etiology	and	mechanism	are	complex	and	unclear	Currently	inflammation	and	the	production	of	autoantibodies	are	considered	to	be	important	pathological	mechanisms	of	SLE	and	estrogen	contributes	to	the	occurrence	and	development	of	SLE	Therefore	in	order	to	explore	whether	BPA	exposure	can	affect	the	development	of	SLE	and	its	possible	mechanism	we	used	MRL	lpr	lupus-prone	mice	and	C57	BL6	female	mice	exposed	to	0	1	and	0	2	g	mL	BPA	for	6	weeks	We	discovered	that	BPA	exposure	increased	the	concentration	of	serum	anti-dsDNA	antibody	and	IL-17	and	the	level	of	ROR	t	protein	the	transcription	factor	of	Th17	cells	Moreover	there	were	higher	expression	of	p-PI3K	p-AKT	p-mTOR	ULK	Rubicon	P62	Becline1	and	LC3	protein	in	spleen	tissue	of	BPA	exposed	MRL	lpr	mice	compared	with	the	control	However	there	were	no	significant	changes	in	the	expression	of	IL-17	ROR	t	or	mTOR	in	C57	mice	exposed	to	BPA	at	the	same	dose	Our	study	implied	that	BPA	exposure	induced	the	development	of	SLE	which	might	be	related	to	the	up-regulation	of	PI3K	AKT	mTOR	signaling	pathway	and	abnormal	autophagy	Our	study	indicated	that	lupus	mice	were	more	susceptible	to	BPA	and	provided	a	new	insight	into	the	mechanism	by	which	BPA	exacerbated	SLE	Therefore	our	study	suggested	that	autoimmune	patients	and	susceptible	population	should	be	considered	when	setting	thresholds	for	environmental	BPA	exposure
Systemic	lupus	erythematosus	SLE	is	a	chronic	recurrent	autoimmune	disease	affecting	almost	all	organs	This	study	was	conducted	to	investigate	cognitive	impairment	of	SLE	mice	MRL	lpr	mice	and	explore	associated	pathological	mechanism	Behavior	tests	open-field	test	elevated	plus-maze	test	forced	swimming	test	sucrose	preference	test	and	Morris	water	maze	test	were	conducted	in	MRL	MPJ	and	MRL	lpr	mice	ELISA	test	was	performed	to	determine	levels	of	antibodies	anti-dsDNA	anti-RPA	anti-ACA	and	anti-NR2a	b	and	inflammatory	factors	tumour	necrosis	factor	a	TNF-a	interleukin	IL	-6	IL-8	and	IL-10	Micro-vascular	endothelial	cells	MVECs	were	isolated	identified	and	divided	into	MVECs	NC	anti-NR2a	2b	memantine	glycine	dexamethasone	and	IL-1b	groups	Cell	proliferation	was	measured	using	cell	counting	kit-8	CCK-8	assay	and	Western	blotting	was	applied	to	evaluate	ELAM-1	VCAM-1	ICAM-1	IKBa	p-IKBa	expression	MRL	lpr	mice	demonstrated	lower	locomotion	exploration	ability	higher	anxiety	obvious	depression	symptoms	lower	learning	memory	capability	compared	with	MRL	MPJ	mice	MRL	lpr	mice	demonstrated	high	levels	of	anti-NR2a	b	antibody	and	auto-antibodies	NMDA	receptor	antagonist	memantine	significantly	increased	and	NMDA	receptor	agonist	glycine	significantly	decreased	MVECs	proliferation	compared	with	NC	group	p	0	05	Memantine	significantly	reduced	and	glycine	predominantly	enhanced	TNF-a	IL-6	IL-8	and	IL-10	levels	compared	with	NC	group	p	0	05	NMDA	receptor	antagonist	and	agonist	modulated	adhesion	molecules	expression	in	MVECs	ELAM-1	VCAM-1	and	ICAM-1	expressions	were	significantly	down-modulated	in	memantine	group	and	remarkably	up-modulated	in	glycine	group	compared	with	NC	group	p	0	05	NMDA	receptor	antagonist	and	agonist	regulated	phosphorylation	of	p-IKBa	The	above	effects	of	memantine	evenly	equaled	to	dexamethasone	and	glycine	evenly	equaled	to	IL-1b	In	conclusion	cognitive	impairment	of	MRL	mice	might	be	associated	with	NMDA	receptor-mediated	inflammatory	response	and	production	of	adhesion	molecules	in	MRL	lpr	mice-derived	MVECs
To	investigate	whether	low	complement	levels	can	predict	worse	outcomes	in	patients	hospitalized	with	positive	anti-phospholipid	antibodies
Rheumatic	disorders	are	chronic	and	common	diseases	which	especially	involve	connective	tissue	and	may	be	associated	with	the	damage	to	vital	organs	such	as	heart	and	kidney	Diagnosis	prognosis	determining	the	probability	of	severe	complications	monitoring	and	evaluation	of	the	response	to	treatment	in	such	patients	require	specialized	expensive	and	time-consuming	laboratory	tests
The	aim	of	this	work	is	to	describe	the	clinical	manifestations	at	onset	and	during	follow-up	in	a	monocentric	cohort	of	patients	with	juvenile	systemic	lupus	erythematosus	jSLE	from	the	Paediatric	Rheumatology	group	of	the	Milan	area	PRAGMA
Scholars	are	exploring	novel	diagnostic	and	prognostic	biomarkers	with	higher	sensitivity	and	specificity	for	systemic	lupus	erythematosus	SLE	In	this	regard	DNA	methylation	alterations	have	aroused	attention	The	association	between	the	dysfunction	of	MMP9	and	TNFAIP3	genes	and	SLE	has	been	previously	demonstrated	Therefore	in	this	study	we	investigated	the	methylation	level	of	MMP9	and	TNFAIP3	promoters	in	peripheral	blood	mononuclear	cells	PBMCs	of	SLE	patients	and	healthy	controls
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	disorder	with	a	wide	range	of	clinical	manifestations	including	neurological	issues	in	about	25	-75	of	cases	Among	the	neurological	involvement	cases	most	cases	show	migraine	However	the	prevalence	of	migraine	varied	worldwide	and	in	some	studies	a	higher	incidence	of	migraine	in	SLE	cases	was	reported	compared	to	healthy	controls	In	the	present	study	we	adopted	a	meta-analysis	approach	to	find	out	the	prevalence	of	migraine	in	SLE	patients	worldwide	and	investigate	whether	migraine	frequency	is	more	prevalent	in	SLE	patients	than	controls
Lupus	nephritis	LN	is	a	crucial	organ	involvement	in	systemic	lupus	erythematosus	SLE	Patients	with	LN	have	higher	morbidity	and	mortality	rates	than	those	without	Among	all	patients	with	LN	20-40	had	delayed	onset	but	the	data	for	patients	with	juvenile-onset	SLE	jSLE	who	have	a	higher	percentage	of	LN	than	patients	with	adult-onset	SLE	aSLE	were	limited	This	study	aimed	to	determine	the	risk	factors	for	subsequent	LN	in	patients	with	jSLE
TMA	SLE	SLE	TMA	TMA	TMA	SLE	TMA
Systemic	lupus	erythematosus	SLE	is	a	complex	autoimmune	disease	characterized	by	a	heterogeneous	clinical	picture	that	makes	the	diagnosis	and	follow-up	of	these	patients	difficult	This	study	aimed	to	identify	correlations	between	clinical	immunological	and	genetic	biomarkers	and	clinical	manifestations	in	SLE	A	retrospective	study	of	data	from	medical	records	and	immunological	and	genetic	studies	of	SLE	patients	in	Paraguay	was	carried	out	A	descriptive	analysis	was	performed	based	on	the	type	of	variable	Human	leukocyte	antigen	HLA	allele	frequencies	DPA1	DPB1	DQA1	DQB1	and	DRB1	were	calculated	and	univariate	logistic	regression	analyses	were	performed	between	each	of	the	explanatory	variables	and	the	presence	or	absence	of	each	phenotype	Odds	ratios	95	confidence	intervals	and	p	values	were	recorded	Associations	with	p	0	05	were	considered	statistically	significant	104	SLE	patients	were	included	86	were	female	with	a	mean	age	of	32	80	10	36	years	An	association	was	identified	between	anti-double	stranded	DNA	anti-dsDNA	and	the	presence	of	the	renal	phenotype	and	between	anti-dsDNA	and	the	absence	of	the	joint	and	hematological	phenotypes	Immunoglobulin	M	isotype	rheumatoid	factor	was	associated	with	the	absence	of	a	renal	phenotype	HLA-DQB1	02	02	and	HLA-DRB1	07	01	were	associated	with	the	cutaneous	phenotype	An	association	was	identified	between	age	at	disease	onset	over	30	years	and	the	presence	of	the	joint	phenotype	No	other	associations	were	identified	Potential	clinical	immunological	and	genetic	biomarkers	of	phenotypes	have	been	identified	in	SLE	Paraguayan	patients

The	goal	of	our	study	was	to	evaluate	the	potential	role	of	sTNF-RI	as	a	biomarker	of	renal	involvement	in	SLE	patients	and	active	SLE
Eltrombopag	a	thrombopoietin	receptor	TPO-R	agonist	is	considered	a	second-line	treatment	for	patients	with	refractory	immune	thrombocytopenia	ITP	Systemic	lupus	erythematosus	SLE	is	frequently	associated	with	ITP	In	some	cases	thrombocytopenia	in	SLE	patients	is	attributed	to	concurrent	antiphospholipid	antibodies	APLA	Currently	data	regarding	treatment	with	TPO-R	agonists	for	ITP	in	SLE	or	APLA	patients	are	limited	The	incidence	of	SLE	flare	or	antiphospholipid	syndrome	while	on	TPO-R	agonists	has	not	been	well-studied
Interferon	gamma	IFN	is	a	cytokine	implicated	in	the	pathogenesis	of	autoimmune	diseases	SAM	and	HD	domain-containing	protein	1	SAMHD1	is	an	IFN	-inducible	protein	that	modulates	cellular	dNTP	levels	Mutations	in	the	human	SAMHD1	gene	cause	Aicardi-Gouti	res	AG	syndrome	an	autoimmune	disease	sharing	similar	clinical	features	with	systemic	lupus	erythematosus	SLE	Klotho	is	an	anti-inflammatory	protein	which	suppresses	aging	through	multiple	mechanisms	Implication	of	Klotho	in	autoimmune	response	is	identified	in	rheumatologic	diseases	such	as	SLE	Little	information	exists	regarding	the	effect	of	Klotho	in	lupus	nephritis	one	of	the	prevalent	symptoms	of	SLE	The	present	study	verified	the	effect	of	IFN	on	SAMHD1	and	Klotho	expression	in	MES-13	glomerular	mesangial	cells	a	special	cell	type	in	glomerulus	that	is	critically	involved	in	lupus	nephritis	IFN	upregulated	SAMHD1	expression	in	MES-13	cells	through	the	Janus	kinase-signal	transducer	and	activator	of	transcription	1	JAK-STAT1	and	the	nuclear	factor	kappa	B	NF	B	signaling	pathways	IFN	decreased	Klotho	protein	expression	in	MES-13	cells	Treatment	of	MES-13	cells	with	recombinant	Klotho	protein	inhibited	SAMHD1	expression	by	blocking	IFN	-induced	NF	B	nuclear	translocation	but	showed	no	effect	on	JAK-STAT1	signaling	Collectively	our	findings	support	the	protective	role	of	Klotho	in	attenuating	lupus	nephritis	through	the	inhibition	of	IFN	-induced	SAMHD1	expression	and	IFN	downstream	signaling	in	MES-13	cells
Several	studies	have	compared	the	clinical	features	and	outcomes	of	late-	and	early-onset	systemic	lupus	erythematosus	SLE	patients	However	these	previous	studies	were	uncontrolled	The	current	study	aimed	to	compare	late-	and	early-onset	SLE	patients	while	controlling	for	sex	and	year	at	diagnosis	1	year
The	aim	of	this	study	was	to	investigate	serum	levels	of	soluble	B-cell	maturation	antigen	sBCMA	in	childhood-onset	systemic	lupus	erythematous	cSLE	patients	with	renal	involvement	and	to	elucidate	their	association	with	clinical	characteristics
Hydroxychloroquine	HCQ	is	an	antimalarial	agent	used	to	treat	mucocutaneous	musculoskeletal	constitutional	manifestations	of	systemic	lupus	erythematosus	SLE	This	study	assessed	the	efficacy	and	side	effects	of	HCQ	in	children	with	proliferative	lupus	nephritis	LN	This	double-blind	randomized	placebo-controlled	trial	study	was	conducted	on	60	children	with	proliferative	LN	classes	III	and	IV	treated	with	steroids	and	a	mycophenolate	MMF	regimen	Patients	were	categorized	into	two	groups	the	HCQ	group	n	30	and	the	placebo	group	n	30	They	were	evaluated	initially	at	6-	and	a	12-month	follow-up	by	mucocutaneous	ophthalmological	examination	and	investigations	BUN	creatinine	24	h	proteinuria	triglycerides	TG	cholesterol	Antids-DNA	C3	C4	Disease	activity	was	assessed	using	the	SLE	disease	activity	index	SLEDAI-2	k	After	12	months	TG	cholesterol	24	h	proteinuria	Antids-DNA	and	SLEDAI	score	were	significantly	decreased	in	the	HCQ	group	P	0	002	0	012	0	031	0	001	respectively	After	12	months	the	cumulative	probabilities	of	developing	primary	end-points	LN	partial	and	complete	remission	were	40	and	60	in	the	HCQ	group	versus	53	3	and	36	7	in	the	placebo	group	P	0	002	After	12	months	the	HCQ	group	experienced	mucocutaneous	alopecia	3	3	hyperpigmentation	10	and	ophthalmological	mild	retinal	changes	6	7	but	they	did	not	differ	significantly	from	the	placebo	group	Cunclusion	HCQ	improved	the	disease	and	LN	activity	in	children	with	proliferative	LN	with	documented	skin	hyperpigmentation	and	mild	retinal	changes	following	HCQ	use	in	a	few	cases	This	study	was	registered	on	http	www
Systemic	lupus	erythematosus	is	a	chronic	autoimmune	disease	of	which	clinical	presentation	is	vastly	heterogeneous	ranging	from	mild	skin	rashes	to	severe	renal	diseases	Treatment	goal	of	this	illness	is	to	minimize	disease	activity	and	prevent	further	organ	damage	In	recent	years	much	research	has	been	done	on	the	epigenetic	aspects	of	SLE	pathogenesis	for	among	the	various	factors	known	to	contribute	to	the	pathogenic	process	epigenetic	factors	especially	microRNAs	bear	the	most	therapeutic	potential	that	can	be	altered	unlike	congenital	genetic	factors	This	article	reviews	and	updates	what	has	been	discovered	so	far	about	the	pathogenesis	of	lupus	while	focusing	on	the	dysregulation	of	microRNAs	in	lupus	patients	in	comparison	to	healthy	controls	along	with	the	potentially	pathogenic	roles	of	the	microRNAs	commonly	reported	to	be	either	upregulated	or	downregulated	Furthermore	this	review	includes	microRNAs	of	which	results	are	controversial	suggesting	possible	explanations	for	such	discrepancies	and	directions	for	future	research	Moreover	we	aimed	to	emphasize	the	point	that	had	been	overlooked	so	far	in	studies	regarding	microRNA	expression	levels	that	is	which	specimen	was	used	to	assess	the	dysregulation	of	microRNAs	To	our	surprise	a	vast	number	of	studies	have	not	considered	this	factor	and	have	analyzed	the	potential	role	of	microRNAs	in	general	Despite	extensive	investigations	done	on	microRNA	levels	their	significance	and	potential	role	remain	a	mystery	which	calls	for	further	studies	on	this	particular	subject	in	regard	of	which	specimen	is	used	for	assessment
Accumulating	evidence	has	demonstrated	that	an	association	between	chronic	pain	and	autoimmune	diseases	AIDs	Nevertheless	it	is	unclear	whether	these	associations	refer	to	a	causal	relationship	We	used	a	two-sample	Mendelian	randomization	MR	method	to	determine	the	causal	relationship	between	chronic	pain	and	AIDs
Juvenile	systemic	lupus	erythematosus	JSLE	is	a	multifaceted	multifactorial	disorder	with	an	unclear	etiopathogenesis	Environmental	factors	genetic	factors	and	dysregulated	and	defective	immune	system	responses	are	known	to	have	a	role	in	JSLE	etiopathogenesis	NLRP3	inflammasome	as	an	important	contributor	to	immune-mediated	inflammatory	responses	is	assumed	to	be	involved	in	JSLE	etiopathogenesis	To	determine	whether	the	NLRP3	genetic	variants	are	altered	in	patients	with	JSLE	Fifty-three	patients	diagnosed	with	JSLE	and	56	healthy	sex-matched	controls	were	studied	NLRP3	C	G	rs10754558	C	T	rs3806265	C	T	rs4612666	A	C	rs35829419	gene	polymorphisms	were	evaluated	using	a	TaqMan	single-nucleotide	polymorphism	assay	C	allele	at	position	rs3806265	was	detected	in	higher	frequencies	in	patients	than	in	the	control	group	37	74	vs	23	21	P-value	028	At	the	genotype	level	at	the	same	position	CT	has	a	significantly	higher	frequency	in	patients	than	the	healthy	subjects	75	47	vs	46	43	P-value	003	The	NLRP3	rs3806265	CT	genotype	was	detected	at	a	higher	frequency	in	patients	with	JSLE	than	in	the	healthy	control	group
Systemic	lupus	erythematosus	is	a	chronic	connective	tissue	disease	of	unknown	origin	and	unpredictable	course
Systemic	Lupus	Erythematosus	SLE	is	a	chronic	multisystem	inflammatory	autoimmune	disease	that	disproportionately	affects	women	Trends	in	SLE	prevalence	and	clinical	course	differ	by	ancestry	with	those	of	African	American	ancestry	presenting	with	more	active	severe	and	rapidly	progressive	disease	than	European	Americans	Previous	research	established	altered	epigenetic	signatures	in	SLE	patients	compared	to	controls	However	the	contribution	of	aberrant	DNA	methylation	DNAm	to	the	risk	of	SLE	by	ancestry	and	differences	among	patients	with	SLE-associated	Lupus	Nephritis	LN	has	not	been	well	described	We	evaluated	the	DNA	methylomes	of	87	individuals	including	41	SLE	patients	with	and	without	LN	and	46	controls	enrolled	in	an	ancestry	diverse	well-characterized	cohort	study	of	established	SLE	41	SLE	patients	20	SLE-LN	21	SLE-LN-	and	46	sex-	race-	and	age-matched	controls	55	African	American	45	European	American	Participants	were	genotyped	using	the	Infinium	Global	Diversity	Array	GDA	and	genetic	ancestry	was	estimated	using	principal	components	Genome-wide	DNA	methylation	was	initially	measured	using	the	Illumina	MethylationEPIC	850K	Beadchip	array	followed	by	methylation-specific	qPCR	to	validate	the	methylation	status	at	putative	loci	Differentially	Methylated	Positions	DMP	were	identified	using	a	case-control	approach	adjusted	for	ancestry	We	identified	a	total	of	51	DMPs	in	CpGs	among	SLE	patients	compared	to	controls	Genes	proximal	to	these	CpGs	were	highly	enriched	for	involvement	in	type	I	interferon	signaling	DMPs	among	European	American	SLE	patients	with	LN	were	similar	to	African	American	SLE	patients	with	and	without	LN	Our	findings	were	validated	using	an	orthogonal	methyl-specific	PCR	for	three	SLE-associated	DMPs	near	or	proximal	to	MX1	USP18	and	IFITM1	Our	study	confirms	previous	reports	that	DMPs	in	CpGs	associated	with	SLE	are	enriched	in	type	I	interferon	genes	However	we	show	that	European	American	SLE	patients	with	LN	have	similar	DNAm	patterns	to	African	American	SLE	patients	irrespective	of	LN	suggesting	that	aberrant	DNAm	alters	activity	of	type	I	interferon	pathway	leading	to	more	severe	disease	independent	of	ancestry
Deposition	of	immune	complexes	in	the	glomerulus	leads	to	irreversible	renal	damage	in	lupus	nephritis	LN	of	which	podocyte	malfunction	arises	earlier	Fasudil	the	only	Rho	GTPases	inhibitor	approved	in	clinical	settings	possesses	well-established	renoprotective	actions	yet	no	studies	addressed	the	amelioration	derived	from	fasudil	in	LN	To	clarify	we	investigated	whether	fasudil	exerted	renal	remission	in	lupus-prone	mice	In	this	study	fasudil	20	mg	kg	was	intraperitoneally	administered	to	female	MRL	lpr	mice	for	10	weeks	We	report	that	fasudil	administration	swept	antibodies	anti-dsDNA	and	attenuated	systemic	inflammatory	response	in	MRL	lpr	mice	accompanied	by	preserving	podocyte	ultrastructure	and	averting	immune	complex	deposition	Mechanistically	it	repressed	the	expression	of	CaMK4	in	glomerulopathy	by	preserving	nephrin	and	synaptopodin	expression	And	fasudil	further	blocked	cytoskeletal	breakage	in	the	Rho	GTPases-dependent	action	Further	analyses	showed	that	beneficial	actions	of	fasudil	on	the	podocytes	required	intra-nuclear	YAP	activation	underlying	actin	dynamics	In	addition	in	vitro	assays	revealed	that	fasudil	normalized	the	motile	imbalance	by	suppressing	intracellular	calcium	enrichment	thereby	contributing	to	the	resistance	of	apoptosis	in	podocytes	Altogether	our	findings	suggest	that	the	precise	manners	of	crosstalks	between	cytoskeletal	assembly	and	YAP	activation	underlying	the	upstream	CaMK4	Rho	GTPases	signal	in	podocytes	is	a	reliable	target	for	podocytopathies	treatment	and	fasudil	might	serve	as	a	promising	therapeutic	agent	to	compensate	for	the	podocyte	injury	in	LN
Vitamin	D	is	a	steroid	hormone	with	potent	immune-modulating	properties	It	has	been	shown	to	stimulate	innate	immunity	and	induce	immune	tolerance	Extensive	research	efforts	have	shown	that	vitamin	D	deficiency	may	be	related	to	the	development	of	autoimmune	diseases	Vitamin	D	deficiency	has	been	observed	in	patients	with	rheumatoid	arthritis	RA	and	has	been	shown	to	be	inversely	related	to	disease	activity	Moreover	vitamin	D	deficiency	may	be	implicated	in	the	pathogenesis	of	the	disease	Vitamin	D	deficiency	has	also	been	observed	in	patients	with	systemic	lupus	erythematosus	SLE	It	has	been	found	to	be	inversely	related	to	disease	activity	and	renal	involvement	In	addition	vitamin	D	receptor	polymorphisms	have	been	studied	in	SLE	Vitamin	D	levels	have	been	studied	in	patients	with	Sjogren	s	syndrome	and	vitamin	D	deficiency	may	be	related	to	neuropathy	and	the	development	of	lymphoma	in	the	context	of	Sjogren	s	syndrome	Vitamin	D	deficiency	has	been	observed	in	ankylosing	spondylitis	psoriatic	arthritis	PsA	and	idiopathic	inflammatory	myopathies	Vitamin	D	deficiency	has	also	been	observed	in	systemic	sclerosis	Vitamin	D	deficiency	may	be	implicated	in	the	pathogenesis	of	autoimmunity	and	it	may	be	administered	to	prevent	autoimmune	disease	and	reduce	pain	in	the	context	of	autoimmune	rheumatic	disorders
Immunoglobulin	gamma-3	chain	C	IGHG3	levels	have	been	detected	in	the	blood	and	tissue	of	patients	with	systemic	lupus	erythematosus	SLE	This	study	aims	to	assess	its	clinical	value	by	measuring	and	comparing	levels	of	IGHG3	in	different	body	fluids	in	patients	with	SLE	The	levels	of	IGHG3	in	saliva	serum	and	urine	from	181	patients	with	SLE	and	99	healthy	controls	were	measured	and	analyzed	In	patients	with	SLE	and	healthy	controls	salivary	IGHG3	levels	were	3078	9	2473	8	and	1413	6	1075	3	ng	mL	serum	IGHG3	levels	were	478	1	160	9	and	364	4	97	9	g	mL	and	urine	IGHG3	levels	were	64	0	74	5	and	27	1	16	2	ng	mL	respectively	all	p	0	001	Salivary	IGHG3	was	correlated	with	ESR	correlation	coefficient	r	0	173	p	0	024	Serum	IGHG3	was	correlated	with	leukocyte	count	r	-0	219	p	0	003	lymphocyte	count	r	0	22	p	0	03	anti-dsDNA	antibody	positivity	r	0	22	p	0	003	and	C3	levels	r	-0	23	p	0	002	Urinary	IGHG3	was	correlated	with	hemoglobin	level	r	-0	183	p	0	021	ESR	r	0	204	p	0	01	anti-dsDNA	antibody	positivity	r	0	262	p	0	001	C3	levels	r	-0	202	p	0	011	and	SLE	disease	activity	index	r	0	332	p	0	01	Urinary	IGHG3	was	higher	in	patients	with	nephritis	than	in	those	without	119	5	110	0	vs	49	8	54	4	ng	mL	p	0	01	IGHG3	was	increased	in	the	saliva	serum	and	urine	of	patients	with	SLE	While	salivary	IGHG3	was	not	identified	to	be	specific	to	SLE	disease	activity	serum	IGHG3	showed	correlations	with	clinical	characteristics	Urinary	IGHG3	levels	were	associated	with	disease	activity	and	renal	involvement	in	SLE
Anti-Ro	antibody-positive	mothers	are	frequently	referred	for	serial	echocardiography	due	to	the	fetal	risk	of	developing	heart	block	and	endocardial	fibroelastosis	Little	is	known	why	only	some	and	not	all	offspring	develop	these	cardiac	manifestations	of	neonatal	lupus	CNL	This	prospective	study	examined	associations	between	anti-Ro	antibody	titers	and	fetal	CNL
To	determine	the	possible	predictive	value	of	self-efficacy	on	health-related	quality	of	life	HRQoL	in	patients	with	SLE
The	prevalence	and	clinical	significance	of	anti-neutrophil	cytoplasmic	antibodies	ANCAs	in	patients	with	lupus	nephritis	LN	is	not	fully	elucidated	Our	aim	was	to	determine	whether	LN	patients	with	ANCA	positivity	had	different	clinicopathological	features	and	outcomes	compared	to	ANCA-negative	patients
Patients	with	systemic	lupus	erythematosus	SLE	have	an	increased	risk	of	vascular	thrombosis	compared	to	the	general	population	Therefore	biomarkers	for	predicting	the	risk	of	thrombosis	in	patients	with	SLE	are	needed
SLE	is	an	autoimmune	disease	characterised	by	persistent	inflammation	and	autoantibody	production	Genetic	predisposition	and	environmental	factors	such	as	a	high-fat	diet	HFD	may	contribute	to	lupus	development	However	the	immune	cell	profile	and	gender	difference	in	response	to	HFD	in	lupus	have	not	been	reported	Here	we	investigated	the	impact	of	HFD	on	lupus	pathogenesis	and	autoimmunity	using	lupus-prone	mice
Patients	with	SLE	systemic	lupus	erythematosus	have	a	higher	risk	of	infection	due	to	dysregulated	immune	system	as	well	as	long-term	use	of	immunosuppressants	IS	This	could	influence	the	risk	of	COVID-19	and	its	outcome

An	18-year-old	Japanese	woman	with	systemic	lupus	erythematosus	experienced	dyspnoea	headache	tinnitus	and	purpura	for	2	weeks	and	was	admitted	to	our	hospital	The	patient	had	been	diagnosed	with	systemic	lupus	erythematosus	and	secondary	immune	thrombocytopenia	8	years	before	and	treated	with	high-dose	prednisolone	and	mycophenolate	mofetil	Since	the	blood	test	on	admission	showed	haemolytic	anaemia	with	a	positive	direct	Coombs	test	and	anti-glycoprotein	IIb	IIIa	antibodies	the	patient	was	initially	diagnosed	with	Evans	syndrome	ES	The	patient	was	treated	with	pulse	intravenous	methylprednisolone	followed	by	45	mg	day	prednisolone	however	the	patient	s	platelet	count	did	not	normalise	Based	on	a	low	level	of	a	disintegrin-like	and	metalloproteinase	with	thrombospondin	type	1	motif	13	ADAMTS-13	activity	and	a	high	level	of	ADAMTS-13	inhibitors	a	diagnosis	of	acquired	thrombotic	thrombocytopenic	purpura	TTP	was	confirmed	After	undergoing	therapeutic	plasma	exchange	for	6	consecutive	days	the	patient	s	platelet	count	recovered	rapidly	Although	concurrent	acquired	TTP	and	ES	have	not	been	reported	previously	the	findings	from	this	case	highlight	the	importance	of	measuring	ADAMTS-13	activity	and	inhibitors	to	rule	out	acquired	TTP	especially	when	ES	is	refractory	to	glucocorticoids
To	investigate	the	dietary	patterns	and	lifestyles	of	patients	with	lupus	gastrointestinal	GI	involvement	and	to	reveal	the	possible	role	of	organ-specific	involvement	of	systemic	lupus	erythematosus	SLE	on	daily	diet
Although	skin	manifestations	are	common	in	systemic	lupus	erythematosus	SLE	there	is	still	a	lack	of	a	diagnostic	marker	for	cutaneous	involvement	Pentraxin3	PTX3	has	been	studied	in	SLE	patients	however	it	has	not	been	investigated	in	relation	to	cutaneous	manifestations
Pancytopenia	due	to	systemic	lupus	erythematosus	SLE	is	rarely	reported	and	among	those	reported	it	is	mostly	due	to	immunologically	mediated	cell	destruction	Pancytopenia	due	to	bone	marrow	fibrosis	secondary	to	SLE	is	an	extremely	rare	entity	Myelofibrosis	secondary	to	SLE	per	se	is	reported	only	in	21	cases	in	the	literature	Ours	probably	is	the	22nd	case	report	on	SLE	with	myelofibrosis	Primary	presentation	of	SLE	with	bleeding	manifestation	is	also	a	rare	phenomenon	Partial	to	complete	regression	of	myelofibrosis	is	noted	following	treatment	in	secondary	myelofibrosis	caused	by	SLE	We	report	a	case	of	a	woman	in	her	late	40s	who	presented	to	us	with	bleeding	manifestations	of	petechial	rash	and	menorrhagia	which	on	further	evaluation	showed	pancytopenia	due	to	myelofibrosis	secondary	to	SLE	Our	case	underlines	multiple	features	like	primary	bleeding	manifestation	and	regression	of	myelofibrosis	following	treatment	which	is	rarely	reported	in	association	with	SLE
IGU	IGU	a	novel	immunomodulatory	agent	for	rheumatoid	arthritis	has	been	shown	to	be	effective	and	safe	as	monotherapy	in	a	small	population	with	refractory	lupus	nephritis	LN	The	aim	of	this	prospective	study	was	to	evaluate	the	efficacy	and	safety	of	IGU	as	an	add-on	therapy	in	patients	with	refractory	LN	in	the	context	of	clinical	practice
Studies	of	real-world	effectiveness	of	belimumab	in	adults	with	systemic	lupus	erythematosus	have	shown	improved	disease	control	and	decreased	oral	glucocorticoid	use	However	belimumab	use	outside	of	clinical	trial	settings	has	not	been	well	studied	in	childhood-onset	systemic	lupus	erythematosus	cSLE	We	aimed	to	characterize	indications	for	belimumab	use	and	evaluate	oral	glucocorticoid	doses	and	disease	activity	scores	in	the	year	following	belimumab	initiation	at	a	single	large	pediatric	rheumatology	center
Previous	studies	have	shown	systemic	lupus	erythematosus	SLE	patients	had	a	significantly	higher	prevalence	of	thyroid	diseases	and	hypothyroidism	than	matched	controls	and	some	case	reports	showed	SLE	may	occur	after	Hashimoto	s	thyroiditis	HT
The	clinical	presentation	of	mercury	Hg	intoxication	may	mimic	rheumatic	diseases	Hg	exposure	is	associated	with	systemic	lupus	erythematosus	SLE	-like	disease	in	genetically	susceptible	rodents	and	Hg	is	among	the	environmental	factors	in	the	development	of	SLE	in	humans	Herein	we	presented	a	case	with	clinical	and	immunological	features	suggestive	of	SLE	but	diagnosed	with	Hg	intoxication
To	clarify	the	controversy	between	systemic	lupus	erythematosus	SLE	and	thyroid	disease	our	study	was	designed	to	determine	whether	or	not	thyroid	problems	are	associated	with	SLE
In	our	study	in	which	the	relationship	between	juvenile	idiopathic	arthritis	JIA	and	particular	environmental	factors	was	evaluated	a	correlation	could	not	be	established	between	the	rate	or	duration	of	breastfeeding	and	the	development	or	severity	of	the	disease	Int	J	Rheum	Dis	25	2022	1376	It	was	determined	that	the	time	of	introduction	to	cow	s	milk	differed	in	JIA	and	juvenile-onset	systemic	lupus	erythematosus	patient	groups	compared	to	healthy	controls	On	the	other	hand	the	fact	that	income	level	and	maternal	literacy	were	associated	with	high	disability	and	damage	scores	and	frequent	recurrence	rates	stood	as	one	of	the	remarkable	results	of	our	study	Kao	et	al	drew	attention	to	the	relationship	between	socioeconomic	status	and	chronic	arthritis	and	quoted	an	adult	study	The	role	of	the	parent	factor	has	been	stressed	and	the	effect	of	maternal	stress	on	disease	development	has	been	discussed	Although	JIA	is	a	heterogeneous	disease	and	the	tribulation	of	measuring	the	direct	impact	of	environmental	elements	are	limiting	factors	it	is	essential	to	determine	the	parts	that	can	be	controlled	to	some	extent	and	the	precautions	to	be	taken
Analyzed	the	clinical	features	and	treatment	process	of	the	patient	suffering	from	immunodeficiency	with	systemic	lupus	erythematosus	SLE	-like	syndrome	in	a	novel	mutation	of	PRKDC
This	case	series	examines	the	efficacy	of	anifrolumab	as	a	therapeutic	option	for	patients	with	lupus	erythematosus
To	evaluate	the	utility	of	neutrophil	to	lymphocyte	ratio	NLR	systemic	immune-inflammation	index	SII	and	systemic	immune-response	index	SIRI	in	the	prediction	of	adverse	pregnancy	outcomes	in	pregnant	women	with	systemic	lupus	erythematosus	SLE	This	retrospective	case-control	study	was	conducted	in	Ankara	City	Hospital	perinatology	clinic	between	2019	and	2023	First-trimester	NLR	SII	NLR	X	platelet	count	and	SIRI	NLR	X	monocyte	count	values	were	compared	between	pregnant	women	with	SLE	n	29	and	low-risk	controls	n	110	Afterward	pregnant	women	with	SLE	were	divided	into	two	groups	1	SLE	with	perinatal	complications	n	15	and	2	SLE	without	perinatal	complications	n	14	NLR	SII	and	SIRI	values	were	compared	between	the	two	subgroups	Finally	a	ROC	analysis	was	performed	to	determine	optimal	cut-off	values	for	NLR	SII	and	SIRI	in	the	prediction	of	composite	adverse	pregnancy	outcomes	The	study	group	had	significantly	higher	first-trimester	NLR	SII	and	SIRI	values	compared	to	the	controls	The	SLE	with	perinatal	complications	group	had	significantly	higher	NLR	SII	and	SIRI	values	than	the	SLE	group	without	perinatal	complications	p	0	05	Optimal	cut-off	values	were	6	5	66	7	sensitivity	71	4	specificity	1612	6	73	3	sensitivity	71	4	specificity	and	4	7	73	3	sensitivity	77	6	specificity	for	NLR	SII	and	SIRI	respectively	SII	SIRI	and	NLR	may	be	used	to	predict	adverse	pregnancy	outcomes	in	pregnant	women	with	SLE
Numerous	studies	suggest	that	neutrophils	might	have	a	crucial	role	in	the	pathogenesis	of	systemic	autoimmune	diseases	through	neutrophil	extracellular	trap	NET	formation	production	of	pro-inflammatory	cytokines	and	organ	destruction	NET	components	that	are	released	into	extracellular	spaces	can	be	considered	autoantigens	which	contribute	to	causing	a	break	in	self-tolerance	Subsequently	this	leads	to	the	development	of	autoimmune	responses	in	predisposed	individuals	Additionally	an	imbalance	between	NET	formation	and	NET	degradation	may	prolong	immune	system	contact	with	these	modified	autoantigens	and	enhance	NET-induced	tissue	damage	In	this	review	we	discuss	the	generation	and	clearance	of	the	NET	as	well	as	the	role	of	NETosis	in	the	pathogenesis	of	autoimmune	disorders	including	rheumatoid	arthritis	RA	systemic	lupus	erythematosus	SLE	anti-neutrophil	cytoplasmic	antibodies	ANCA	-associated	vasculitis	AAV	multiple	sclerosis	MS	psoriasis	antiphospholipid	syndrome	APS	and	Type-1	diabetes	mellitus	T1DM


To	investigate	the	epidemiology	and	infectious	characteristics	of	Epstein-Barr	virus	EBV	infection	among	children	in	Shanghai	China	from	2017	to	2022
Prolactin	PRL	is	elevated	in	B-cell-mediated	lymphoproliferative	diseases	and	promotes	B-cell	survival	Whether	PRL	or	PRL	receptors	drive	the	evolution	of	B-cell	malignancies	is	unknown	We	measure	changes	in	B	cells	after	knocking	down	the	pro-proliferative	anti-apoptotic	long	isoform	of	the	PRL	receptor	LFPRLR	in	vivo	in	systemic	lupus	erythematosus	SLE	-	and	B-cell	lymphoma-prone	mouse	models	and	the	long	plus	intermediate	isoforms	LF	IFPRLR	in	human	B-cell	malignancies	To	knockdown	LF	IFPRLRs	without	suppressing	expression	of	the	counteractive	short	PRLR	isoforms	SFPRLRs	we	employ	splice-modulating	DNA	oligomers	In	SLE-prone	mice	LFPRLR	knockdown	reduces	numbers	and	proliferation	of	pathogenic	B-cell	subsets	and	lowers	the	risk	of	B-cell	transformation	by	downregulating	expression	of	activation-induced	cytidine	deaminase	LFPRLR	knockdown	in	lymphoma-prone	mice	reduces	B-cell	numbers	and	their	expression	of	BCL2	and	TCL1	In	overt	human	B-cell	malignancies	LF	IFPRLR	knockdown	reduces	B-cell	viability	and	their	MYC	and	BCL2	expression	Unlike	normal	B	cells	human	B-cell	malignancies	secrete	autocrine	PRL	and	often	express	no	SFPRLRs	Neutralization	of	secreted	PRL	reduces	the	viability	of	B-cell	malignancies	Knockdown	of	LF	IFPRLR	reduces	the	growth	of	human	B-cell	malignancies	in	vitro	and	in	vivo	Thus	LF	IFPRLR	knockdown	is	a	highly	specific	approach	to	block	the	evolution	of	B-cell	neoplasms
We	evaluated	the	reasons	for	requesting	anti-nuclear	antibody	ANA	analysis	in	clinical	practice	at	a	tertiary	center	and	the	performance	of	ANA	in	pediatric	autoimmune	diseases	Patients	under	18	years	of	age	who	underwent	ANA	testing	for	various	symptoms	between	2013	and	2017	were	included	We	retrieved	data	from	medical	records	including	demographic	and	clinical	characteristics	diagnoses	ANA	results	titers	and	staining	patterns	The	performance	assessment	tools	were	calculated	according	to	the	ANA	titer	for	autoimmune	diseases	Risk	factors	for	autoimmune	diseases	in	ANA-positive	patients	were	evaluated	using	logistic	regression	analysis	Changes	in	ANA	titer	and	seroconversion	were	evaluated	using	repeated	ANA	analyses	A	total	of	3812	patients	underwent	ANA	Medical	records	of	3320	patients	were	obtained	The	rate	of	ANA	positivity	was	27	4	ANA	was	requested	most	frequently	because	of	musculoskeletal	findings	in	1355	patients	40	8	Juvenile	idiopathic	arthritis	n	174	20	2	was	the	most	common	diagnosis	in	ANA-positive	patients	followed	by	systemic	lupus	erythematosus	n	52	6	For	autoimmune	diseases	a	titer	of	1	100	a	sensitivity	of	40	1	and	a	specificity	of	77	1	were	observed	At	a	titer	1	1000	the	sensitivity	and	specificity	were	24	1	and	89	respectively	Homogeneous	staining	was	an	additional	risk	factor	for	autoimmune	diseases	in	ANA-positive	patients	by	multivariate	logistic	regression	analysis	OR	95	CI	4	562	3	076-6	766	p	0	001	Conclusion	Our	results	revealed	that	the	performance	of	the	ANA	test	in	diagnosing	autoimmune	diseases	in	pediatric	clinical	practice	was	poor	Therefore	clinical	findings	should	be	carefully	evaluated	before	ANA	testing	is	performed	What	is	Known	ANA	can	be	detected	in	systemic	autoimmune	rheumatic	diseases	The	diagnostic	role	of	ANA	is	controversial	especially	in	childhood	What	is	New	One	in	four	patients	who	requested	the	ANA	test	had	an	autoimmune	disease	Less	than	half	of	patients	with	an	autoimmune	disease	had	ANA	positivity
Anti-neutrophil	cytoplasmic	antibody	ANCA	-associated	vasculitides	AAVs	present	with	a	complex	phenotype	and	are	associated	with	high	mortality	and	multi-organ	involvement	We	sought	to	define	the	transcriptional	landscape	and	molecular	endotypes	of	AAVs	and	compare	it	to	systemic	lupus	erythematosus	SLE
Autoreactive	B	cell	responses	are	essential	for	the	development	of	systemic	lupus	erythematosus	SLE	Fibroblastic	reticular	cells	FRCs	are	known	to	construct	lymphoid	compartments	and	regulate	immune	functions	Here	we	identify	spleen	FRC-derived	acetylcholine	ACh	as	a	key	factor	that	controls	autoreactive	B	cell	responses	in	SLE	In	SLE	CD36-mediated	lipid	uptake	leads	to	enhanced	mitochondrial	oxidative	phosphorylation	in	B	cells	Accordingly	the	inhibition	of	fatty	acid	oxidation	results	in	reduced	autoreactive	B	cell	responses	and	ameliorated	diseases	in	lupus	mice	Ablation	of	CD36	in	B	cells	impairs	lipid	uptake	and	differentiation	of	autoreactive	B	cells	during	autoimmune	induction	Mechanistically	spleen	FRC-derived	ACh	promotes	lipid	influx	and	generation	of	autoreactive	B	cells	through	CD36	Together	our	data	uncover	a	novel	function	of	spleen	FRCs	in	lipid	metabolism	and	B	cell	differentiation	placing	spleen	FRC-derived	ACh	in	a	key	position	in	promoting	autoreactive	B	cells	in	SLE
In	rheumatology	this	year	has	seen	an	expansion	of	knowledge	about	the	treatment	of	rheumatoid	arthritis	with	the	availability	of	results	from	randomized	trials	evaluating	a	new	molecule	targeting	IL-6	and	regarding	the	safety	profile	of	tofacitinib	compared	to	TNF-alpha	inhibitors	Interesting	data	on	the	outcome	of	pregnancy	in	patients	with	spondylarthritis	have	also	been	published	New	molecules	and	different	treatment	strategies	have	shown	promising	results	in	psoriatic	arthritis	and	systemic	lupus	erythematosus	The	utility	of	botulinum	toxin	A	injections	for	Raynaud	s	phenomenon	and	the	efficacy	of	transplantation	of	autologous	adipose-derived	regenerative	cells	for	the	treatment	of	hand	dysfunctions	have	been	questioned	by	2	randomized	controlled	trials	of	patients	with	systemic	sclerosis
Systemic	lupus	erythematosus	and	rheumatoid	arthritis	are	just	2	of	several	autoimmune	connective	tissue	diseases	that	are	primarily	chronic	in	nature	but	can	present	to	the	emergency	department	by	virtue	of	an	acute	exacerbation	of	disease	Beyond	an	acute	exacerbation	of	disease	their	predilection	for	invading	multiple	organ	systems	lends	itself	to	the	potential	for	patients	presenting	to	the	emergency	department	with	either	a	single	or	isolated	symptom	or	a	myriad	of	signs	and	or	symptoms	indicative	of	a	degree	of	disease	complexity	and	severity	that	warrant	timely	recognition	and	resuscitation
The	coronavirus	SARS-CoV-2	which	is	the	cause	of	COVID-19	disease	in	infected	patients	has	led	to	an	ongoing	worldwide	pandemic	Although	SARS-CoV-2	vaccination	had	a	dramatic	positive	effect	on	the	course	of	COVID-19	there	has	been	increasing	evidence	of	adverse	effects	after	SARS-CoV-2	vaccination	This	meta-analysis	highlights	the	association	between	SARS-CoV-2	vaccination	and	de	novo	induction	or	aggravation	of	inflammatory	and	autoimmune	skin	diseases
Activated	lymphocyte-derived	DNA	ALD-DNA	has	been	reported	to	drive	the	polarization	of	macrophages	toward	M2b	producing	inflammatory	cytokines	and	inducing	inflammation	correspondingly	playing	an	essential	role	in	the	development	of	systemic	lupus	erythematosus	SLE	Recently	accumulating	evidence	has	pinpointed	metabolic	adaptation	as	the	crucial	cell-intrinsic	determinant	for	inflammatory	response	in	which	glucose	metabolism	is	the	key	event	However	whether	and	how	glucose	metabolism	was	involved	in	ALD-DNA-induced	macrophage	inflammatory	response	and	SLE	development	remains	unclear	Herein	we	performed	glucose	metabolomic	analyses	of	ALD-DNA-stimulated	macrophages	and	uncovered	increased	glycolysis	and	diminished	pentose	phosphate	pathway	PPP	as	well	as	enhanced	glycogenesis	In	ALD-DNA-stimulated	macrophages	increased	glycolysis	resulted	in	higher	lactate	production	whereas	diminished	PPP	efficiently	led	to	lower	levels	of	nicotinamide	adenine	dinucleotide	phosphate	NADPH	with	higher	levels	of	reactive	oxygen	species	ROS	While	blockade	of	lactate	generation	exerted	no	significant	effect	on	macrophage	inflammation	in	response	to	ALD-DNA	scavenging	ROS	fundamentally	inhibited	the	inflammatory	response	of	ALD-DNA-stimulated	macrophages	Further	cyclic	adenosine	monophosphate	cAMP	a	master	for	regulating	glycogen	metabolism	was	downregulated	by	ALD-DNA	in	macrophages	which	subsequently	imbalanced	glycogen	metabolism	toward	glycogenesis	but	not	glycogenolysis	Administration	of	cAMP	effectively	restored	glycogenolysis	and	enhanced	PPP	which	correspondingly	reduced	ROS	levels	and	inhibited	the	inflammatory	response	of	ALD-DNA-stimulated	macrophages	Finally	blocking	glucose	metabolism	using	2-deoxy-D-glucose	2-DG	efficiently	restricted	macrophage	inflammatory	response	and	alleviated	ALD-DNA-induced	lupus	disease	Together	our	findings	demonstrate	that	ALD-DNA	drives	the	adaptation	of	glucose	metabolism	for	inducing	macrophage	inflammatory	response	in	SLE	which	might	further	our	understanding	of	disease	pathogenesis	and	provide	clues	for	interventive	explorations
Many	studies	have	found	that	glucocorticoid	GC	combined	with	hydroxychloroquine	HCQ	has	a	good	clinical	effect	in	the	treatment	of	systemic	lupus	erythematosus	SLE	rash	but	there	is	no	relevant	systematic	evaluation	at	present	The	purpose	of	this	study	was	to	systematically	evaluate	and	analyze	the	effectiveness	and	safety	of	GC	combined	with	HCQ	in	the	treatment	of	SLE	rash
The	severe	acute	respiratory	syndrome	coronavirus	2	SARS-CoV-2	virus	has	become	a	worldwide	pandemic	since	first	discovered	in	2019	Systemic	lupus	erythematosus	SLE	flare	has	been	reported	in	the	post-infectious	period	In	Colombia	the	fourth	pandemic	wave	started	at	the	beginning	of	2022	when	we	observed	flare	of	3	SLE	patients	during	active	infection
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	inflammatory	disease	Src	homology	2	domain	containing	protein	tyrosine	phosphatase	SHP2	is	a	member	of	the	protein	tyrosine	phosphatases	PTPs	family	To	date	relationship	between	SHP2	and	SLE	pathogenesis	is	not	elucidated
Objective	To	characterize	the	incidence	density	of	systematic	lupus	erythematosus	SLE	in	Yinzhou	District	of	Ningbo	from	2016	to	2021	and	compare	the	age	and	gender	specific	differences	Methods	A	retrospective	cohort	study	was	conducted	based	on	the	related	data	from	2015	to	2021	collected	from	the	Health	Information	Platform	of	Yinzhou	Suspected	SLE	cases	in	local	residents	were	identified	by	fuzzy	matching	of	International	Classification	of	Diseases	10th	edition	code	M32	or	Chinese	text	lupus	The	classification	criteria	from	Systemic	Lupus	International	Collaboration	Clinics-2012	and	The	European	League	Against	Rheumatism	American	College	of	Rheumatology-2019	were	used	for	case	verification	SLE	cases	were	identified	with	specific	algorithm	based	on	verification	results	and	new	cases	were	identified	with	1	year	as	the	washout	period	The	incidence	density	and	95	CI	were	estimated	by	Poisson	distribution	Results	From	2016	to	2021	a	total	of	1	551	921	permanent	residents	were	registered	in	Yinzhou	in	whom	51	52	were	women	The	M	Q1	Q3	age	at	enrollment	was	40	38	27	54	53	54	years	The	M	Q1	Q3	of	follow-up	person-years	was	3	83	0	41	5	83	years	There	were	451	new	SLE	cases	in	which	352	were	women	78	05	The	6-year	incidence	density	was	8	14	100	000	person-years	95	CI	7	41	100	000	person-years-8	93	100	000	person-years	for	the	total	population	3	68	100	000	person-years	95	CI	2	99	100	000	person-years-4	48	100	000	person-years	for	men	and	12	37	100	000	person-years	95	CI	11	11	100	000	person-years-	13	73	100	000	person-years	for	women	The	incidence	density	in	men	appeared	a	small	peak	at	20-29	years	old	and	began	to	increase	with	age	from	40	years	old	The	incidence	density	in	women	was	highest	in	age	group	20-29	years	16	57	100	000	person-years	and	remained	to	be	high	until	30-79	years	old	The	incidence	density	of	SLE	in	Yinzhou	show	no	significant	temporal	trend	from	2016	to	2021	men	P	0	848	women	P	1	000	Conclusions	The	incidence	density	of	SLE	in	Yinzhou	from	2016	to	2021	was	similar	to	those	of	other	areas	in	China	SLE	has	a	high	incidence	in	women	especially	in	the	young	and	elderly	suggesting	that	more	attention	should	be	paid	to	the	diagnosis	and	treatment	of	SLE	in	women
Systemic	lupus	erythematosus	SLE	is	a	clinically	and	biologically	heterogeneous	autoimmune	disease	We	explored	whether	the	deconvolution	of	whole	blood	transcriptomic	data	could	identify	differences	in	predicted	immune	cell	frequency	between	active	SLE	patients	and	whether	these	differences	are	associated	with	clinical	features	and	or	medication	use
Systemic	lupus	erythematosus	SLE	is	an	autoimmune	disease	caused	by	many	polyclonal	autoantibodies	and	characterized	by	numerous	comorbid	lesions	of	internal	organs	and	systems	Research	with	respect	to	the	role	of	various	infectious	agents	in	the	development	and	course	of	SLE	and	primarily	the	role	of	cytomegalovirus	CMV	and	Epstein-Barr	virus	EBV	is	ongoing	It	is	important	to	find	out	whether	patients	with	SLE	are	infected	with	CMV	and	EBV	since	the	clinical	manifestations	of	SLE	and	active	viral	infection	are	similar	Aim	-	to	find	out	the	infection	of	SLE	patients	with	CMV	and	EBV	The	study	included	115	patients	with	SLE	among	whom	women	of	working	age	predominated	The	study	was	conducted	in	three	stages	to	find	out	CMV	infection	to	detect	EBV	infection	to	determine	the	simultaneous	infection	of	SLE	patients	with	CMV	and	EBV	and	in	particular	their	active	phases	The	actual	material	was	processed	on	a	personal	computer	in	Excel	Microsoft	and	IBM	SPSS	Statistics	using	descriptive	statistics	It	was	found	that	the	serum	of	the	vast	majority	of	SLE	patients	has	specific	antibodies	to	CMV	and	only	three	have	no	antibodies	to	the	virus	IgM	antibodies	to	CMV	were	detected	in	22	61	of	patients	which	may	indicate	an	active	phase	of	infection	Most	often	the	CMV	seroprofile	was	detected	as	a	combination	of	IgG	and	IgM	-	74	78	among	patients	with	SLE	It	was	established	that	the	absolute	majority	of	SLE	patients	are	infected	with	EBV	98	26	Active	EBV	infection	was	found	in	15	65	of	SLE	patients	and	chronic	persistent	-	in	53	91	Most	often	53	91	there	are	SLE	patients	with	a	seroprofile	in	the	combination	of	EBV	IgG	to	NA	IgG	to	EA	VCA	IgM	-	Most	often	41	74	SLE	patients	had	a	combination	of	laboratory	markers	of	viral	infection	in	the	form	of	seroprofile	CMV	IgG	IgM	-	EBV	IgG	to	EA	IgG	to	NA	IgM	to	VCA	-	The	active	phase	of	CMV	and	or	EBV	infection	was	present	in	32	17	of	SLE	patients	of	which	16	52	had	only	active	CMV	infection	9	57	-	only	active	EBV	infection	and	6	09	-	a	combination	of	active	CMV	and	EBV	infections	which	indicates	that	more	than	a	third	of	SLE	patients	have	active	CMV	and	or	EBV	infections	which	can	affect	the	clinical	manifestations	of	the	disease	and	require	specific	treatment	tactics	Almost	all	patients	with	SLE	are	infected	with	CMV	among	whom	22	61	of	patients	have	active	infection	The	absolute	majority	of	SLE	patients	are	infected	with	EBV	of	which	15	65	had	an	active	infection	Most	often	SLE	patients	had	a	combination	of	laboratory	markers	of	infection	in	the	form	of	seroprofile	CMV	IgG	IgM	-	EBV	IgG	to	EA	IgG	to	NA	IgM	to	VCA	-	The	active	phase	of	CMV	and	or	EBV	infection	was	present	in	32	17	of	patients	with	SLE	of	which	16	52	had	only	active	CMV	infection	9	57	only	active	EBV	infection	and	6	09	-	a	combination	of	active	CMV	and	EBV	infections
To	combine	targeted	transcriptomic	and	proteomic	data	in	an	unsupervised	hierarchical	clustering	method	to	stratify	patients	with	childhood-onset	SLE	cSLE	into	similar	biological	phenotypes	and	study	the	immunological	cellular	landscape	that	characterises	the	clusters
Purtscher-like	retinopathy	an	occlusive	microvasculopathy	is	a	rare	and	severe	ophthalmic	complication	of	systemic	lupus	erythematosus	SLE	characterized	by	a	sudden	loss	of	vision	with	retinal	whitening	cotton	wool	spots	and	minimal	intraretinal	hemorrhage	Recovery	in	visual	acuity	is	usually	poor	even	with	prompt	treatment	This	case	showed	a	patient	with	SLE	concurrent	Purtscher-like	retinopathy	treated	with	rituximab	and	interleukin-2	IL-2	with	good	prognosis	A	16-year-old	female	with	a	2-year	history	of	SLE	was	admitted	because	of	unrelieved	disease	activity	of	SLE	when	treated	with	a	high	dose	of	corticosteroids	and	immunosuppressants	and	she	further	suffered	from	reduced	visual	acuity	in	both	eyes	She	was	diagnosed	with	Purtscher-like	retinopathy	secondary	to	SLE	after	ocular	examination	Rituximab	and	low-dose	IL-2	for	systemic	treatment	and	intravitreal	injection	of	anti-vascular	endothelial	growth	factor	antibody	to	right	eye	were	given	The	SLE	disease	was	completely	relieved	with	the	sight	recovering	and	no	recurrence	of	Purtscher-like	retinopathy	was	reported	during	6-year	follow-up	Purtscher-like	retinopathy	associated	with	SLE	should	be	treated	early	and	promptly	Rituximab	should	be	considered	in	SLE	patients	with	Purtscher-like	retinopathy	who	have	an	incomplete	response	to	initial	immunosuppressive	therapy	and	low-dose	IL-2	may	help	induction	of	clinical	remission
